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This thesis aims to investigate the acoustic properties of ultrasound contrast agents 
(UCAs) at high ultrasound frequencies. In recent years, there has been increasing 
development in the use of high frequency ultrasound in the fields of preclinical, 
intravascular, ophthalmology and superficial tissue imaging. Although research 
studying the acoustic response of UCAs at low diagnostic ultrasonic frequencies has 
been well documented, quantitative information on the acoustical properties of UCAs 
at high ultrasonic frequencies is limited.  
 
In this thesis, acoustical characterisation of three UCAs was performed using a 
preclinical ultrasound scanner (Vevo 770, VisualSonics Inc., Canada).  Initially the 
acoustical characterisation of five high frequency transducers was measured using a 
membrane hydrophone with an active element of 0.2 mm in diameter to quantify the 
transmitting frequencies, pressures and spatial beam profiles of each of the 
transducers.  Using these transducers and development of appropriate software, high 
frequency acoustical characterisation (speed and attenuation) of an agar-based tissue 
mimicking material (TMM) was performed using a broadb nd substitution 
technique.  The results from this study showed thate acoustical attenuation of 
TMM varied nonlinearly with frequency and the speed of sound was approximately 
constant 1548m·s-1 in the frequency range 12-47MHz.  
 
The acoustical properties of three commercially avail ble lipid encapsulated UCAs 
including two clinical UCAs Definity (Lantheus Medical Imaging, USA) and 
SonoVue (Bracco, Italy) and one preclinical UCAs MicroMarker (untargeted) 
(VisualSonics, Canada) were studied using the software and techniques developed 
for TMM characterisation. Attenuation, contrast-to-tissue ratio (CTR) and 
subharmonic to fundamental ratio were measured at low acoustic pressures. The 
results showed that large off-resonance and resonant MBs predominantly contributed 
to the fundamental response and MBs which resonated  half of the driven 
 
 II  
frequency predominantly contributed to subharmonic response. The effect of needle 
gauge, temperature and injection rate on the size distribution and acoustic properties 
of Definity and SonoVue was measured and was found to have significant impacts. 
 
Acoustic characterisations of both TMM and UCAs in this thesis extend our 
understanding from low frequency to high frequency ultrasound and will enable the 
further development of ultrasound imaging techniques and UCAs design specifically 
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Introduction to high frequency ultrasound and 




Clinical diagnostic scanning usually occurs in the fr quency range of 2-15 MHz 
(Hoskins 2002). The range of applications of high frequency ultrasound (>20MHz) 
in life sciences has been increasing in recent years, specifically in the emerging fields 
of preclinical imaging (Foster et al. 2000, Goertz e  al. 2005, Maruvada et al. 2000), 
intravascular ultrasound imaging (IVUS) (Rhee 2007), superficial tissue imaging 
(Vogt et al. 2007) and ophthalmology (Silverman et al. 2008). The research of high 
frequency ultrasound starts from the manufacture and assessment of high frequency 
transducers (Sprague et al. 2011) and ultrasound systems (Foster et al. 2011). 
Ultrasound contrast agents (UCAs) are specifically useful in preclinical research for 
functional imaging of the microcirculation (Foster t al. 2011, Goertz et al. 2005, 
Needles et al. 2011). This PhD project aims to investigate the acoustic 
characterisation of lipid encapsulated UCAs over th high frequency range from 12 
to 43 MHz using a preclinical ultrasound scanner (Vevo 770, VisualSonics Inc., 
Canada). In this chapter, the background of ultrasound and UCAs are reviewed 
mainly focusing on the principle, application and acoustic properties. 
1.2 ULTRASOUND 
1.2.1 Principles of ultrasound  
Ultrasound is the transmission of mechanical vibraton hrough a medium (gas, liquid 
or solid) with a frequency greater than the upper limit of human hearing 20 kHz 
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(McDicken 1991).  In medical applications, ultrasound is often used to produce 
images of human tissue, which mainly comes from three aspects: (1) the reflection 
and refraction of the ultrasonic waves at large boundaries, (2) the scatter of the 
ultrasound wave from small particles, (3) the sound absorption by the bio-tissue 
(Hoskins 2002).  
1.2.2 Properties of ultrasound transducer 
Ultrasound transducer refers to the device manufactred of piezoelectric material that 
is capable of converting the energy between sound wave and electronic signal 
(Zagzebski 1996). An array transducer is most commonly used in clinical ultrasound 
due to the advantage in temporal resolution, adjustable focal length and bandwidth 
(Hoskins et al. 2010), although a single element transducer may be used in special 
applications, e.g., ophthalmology (Silverman 2009) and in research like studies of 
this thesis. Types of array transducers include linar-, curvilinear, phased- and 
annular- array, classified by the assembled shape of piezoelectric elements. Except 
annular array, all the other three types of transducer enable electronic beam steering 
across the imaging field without mechanical movement of the transducer (Zagzebski 
1996).  
1.2.3 Applications of ultrasound 
Compared with other non-invasive medical imaging techniques in clinical diagnosis 
(e.g., computed tomography (CT), positron emission t mography (PET) and 
magnetic resonance imaging (MRI)), the popularity of ultrasound arises from its cost 
effective, portable advantage, providing high resoluti n and real-time images and 
most importantly the lack of ionizing radiation (Kips et al. 2008). Table 1.1 
summaries the penetration and resolution of the discussed modalities. In addition to 
imaging, ultrasound can also be used in therapeutic medical tool and mainly applies 




Table 1. 1: Parameters of various clinical imaging modalities (Dobrucki and 
Sinusas 2005)  
 
Modality Penetration Spatial resolution Temporal resolution 
Ultrasound mm-cm 50-500 µm real time 
CT No limit 50-200 µm min 
PET No limit 1-2 mm 10s-min 
MRI No limit 25-100 µm min-hrs 
 
 
1.2.3.1 The principal of imaging modes and techniqu es  
 
Ultrasound imaging is widely used in medical diagnosis, such as cardiology, 
obstetrics, gynecology and abdominal imaging (Ali et al. 2008).  It is predominantly 
a pulse-echo technique which is used in ultrasound imaging technique (Fish 1990). 
The speed of sound varies as it travels through different media. Media have an 
acoustic impedance that is equal to the product of the velocity and density of the 
material. The impedance mismatch between two adjacent m dia through which the 
sound propagates leads to the difference in amplitude of the reflected echoes. The 
amplitude of the echo determines the brightness of the pulse displayed on the screen. 
The distance between the reflection or scatter intefac s is determined by the time of 
arrival of the echoes from these interfaces to the scanner, assuming a speed of sound 
in soft tissue of 1540 m·s-1. Pulse-echo imaging basically functions in two modes: B-
mode and M-mode.  
 
Brightness modulation (B-mode) is the most commonly used ultrasound imaging 
mode. Two dimensional greyscale images in B-mode are generated by ultrasound 
beam scanning through the tissue. The brightness of each spot on the image indicates 
the amplitude of the echo and the position calculated from the time of arrival of the 
returning echo. Motion mode (M-mode) is primarily designed to show the rapid 
motion of heart valves or vessel wall along one ultrasound line. The sweeping lines 
indicating the movement of all the points at various depths down one scan line as a 
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function of time. Due to fixing on only one scanning line, M-mode improves the 
temporal resolution and hence is particularly useful in visualising fast-moving 
structures such as heart valves.  
 
Doppler mode is used to display blood velocity within a pre-selected sample 
volume. The velocity is calculated using the Doppler effect, which calculates the 
shift in the observed frequency of a wave resulting from the motion of the wave 
source or scatterer (McDicken 1991). The mathematical expression of Doppler 
principle is: 






θ=                                                    (1.1) 
 
where Df  is the Doppler shift. 0f  and care the frequency and speed of the incident 
ultrasonic wave. θ  is the angle between the testing object (e.g., vessels) and the 
insonating ultrasound beam, v is the moving speed of the object, for example the 
velocity of blood fluid. Thus by measuring the Doppler shift, the velocity and the 
direction of the reflector or scatterer are monitored.  Pulsed-wave (PW) Doppler, 
Colour Doppler and Power Doppler are three common used modes in a clinical 
ultrasound scanner. 
 
PW Doppler ultrasound is used to depict the movement of blood within the
selected sample volume – usually positioned within a blood vessel. The Doppler 
sample volume is aligned along the length of the vessel enabling the velocity of 
blood to be calculated using equation 1.1. On the graphic display of the PW-Doppler 
mode, there is a baseline indicating that there is no blood flow. If the fluid is moving 
away from the transducer, then there is a negative frequency shift and a positive 
frequency shift if blood moving towards transducer. Colour Doppler echoes are 
displayed with colours rather than grey scale brightness. The colours depict local 
flow in the x-y plane by estimating the mean Doppler frequency shift at a particular 
position. The brightness of the colour represents the intensity of the echoes 
(Martinoli et al. 1998).  Power Doppler depicts the amplitude or power of Doppler 
signals rather than the frequency shift. The power is determined by the amount of 
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flow present and leads to advantages including: higher sensitivity to flow and better 
edge definition of the smaller vessels, but at the expense of directional and velocity 
information (Martinoli et al. 1998).  
 
Ultrasonic elastographic technique measures the Young’s modulus of tissue to 
help diagnose the lesion and tumour in the tissue as the malignant tumour is 
generally stiffer than the benign tissue (Ophir et al. 2002).  Two underlying 
ultrasound approaches are generally used to measure the Young’s modulus, E 
(Hoskins et al. 2010). The first method is strain technique, i.e., static method, 
E=stress/strain, where strain, the change in dimension of tissue (equal to the relative 
displacement dividing the original length) is measured after applying a known force, 
stress equals the quotient of the force and the cross-sectional area. The second 
method is shear-wave technique, i.e., dynamic method, E=3ρCs2, ρ is the density, Cs 
is the measured speed of the shear wave after inducing shear waves in tissue. 
 
1.2.3.2 Therapeutic ultrasound 
 
Therapeutic ultrasound has been studied in the fields of physiotherapy (mainly in 
treating soft tissue injuries, accelerating wound healing and softening scar tissue), 
bone healing (mainly use low intensity ultrasound to enhance bone repair rate and 
reduce healing times), enhancement of drug/gene uptake (mainly in raising the 
penetration of pharmacologically active drugs through the skin/ increasing the 
transfer rate of genes to diseased tissues and organs) and High Intensity Focused 
ultrasound (HIFU)  (ter Haar 2007).  Among these ultrasound therapies, HIFU is a 
surgical tool by using high intensity focused ultrasound on diseased tissue (Kennedy 
2005) and it is rapidly gaining clinical acceptance (ter Haar 2008). Compared with 
the low intensities (~0.1 W·cm-2) used in common ultrasound imaging, the high 
intensities applied in HIFU are up to 1000 W·cm-2 and show thermal ablation 
(coagulative necrosis) in the focal volume without damaging the surrounding tissue 
(ter Haar 2008). With the guidance of ultrasound or MRI, HIFU has been used 
clinically in treating uterine fibroids, the cancer of liver, kidney, breast, bladder and 
prostate (Kennedy et al. 2003).  
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1.2.4 Measurements of ultrasound parameters 
The acoustic characterisation of ultrasound includes quantification of many 
parameters. In particular the speed of sound, attenua ion and scattering are described 
here because: 1) the accurate knowledge of these parameters directly reflects the 
location of the object and its acoustic signature as discussed in the pulse echo 
imaging (section 1.2.2), 2) they are the parameters to be studied in this thesis. 
The speed of sound c defines as 
 
                                                 ρkc =                                                         (1.2) 
 
where k is stiffness (Pa) of the medium the sound wave propagates, ρ is the density 
(kg·m-3) of the medium. 
 
The attenuation is the reduction in ultrasound intensity as the wave passes through 
the medium. It is caused by absorption, scattering, beam divergence, reflection and 
refraction and increases with frequency (Fish 1990). The attenuation coefficient is 
the intensity decrease per unit path length at a specified frequency and expressed in 
dB·cm-1 (AIUM 1995). 
 
The scattering describes the process in which part of the wave energy is redirected 
and appears separately to the original incident direction when a wave travels through 
a non-uniform medium (Hill 1986). Backscatter coefficient is the mean acoustic 
power backscattered into a unit solid angle per unit inc dent intensity per unit volume 
at a specified frequency and expressed in cm-1·sr-1 (AIUM 1995). 
1.2.5 High frequency ultrasound imaging and charact eristics 
With the development of high frequency ultrasound transducers, the well-established 
clinical imaging techniques can be transferred intoapplication at high frequencies.  
Preclinical imaging is one of the most important applications for studying models of 
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the human disease like cancer (sizing tumour, quantifying tumour blood flow, 
contrast imaging, molecular imaging of angiogenesis) and cardiovascular disease 
(quantifying function of left ventricle, contrast perfusion imaging), and exploring 
developmental biology (evaluation of the development of embryo, role of mother and 
placenta during pregnancy) in small animals (Foster e  al. 2011, Kagadis et al. 2010, 
Moran et al. 2012). 
 
High frequency ultrasound has improved resolution cmpared to low frequency 
ultrasound. Spatial resolution is a parameter for assessing the imaging ability of a 
system by distinguishing closely spaced objects as distinct and visibly separate 
objects (González and Woods 2001). Specifically, the axial resolution/ lateral 
resolution/ elevation (azimuthal) resolution are defined as the smallest separation of a 
pair of targets at the same range on the beam axis/ in the scan plane/in the elevation 
plane (at the right angle of scan plane), which canbe displayed as two separable 
images (Hoskins 2002). Both lateral resolution and elevation resolution approximate 
to half of the beam width (more details discussed in Chapter 2) on the scanning plane 
and elevation plane, respectively (Hoskins et al. 2010).  Axial resolution 
approximates to half the pulse length (Hoskins et al. 2010). 
 
One of the disadvantages of high frequency ultrasound is that the attenuation of the 
ultrasound beam increases and hence sacrifices penetration depth. To estimate the 
frequency dependence of attenuation α(f), a power law function is commonly used to 
fit the typical attenuation data and can be expressed a : 
 
                                                   ( ) nff 0αα =                                                    (1.3) 
0α  and n are the material parameters characteristic of the sample. For tissues, the 
exponent n is generally in the range 1 ≤n ≤ 2. In particular, it was observed that n = 
1.1 to 1.4 for fatty liver, n = 1.5 for spleen in the frequency range of 2-5 MHz 
(Narayana and Ophir 1984). Thus the choice of the transducer requires a balance 
between the depth of the object to be imaged and the resolution of the image quality. 
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1.3 ULTRASOUND CONTRAST AGENTS 
1.3.1 Background and development  
Ultrasonic contrast agents (UCAs) are gas-filled non-toxic microbubbles (MBs) 
designed to significantly enhance the diagnostic information in ultrasound clinical 
scans (Bouakaz and de Jong 2007). The ultrasound scatter from blood without the 
UCAs is much weaker than that from other tissue, typically 30 to 60 dB weaker at 
diagnostic frequencies (2 - 15 MHz) (Hoff 2001). The aim of introducing UCAs is to 
increase the backscatter of the ultrasound from the blood for several minutes and 
enhance the echo strength in grey scale or Doppler (Harvey et al. 2001).  Figure 1.1 
shows an improvement of endocardial definition after contrast administration by 
demonstrating a comparison of a four-chamber view of human heart pre and post 
contrast injection.  
 
                      
Figure 1. 1: Examples of heart images in four-chamber view presenting poor 
endocardial definition at baseline (left panel) and improvement after contrast 
administration (right panel) (Kaufmann et al. 2007). 
 
The early publications of UCAs for medical ultrasound imaging dated back to the 
1960s whereby saline was injected in the supravalvular position to observe the 
echoes from the aortic root and diagnose a defect on the aortic valve (Gramiak and 
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Shah 1968).  Thereafter various classes of UCAs were d veloped such as free and 
encapsulated gas bubbles, colloidal suspensions, emulsions, and aqueous solutions 
(Ophir and Parker 1989). However, considering the instability of the free bubbles, 
toxicity of the colloidal suspensions and low scatter efficiency of emulsions and 
aqueous solutions, encapsulated bubbles proved to be he most promising approach 
for the manufacture of UCAs.  The commercially available UCAs are reconstituted 
as a liquid containing encapsulated MBs with 1–7mµ  in diameter, similar to the size 
of red blood cells (Cosgrove 2006).  
 
Four transpulmonary UCAs are currently approved within European Countries: 
Levovist®, Optison®, SonoVue® and Luminity® (Claudon et al. 2008). Optical 
images of Definity (brand name of Luminity used in US market) after reconstitution 
and dilution are shown in Figure 1.2. The details of these commercial agents are 






              
a. Definity bubble in 40×                     b. Definity bubble in 100× 
Figure 1. 2: Definity observed using an optical microscope (Olympus BH-2) and a 
digital camera system (Leica DC 300F) in a magnification of (a) 40 and (b) 100 
times 
 
The encapsulated bubbles, performing as blood pool tracers, have overcome the 
instability and non-transpulmonary limitation of the free bubbles. By changing the 
surface tension of the MBs, e.g. choosing the type of gas and adjusting the material 
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component, thickness and structure of the shell, the stiffness and flexibility of the 
MBs can be controlled and can therefore influence th ir interaction with the 
ultrasound waves. On one side, the general requirement is to extend the duration of 
MBs in vivo by applying a pliable shell and including a low soluble gas of low 
diffusion, high density and stability. On the other side, fragility of MBs (collapse of 
MBs) and release and dissolution of the gas is helpful in assessment of tissue 
perfusion (Bruce et al. 2004). Additionally, fragility of the MB shell is also important 
for drug and gene delivery because the drug is generally encapsulated within the 
MBs and released after MBs collapse on the targeted tissue (Stride and Saffari 2003). 
Thus, MB composition determines the shell flexibility and fragility, the selection of 
which depends on the choice of application of UCAs. 
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Table 1. 2:  Clinical Ultrasound Contrast Agents licensed in Europe, information gathered from (Bristol-MyersSquibb 2006, Claudon et 




Shell (stiffness) Size 
distribution 
Applications Manufacture In 
production 
Levovist® Air  (H) Galactose and 
palmitic acid as a 
surfactant (L) 











Optison® C3F8 (L) Albumin (H) 
 
95% < 10µm; 
Mean diameter: 
4.5 µm 
Cardiac wall motion studies 
 
GE Healthcare Inc. 
(USA) 
Yes 
SonoVue® SF6 (L) Phospholipids (L) 
 




Cardiac (endocardial border delineation), 
macrovascular (characterisation of focal 


















1.3.2 Physics interactions of MBs with ultrasound w aves 
It has been shown that the magnitude of the peak negativ  pressure, which is 
incorporated in the Mechanical Index (MI), strongly influences MBs behaviour 
(Correas et al. 2001, Whittingham 2007). Since the degree of MB oscillation also 
depends on the properties of the MB itself, such as the shell characteristics, gas 
contained, size and concentration (Hoff 2001), the MI values should not be 
considered as definite thresholds but only as relativ  references. 
 
The Thermal Index (TI) and Mechanical Index (MI) are standard indices for real-
time display of mechanical and thermal acoustic output on diagnostic ultrasound 
equipment, which are used to quantify ultrasound bio-effects and safety.  These 
indices were first prepared by the American Institute of Ultrasound in Medicine 
(AIUM) and National Electrical Manufacturers Association (NEMA) (Patton et al. 
1994). TI is defined as the ratio of the total acoustic power to the power used to 
increase the temperature of tissue by 1°C under assumptions which relate with a 
simple tissue model and beam shapes (Duck et al. 1998). TI provides an estimate of 
the average increase in temperature that may occur in the region of the ultrasound 
scan and is generally displayed in three forms: TI for soft tissue (TIS), TI for bone 
(TIB) and TI for cranial bone (TIC)(BMUS 2009). MI is implemented as a safety 
parameter on ultrasound scanners to evaluate non-thermal ultrasonic bio-effects and 
is defined in Equation 1.4 (Apfel and Holland 1991)   
 





=MI                                                              (1. 4) 
 
where =raP peak rarefractional pressure (MPa), =cnf  transmitting central frequency 
(MHz). As an example, Table 1.3 listed the recommended MI and TI for general 





Table 1. 3: Recommended MI, TI and exposure time for general abdominal and 
peripheral vascular applications, √ symbolizes no scanning times restricted, MI=0.3-
0.7, there is a risk of capillary bleeding (BMUS 2009).  
 
Thermal Index value Mechanical Index value 
0 - 1.0 > 1.0 0 - 0.3 > 0.7 
√ Restrict time to 
1.0<TIB≤1.5 : 120 min 
1.5<TIB≤2.0 : 60 min 
2.0<TIB≤2.5 : 15 min 
2.5<TIB≤3.0 : 4 min 
3.0<TIB≤4.0 : 1 min 
4.0<TIB≤5.0 : 15 sec 
5.0<TIB≤6.0 : 5 sec 
TIB>6: not 
recommended  
√ Risk of cavitation 
with UCAs 
 
The dynamic motion of MBs varies with the local acoustic field shown in Figure 1.3. 
 
                    
 
Figure 1. 3: Response of MBs with MI range in the frequency range 1-9 MHz in 
response to a pressure range from 0.1 to 3MPa (Correas et al. 2001, Harvey et al. 
2000) 
Weak non-destructive nonlinear response 
Non-destructive nonlinear response 




At low MI value (<0.1), MBs respond with linear oscillation (equal expansion and 
contraction) (Burns and Becher 2000) shown in Figure1.4.a. MBs act as efficient 
scatterers due to the large difference in impedance between the gas contained and the 
medium in which the MBs are suspended and also due to the bubbles oscillating in 
the acoustic field (Quaia 2007). Low MI imaging is appropriate for Doppler 
applications as well as for real-time contrast imaging because MBs experience a long 
lifetime (Correas et al. 2001).  
 
In a non-destructive oscillating process when resonance occurs, MBs begin to 
oscillate at the same frequency as the insonation frequency and the acoustic pressure 
response producing maximum signal enhancement. The resonant frequency can be 
approximately calculated by Equation 1.5 (Ophir and Parker 1989). The derivation of 
this equation adapts a linear theory of harmonic osillators by assuming bubbles 
oscillate with small amplitude without considering the damping terms. 
 












f =                                                       (1.5) 
 
where =0f  resonant frequency, =a bubble radius, =0P  the ambient fluid pressure, 
=0ρ  density, =γ  adiabatic ideal gas constant. The predominant resonance 
frequency of clinical MBs occurs within the clinical frequency range 1-20MHz 






     
                      
              (a) Linear response                               (b) Nonlinear response 
 
Figure 1. 4: Diagram of the size variation of MBs with different i sonation pressure 
(a) linear response of MB at low pressure, (b) asymmetry oscillation and nonlinear 
response of MB in response to high insonation pressu (Quaia 2007). 
 
When the MI increases, the pulsation of the MBs becomes nonlinear resulting in 
non-linear signal propagation. Figure 1.4.b illustrates the nonlinear oscillation of 
MBs. Their expansion during the negative cycle of the pressure exceeds the 
contraction during the positive part. At these pressures the nonlinear response at 
harmonic frequencies are different to that of the incident wave (fundamental 
frequency), the frequencies of which include the subharmonic (half of the 
fundamental frequency),  ultraharmonic (1.5 times of the fundamental frequency), 
second harmonic and higher harmonics (Correas et al. 2001).  
 
Using high MI (>1) values leads to the destruction of MBs (Whittingham 2007). The 
shell is broken and the gas rapidly diffuses into the surrounding medium. The sudden 
collapse of MBs produces a transient response, known as stimulated acoustic 
emission (SAE). SAE is a short-lived phenomenon due to the dissolution of the gas, 
but it provides the most sensitive detection of UCAs particularly when coupled with 
colour or power Doppler (Correas et al. 2001). Other applications of these 
characteristics of MBs are described in section 1.3.6. 
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1.3.3 Overview of MBs phenomena  
Dynamic behaviour of encapsulated MBs has been summarized and categorized by 
Postema (Postema et al. 2004). There are a number of MB phenomena that have been 
observed by ultra-high speed cameras: oscillation, translation, coalescence and 
bounce, fragmentation, sonic cracking and jetting. Oscillation is the alternate 
expanding and contracting bubble response to an acousti  pulse. At low driving 
pressures, bubbles pulsate moderately. When acousti amplitude increases, inertial 
(transient) cavitation occurs: a longer expansion phase of the MBs which is followed 
by a rapid contraction (collapse) (Postema 2004).  MB translation has been attributed 
to primary and secondary radiation acoustic forces, the former of which is due to the 
pressure gradient across the bubble surface and the latter of which is due to the 
varying pressure fields generated by oscillating bubbles.  When MBs translate 
towards each other, two or more bubbles can fuse.  This phenomenon is named 
coalescence. If coalescence does not occur, the bubbles appear to effectively bounce 
off one another (Postema et al. 2004). Coalescence is mainly caused by the attracting 
molecular force (Van der Waals force) between the adjacent bubbles when they 
become close and thin shell surface of expanding bubble reaches a thickness 
threshold around 0.1µm at which point the two shells of bubbles merge to form a 
larger bubble (Duineveld 1997).  Fragmentation is the fission of MBs into smaller 
bubbles. Sonic cracking is the process of gas escaping from MBs because of the 
ultrasound wave causing shell defects.  Jetting is the asymmetrical collapse of a 
microbubble near a boundary resulting in a high speed j t projected through the 
bubble towards the boundary (Barnett 1998). The therapeutic potentials of these 
phenomena in drug and gene delivery have been considered (Postema et al. 2004) 
and discussed in section 1.3.6. 
1.3.4 Theoretical modelling of UCAs 
The behaviour of MBs when insonated by ultrasound can be investigated through 
two main tools: theoretical modelling and experiments.  The theoretical modelling 
tool for studying MBs can be catalogued into two approaches (Leighton and 
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Dumbrell 2004): 1) a study of empirical acoustic scattering cross-sections, 2) 
dynamics of single MBs.  
 
Acoustic scattering is a diffuse reflection as opposed to specular reflection. 
Scattering of ultrasound occurs when waves propagate through a non-uniform 
medium and part of the energy is forced to deviate from its original trajectory (Hill 
1986). It is a function of the scattering cross-sectionσ . The average diameter of the 
UCAs is less than the capillary diameter 7 µm and thus the UCAs are much smaller 
than the wavelength of the high frequency ultrasound (e.g., frequency = 30 MHz, 
wavelength = 51 µm), not to mention the wavelength (200 µm -500µm) of the 
diagnostic ultrasound (assuming speed of sound is 1540 m·s-1). Thus, scattering from 
UCAs can be explained using Rayleigh scattering theory. Rayleigh scattering 
describes a linear scatterer (when MB driven at low pressure), the size of which is 
much smaller than the incident ultrasound pulse wavelength, σ  is defined as (Morse 
and Ingard 1986): 
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where R is the radius of the scatterer (<< λ), λ is the wavelength, k=2π/λ is the 
wavenumber, sκ  and κ  are the compressibility of the scatterer and the surrounding 
medium, sρ  and ρ  are the density of the scatterer and the surrounding medium.  AR 
is the amplitude term, 2kγ is the compressibility term and 
2
pγ  is the density term. 
 
The advantage of the first type of theoretical modelling tool is that it is simple to 
apply and the simulation of the scattering cross section can be directly related to the 
measurement of MB population. However, this class provides limited information of 





The second type of studies the dynamic oscillation of single bubble based on the 
previous models. Rayleigh-Plesset-Noltingk-Neppiras-Poritsky (RPNNP) model 
(Leighton 1997) (Equation 1.7) is the basic motion equation for simulating UCAs 
and describing the radical oscillation of a free bub le in a viscous and incompressible 
fluid. 
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Parameters of MB:  
R is the instantaneous radius of MB, R& =dR/dt is the speed of MB wall, R&& = d2R/dt2, 




(P0 – Pv + 2σ/R0) is the pressure of the gas in the MB at equilibrium status, P0 is the 
hydrostatic pressure at rest, Pv is the vapour pressure in the MB, 2σ/R0 is the Laplace 
pressure and σ is the surface tension, P(t) is the driving pressure. 
 
Parameters of liquid:  
ηL is the dynamic viscosity, ρL is the density. 
 
In addition to the RPNNP equation, other motion models e.g., Herring, Trilling, 
Keller-Miksis equations were developed with consideration of the radiation damping 
(caused by compressive liquid) and thermal damping (caused by thermal conduction 
between the gas and liquid) (Doinikov and Bouakaz 2011). 
 
Based on the RPNNP model, models for encapsulation of the MBs were explored 
using two methods (Doinikov and Bouakaz 2011): 1) adding phenomenological 
terms of empirical observations or ad hoc assumptions from encapsulated bubbles to 
RPNNP equation (e.g., de Jong model) and 2) rigorous derivation from RPNNP 




Solving these differential equations yields the bubble radius as a function of time. 
The scattered pressure P(r) at distance r can be calculated using Equation 1.8 
(Vokurka 1985), 
                                          ( ) ( )22RRR
r
R
rP &&& += ρ                                                    (1.8) 
where ρ is the density of the liquid, R is the radius of the MBs, R& = dR/dt is the 
speed of MB wall, R&& = d2R/dt2. 
1.3.5 Experimental study of UCAs  
Optical and acoustic methods are the two main experimental tools to study UCAs. 
Results obtained from these experimental methods can be inserted into theoretical 
models, such as Equation 1.7, and can be used to inform the model optimizations of 
single bubbles.  
 
Optical experiments using high-speed camera capture the radial oscillation of 
individual MBs and the acoustic and frequency respon e can be calculated. Two such 
systems were built: Brandaris128 in Erasmus MC (Chin et al. 2003) and the other in 
the Centre for Ultrasound Molecular Imaging and Therap utics, University of 
Pittsburgh (Chen et al. 2012). Based on a design of rotating mirror camera, both 
systems have a maximal frame rate of 25 Mega-frames per econd and can save 128 
frames in a single run, while the camera in Pittsburgh shows a higher resolution 
(1392×1040 pixels) than the one in Erasmus (500×292 pixels). 
 
The limitation of the theoretical models and the corresponding experimental results 
are that only the wall dynamics and the radiated pressure field of bubble are 
calculated and no key propagation characteristics e.g., speed of sound, backscatter 
and attenuation are determined. From the description of pulse echo imaging, the 
travel time of the received signals depends on the accurate knowledge of the speed of 
sound through the medium through which the ultrasound wave is travelling. The 
interpretation of the amplitude of the received signal is compromised without the 
correct information of attenuation (Leighton and Dumbrell 2004). Acoustic 
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backscatter measurement is a direct measurement of the efficiency of the UCAs to 
scatter ultrasound back to the transducer (Hoff 2001). 
 
The physical properties of the MBs and their response to ultrasound are not fully 
understood and still attract continuing research. These properties are generally 
divided into three aspects (Sboros 2008): the effect of the ultrasonic pulse 
(frequency, phase, acoustic pressure, pulse duration), the MB composition (shell, 
gas, MBs dispersions), and the MBs environment (the liquid environment, the 
presence of a wall, tube and other MBs). All these factors impact the oscillation of 
the MBs, and further determine their scattering and effectiveness for contrast 
enhanced imaging. The published work does not present a comprehensive description 
of the behaviour of MBs in the ultrasound field due to the usage of varying UCAs 
(both in-house and commercial compositions) under varied experimental conditions. 
This thesis is predominantly experimental and focuses on the bulk acoustic 
characterisation of UCAs. 
1.3.6 Techniques and applications of UCAs  
1.3.6.1 Techniques of contrast imaging 
 
It is assumed that after injection of UCAs, the MBs mix freely with the blood and 
thus highlight the presence of blood within the body. The key to enhancing the signal 
to noise of the contrast-enhanced image is to separate the signal from UCAs and the 
surrounding tissue to study the blood flow pattern of the lesion. The techniques 
behind contrast applications are generally classified based on the pulse transmission 
and signal processing (Quaia 2007) and can be categoriz d under two mechanisms: 
1) at low insonation pressure, the nonlinear respone from MB oscillations without 
destruction; 2) at high pressure, the nonlinear respon e from the disruption of MBs 
(Claudon et al. 2008). The second technique also known as high MI imaging or 
intermittent imaging or stimulated acoustic emission is generally applied in perfusion 
studies (Hoskins et al. 2010). It used high power multi-pulses to disrupt MBs then 
observed the subsequent refilling of MBs in tissue under low MI values (Chomas et 
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al. 2001). As an example of perfusion, Figure 1.5 shows a variation in backscatter 
signal in a selected ROI within the myocardium after infusion of SonoVue using a 
pulse-inversion imaging technique.  The principle of pulse-inversion technique is 
shown in Figure 1.7.  The sharp decline in amplitude represents the disruption of 
microbubbles after a high MI insonation. The following curve shows the reperfusion 
of the microbubbles under a low MI value and its oscillatory variation represents the 
movement of the heart. 
 
Figure 1. 5: Example of clinical contrast perfusion study of apical two-chamber view 
of left ventricle. Image courtesy of Dr Stephen Glen, Sterling Royal Infirmary, 
Scotland. 
 
More imaging techniques focus on the nonlinear prope ties of MBs when insonated 
using non-destructive low-pressure ultrasound pulses. Table 1.4 lists the typical 
methods of grey scale imaging of contrast microbubbles employed by ultrasound 
researchers. Although contrast has been used to rescue failed Doppler examinations 
in detecting renal arteries and hepatic arteries (Leen 2001, Sidhu et al. 2006), 
methods for Doppler imaging are not included due to the limitations in blooming 
artefact (an artefact caused by the abnormal increase in flow signal strength 
displaying as the grey signal changing to colour in the region of no significant blood 




Second harmonic imaging utilises the nonlinear prope ties of the MBs at higher 
insonating pressure (0.1<MI<0.5 (Correas et al. 2001)) and multi-cycle pulse (Qin et 
al. 2009) to separate the blood signal from the surrounding tissue (de Jong et al. 
2000). However, with increasing insonating pressure th  second harmonic 
component of tissue increases accordingly. The tissue harmonic signal is caused by 
the nonlinear propagation of the sound wave through tissue in terms of the distortion 
of the waveform. Specifically, the compression part of he signal becomes tall and 
narrow while the rarefaction part becomes short and wide shown in Figure 1.6 (Duck 
2002). The distorted compression part of the wave is in response to the harmonic 
components in the spectrum (Hoskins et al. 2010). Subharmonic imaging is 
introduced since the subharmonic component is a unique property of MBs, i.e., tissue 
does not generate subharmonics, but compromises resolution especially in the 
clinical frequency range (de Jong et al. 2000). More detailed description of the 
generation of subharmonics is given in Chapter 6. 
 
Table 1. 4:  Summary of non-destructive contrast ultrasound techniques (Quaia 
2007).  Micro-flow imaging is used to observe the slow perfusion within an organ by 












- 2nd harmonic 
- Subharmonic  



















                                   (a) 
                                   (b) 
Figure 1. 6: An example of nonlinear propagation of 2.25 MHz pulse through water 
(a) the waveform at the transducer and (b) the distorted waveform after propagating 
0.6m (Humphrey 2000). 
 
Pulse inversion technique shown in Figure 1.7 is a typical phase modulation method 
in which two successive pulses of opposite phase at low pressure are transmitted and 
the two received signals are summed. At low pressur, the linearity of the tissue 
leads to the cancellation of the two signals whereas the nonlinear components from 




Figure 1. 7: Basic principle of pulse inversion imaging (Burns et al. 2000) 
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Similarly using the linearity of the tissue and the nonlinear response of MBs to 
ultrasound at low pressure, other modulations like amplitude or a combination of 
phase and amplitude modulation (Cadence contrast pul e sequencing shown in 
Figure 1.8) improve the sensitivity of detection of MBs (Quaia and Whittingham 
2005). Chirp excitation represents one type of coded transmission pulses which 
improves the signal to noise ratio and increases th sensitivity at low transmission 
amplitude (Quaia and Whittingham 2005). This method transmits a chirp signal 
(frequency and amplitude of the signal varied with t me) and employs a matched 
filter as a reference signal to compare and integra with the received signals, the 






Figure 1. 8: Basic principle of Cadence contrast pulse sequencing (Quaia and 
Whittingham 2005), (a) the transmitting three pulses include two pulses for which the 
amplitude is half of the other one with inverse phase, the sum of the resultant pulses 
through (b) a linear system, and through (c) and (d) a nonlinear system in terms of  






1.3.6.2 Applications of imaging 
 
UCAs for medical imaging has been applied in the fields of heart (Edler and 
Lindström 2004), liver (Leen et al. 2006), kidney (Bertolotto et al. 2008), pancreas 
(Badea et al. 2009), blunt abdominal trauma (Catalano et al. 2009). 
Recommendations on clinical practice have been reviewed extensively by European 
Federation of Societies for Ultrasound in Medicine and Biology (EFUMB) (Claudon 
et al. 2008, Claudon et al. 2012, Piscaglia et al. 2011). Echocardiography and 
ultrasound of focal liver disease have been reported to evolve most with contrast-





Echocardiography has been routinely used in bedside clinical diagnosis for the  
evaluation of myocardial function, cardiac anatomy and blood flow, because the 
relative blood volume fraction of myocardium primarily consists of capillaries, 
arterioles and venules (Kaufmann et al. 2007). For the patients who have difficulty 
with transthoracic ultrasound imaging due to obesity, recent thoracic surgery and 
lung disease, the evolvement of UCAs improves the sensitivity for microvasculature 
imaging and echocardiography, which is referred as myocardial contrast 
echocardiography (MCE). Left ventricular cavity opacification (LVO) has been 
approved clinically for increasing endocardial border elineation and detecting wall 
motion abnormalities operated at MI (0.4-0.5) (Kaufmann et al. 2007).  
Quantification of myocardial blood volume and flow rate employs the principle of 
perfusion by insonating high MI to disrupt the MBs (Wei et al. 1998). Figure 1.9 
shows an example of a perfusion curve. The plateau of Video intensity (A) of the 
perfusion curve represents the blood volume in the m asured region. The 
replenishing rate (β) of MBs into the microvasculature after the destruction of MBs 









Figure 1. 9: An example of perfusion curve as pulse interval (x axis) versus video 
intensity (y axis), dash line is the model prediction and solid line is the experimental 
observation. The function is used to derive the blood volume A and replenishing rate 




The liver imaging for lesion characterisation is of most advanced areas in the 
development of CEUS (Claudon et al. 2008). The appearance and flow of UCAs 
post-injection follow the blood supply of the liver and this process is divided into 3 
phases: arterial, portal venous (PV) and later phases. Table 1.5 shows the time for 
visualizing these 3 phases, in which arterial phase is for acquiring the vascular 
pattern, PV and late phase is notably important for identifying the property of the 
focal lesion. Hypo-enhancing image is generally rega ded as malignant lesions 
because here the wash out of UCAs is slower than the normal liver tissue shown in 
Figure 1.10. Iso- or hyper-enhancing image is mostly from the benign lesions. Low 
MI technique is recommended for CEUS for liver imaging n the clinical practice. 
More details of characterizing the lesions in response of the phases can be found in 




      
 
Figure 1. 10: Left image with an echogenic liver metastasis (betwe n callipers) 
acquired in fundamental imaging, Right image acquired 1 min 24 secs after bolus 
injection of SonoVue (portal-venous stage).  Images courtesy of Dr Paul Sidhu, 
King’s College Hospital, London, UK. 
 
Table 1. 5: Hepatic vascular phases in CEUS (visualization post injection time) 
(Claudon et al. 2012). The onset of each phase time may vary due to the difference in 
individual global haemo-dynamic situation  
 
Visualization post-injection time (seconds) Phase 
Start End 
Arterial 10 - 20 30 - 45 
Portal-venous (PV) 30 - 45 120 





Another important area of research is in the area of drug and gene delivery and 
targeting of UCAs. Drugs and genes can be incorporated into UCAs by tailoring the 
physical properties of MBs and coating materials (Unger et al. 2001). As vehicles, 
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MBs may load drugs either outside or inside (Unger et al. 2002). Outside, drugs may 
be attached to the membrane surrounding, or imbedded within, the membrane or 
bound non-covalently to the surface of the MBs.  Inside, drugs may enter into the 
MBs or some drugs e.g. hydrophobic drugs can form a oil layer (i.e. film) around 
MBs then the entire is stabilized by a membrane (Unger et al. 2002). Targeted UCAs 
allows attachment of the microbubbles to specific markers of disease by choosing an 
appropriate attachment strategy 1) electrostatic or intrinsic properties of shell 
components (Lindner 2002); 2) ligands (monoclonal antibody, carbohydrate ligand, 
covalent or avidin-biotin pair, long polymer spacer arm between the MB membrane 
and ligand) (Liu et al. 2006). Triggered by ultrasound, the cavitation of MBs releases 
the carried drugs or genes on the targeted site of the lesion and increases the 
permeability of the tissue (known as sonoporation). Preclinical studies have been 
performed using these techniques to improve cancer treatment (Frenkel 2008) and 
thrombolysis (Takeuchi et al. 1999).  
 
The reviews of the fundamental and subharmonic response of UCAs at high 
frequency are included in the introduction section of Chapter 5 and 6, respectively. 
1.4 THESIS OUTLINE 
 
This thesis describes the experimental set-up and methods employed to quantify the 
acoustic characterisation of lipid encapsulated UCAs at high frequencies. The 
structure of thesis is briefly outlined below. 
 
Chapter 1 introduced the background of ultrasound, UCAs and the interaction 
between UCAs and ultrasound.  
 
Chapter 2 describes the acoustic characterisation of the preclinical Vevo770 scanner 
used in this thesis. The pressure in response to the power output, transmitting 
frequency and spatial beam profile of each of the fiv  high frequency transducers are 





Chapter 3 presents the experimental set-up and develops MATLAB codes based on a 
broadband substitution technique to calculate the speed and the attenuation of sound 
in an agar-based tissue mimicking material (TMM) over the frequency range 12-
47MHz.   
 
Chapter 4 studies the acoustical properties of three commercially available lipid 
encapsulated UCAs including two clinical UCAs Definity (Lantheus Medical 
Imaging, USA) and SonoVue (Bracco, Italy) and one preclinical UCA MicroMarker 
(untargeted) (VisualSonics, Canada) using the software and techniques developed for 
TMM characterisation. The attenuation and normalized backscatter power are 
investigated as a function of concentration and pressure, respectively. 
 
Chapter 5 presents the influence of size distribution on the fundamental response 
(attenuation and contrast-to-tissue ratio (CTR)) of the three lipid UCAs (Definity, 
SonoVue and MicroMarker) in the frequency range 12-43 MHz. 
 
Chapter 6 presents the theoretical simulation of single MBs using BUBBLESIM 
toolbox and investigates the influence of incident parameters (pressure, frequency 
and number of cycle) on the subharmonic response of three UCAs (Definity, 
SonoVue and MicroMarker). Incorporating the measured size distribution curve, the 
simulation result is compared with the experimental data of subharmonics of MBs at 
25MHz (transducer 710B).  
 
Chapter 7 investigates the effect of needle gauge, inj ction rate and temperature on 
the size distribution and acoustic properties of Definity and SonoVue in the 
frequency range 17-31 MHz. Statistical comparison is made for the two cases: the in 
vitro (19G needle gauge, 3ml/min injection rate, room temp rature) and in vivo (27G 
and 30G needle gauge, 0.85ml/min injection rate, body temperature). 
 





Characterisation of high frequency ultrasound 
transducers 
 
2.1 AIM  
The aim of this chapter is to characterise the high frequency transducers and to 
discuss the suitable parameter settings for the subsequent experiments. Specifically, 
1) introduce the background of the Vevo 770 scanner a d the procedure of raw data 
acquisition and analysis, 2) plot the beam profile of each transducer, 3) confirm the 
sensitive frequency range of each of the 5 transducers and 4) study the influence of 
the insonation power and pulse length (number of cycles) on the propagation of 
ultrasound through water in the high frequency range. 
2.2 INTRODUCTION 
The Vevo 770 scanner from VisualSonics Inc. is a high resolution, high-frequency 
ultrasound scanner (Figure 2.1).  It operates within e frequency range from 25 to 55 
MHz and supports seven ultrasound imaging modes: B-Mode, M-Mode, 3D-Mode, 
PW (Pulse Wave) Doppler Mode, Tissue Doppler Mode, Power Doppler Mode and 
Digital RF-Mode (VisualSonics 2006). The key advantages are its open architecture 
which allows comprehensive measurement and offline data analysis and an 
additional server connection is available for rapid remote access of files, images and 
measurements, which is beneficial to operator and researcher. The Vevo software 
outputs measurement and data for post-imaging analysis, and also exports image data 
for viewing in other applications, for storage or for use in presentations and 




VisualSonics 700-Series RMV (real-time microvisualiz t on) transducers are 
developed for high-resolution ultrasound imaging for small animal (preclinical) 
research. They feature a light and ergonomic design w th maximum frame rates up to 
200 frames per second (depending on the selection of RMV transducer, the field of 
view and sector size set for image acquisition) (VisualSonics 2006). Figure 2.2 
shows the structure of the transducer.  As a high frequency transducer, the 700-series 
scanhead is a single element transducer which functions as both the source and 
receiving transducer. The component is immersed in a coupling liquid (deionised and 
degassed water) within the transducer assembly. When the probe starts to operate, 
the transducer element is mechanically oscillated to allow the sweeping of the 










Figure 2. 2: The structure diagram of RMV scanhead (VisualSonics 2006) 
 
Table 2.1 lists the main parameters of the transducers used for the experiments in this 
thesis. The five transducers from left to right in Fgure 2.3 are 710B, 707B, 704, 711 
and 708, the central frequency of which increase from 25 MHz to 55 MHz. For each 
of the transducers the physical size of acoustic window decreases with increasing 
frequency. 
 













( µ m) 
Lateral 
Resolution 




710B 25 15 70 140 20.0 
707B 30 12.7 55 115 20 
704 40 6 40 80 14.6 
711 55 6 30 90 8.5 
708 55 4.5 30 70 10.7 
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               (a) 710B         (b) 707B         (c) 704             (d) 711             (e) 708 
Figure 2. 3:  Front view of the transducers in Table 2.1 
2.2.2 RF mode  
Digital radio-frequency (RF) mode is the main research mode of the scanner and able 
to provide the operator with the ability to acquire, digitize and export the raw RF 
data from pre-selected region of interest (ROI) for spectral analysis (VisualSonics 
2006). The RF data has been used extensively to understand the properties of 
biological media in medical ultrasound (Insana et al. 1990, Lizzi et al. 1983). This 
mode is typically useful to study the frequency content of the returning echo. Figure 
2.4 is a typical screen capture of the RF mode.  In the process of scanning, the single 
element transducer sweeps back and forth to generat a real-time B-mode image 
shown in the right upper corner and zoomed in on a ROI shown in the bottom left 
corner of the screen. The red vertical lines in thiszoomed window are individual 
lines of acquisition. For this case, 10 lines are chosen and these are evenly distributed 
throughout the ROI. The signal of the yellow line in the zoomed image is displayed 
in the time domain (red line) and frequency domain (blue line) in the box at the 




During scanning, a number of parameters can be set through the software interface, 
including the transmitting power and number of cycles of the transmission signal, 
overall gain values, the size of ROI and the format of output data. The output format 
of the RF data includes the number of lines (1-100), number of frames (1-1000) and 
number of acquisitions (1-20) per line. Only the RFdata in the pre-selected ROI is 
saved. The A/D converter sampling frequency is 420 MHz (VisualSonics 2006), 
which defines the spectral resolution of the data. 
 
Each raw RF data file is saved in two types: *.rdi (including sampling information 
e.g., number of frame, line, acquisitions per line, etc.) and *.rdb (including the binary 
data in ROI) (VisualSonics 2006). The RF data can be downloaded from the scanner 
and analysis is performed off-line using MATLAB software (MATLAB 2009a, The 




Figure 2. 4:  The screen view of RF mode 
Red dot ROI box in 
the B mode image 
Zoomed ROI window 
Acquisition parameters 
Graph window providing the echo 
form in time and frequency domain 
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2.3   METHODOLOGY  
The beam profiles of five Vevo 770 transducers in M-mode and PW-Doppler mode 
were measured. In M-mode, the transducer repetitively transmits a single beam down 
one line thus generating data from one scan line. In addition the received bandwidth 
was characterised using a reflector.  
 
2.3.1 The measurement of transmitted acoustic press ure using 
hydrophone  
The apparatus were assembled as shown schematically in Figure 2.5. The ultrasound 
wave transmitted by the transducer was received by a membrane hydrophone and 
recorded by an oscilloscope (TDS2024B, Tektronix, Beaverton, Oregon, USA). The 
membrane hydrophone has a 0.2 mm diameter active element made of 
Polyvinylidene Fluoride (PVDF) (Precision Acoustics Ltd., Dorchester, UK) and was 
immersed in a water tank (inner diameter: 30cm, height: 15cm) containing air 
saturated distilled water. The hydrophone was c librated in the frequency range 2-60 
MHz by the National Physical Laboratory in combinaton with a submersible 
preamplifier, DC coupler and a 50 Ω  ‘in-line’ shunt. The sensitivity for the above 
frequency range is provided as a certificate issued by National Physical Laboratory 
and is attached in Appendix 1. A best-fit curve to this data allows the sensitivity of 
the hydrophone at frequencies in between data points to be approximated.  
 
A 3D-positioning system (VisualSonics Inc., Toronto, Canada) includes bench-
mounted adjustable rail system (x - y direction) and a fully adjustable RMV 
transducer stand (z direction) to control the position of the hydrophone and the 
transducer with a step size of 0.1 mm. A physiological monitoring unit (VisualSonics 
Inc., Toronto, Canada) was used to measure the temperatur  of the water in real time. 


















Figure 2. 5:  Schematic of experimental setup used to acquire the beam profile 
 
Figure 2.6 shows the schematic of the typical ultrasonic field of a transducer. 






Figure 2. 6: The schematic of the ultrasonic field from a transducer (VisualSonics 
2006) 
 
Firstly, the signals on y-axis of the focal plane were recorded to plot the beam profile 
and calculate the 3dB beamwidth. This is assumed that t e beam profile is 
symmetrical in the x and y directions because the shape of the transducer head is 
concave. The beam profile describes the spatial distribution of acoustic pressure in 
the ultrasound field generated by an ultrasonic transducer. By moving the 
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hydrophone across the ultrasonic beam in a direction n rmal to the propagation 
direction, the shape of the beam can be determined (Preston 1991).  Specifically, for 
each transducer, the maximum acoustic signal output (an example shown on the 
screen of the oscilloscope in Figure 2.7) was found a  its position was determined 
to be the focus by adjusting the position of the hydrophone near the nominal focal 
position after connecting devices as shown in Figure 2.5. Using the positioning 
system the transducer was then moved in incremental steps of 0.1mm in the y-
direction (5 measurements on either side of focal position) and the signal amplitude 
of peak positive (P+) and peak negative (P-) were obtained at each position. The 
beam profile was plotted by connecting the 11 measurements after converting the 
measured amplitude to pressure using the sensitivity of hydrophone in Appendix 1. 
The 3dB beamwidth (approximately the half-power beamwidth, HPBW) (Van Trees 
2002) is a standard measure of the width of the beam. It is defined to be the point 
from the beam profile where  
                                            0.5 
2 =P or 21=P                                               (2.1) 






Figure 2. 7:  The screen capture of signal displayed on the oscill ope 
 
Secondly, the acoustic pulses were recorded at different depth on the z-axis with a 




Thirdly, the acoustic pulses were measured at different insonation powers from 3% 
to 100% on the nominal focal position.  
2.3.2 The measurement of the reflected signal 
Figure 2.8 shows a schematic diagram of the experimental set-up. The 3dB 
bandwidth represents the frequency range over which the converting efficiency 
between electrical energy and sound energy is more than half of its maximum 
(Hoskins 2010). It was calculated from the frequency spectra obtained from the 
reflected signal from a polished polymethylpentene (TPX) reflector (Boedeker 
Plastics, Texas, USA) placed at the focus of the transducer. This reflector was 
recommended by VisualSonics as providing a suitable ref rence material, the 
magnitude of which would not saturate the received electronics. The TPX reflector 
was placed and scanned in a water bath of air-free distilled water.   
 
Vevo 770 scanner







Figure 2. 8: The experimental set-up used to measure the 3dB bandwidth of the 
transducer  
2.4 RESULTS 
2.4.1 Beam Profile and 3dB beamwidth 
Figure 2.9 and Figure 2.10 show examples of beam profiles of transducer 707B in 
M-mode and PW-Doppler mode. The beam profiles for the other transducers were 
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similar so they are not included. From these two figures, the acoustic pressure of 
peak positive (P+) and peak negative (|P- ) decrease away from the focus (in the 
centre) to the adjacent horizontal displacement.  Based on the beam profiles of 
transducer shown in Figures 2.9 - 2.10, their 3dB beamwidths were calculated and 
listed in Table 2.2. The 3dB beamwidth of other transducers are included in 
Appendix 2. 
 






























































Figure 2. 9: The beam profile of transducer 707B in M mode at 30 MHz-frequency, 
(a) 100% power and (b) 10% power. 
 
 



























































Figure 2. 10: The beam profile of transducer 707B in PW-Doppler mode at 
frequency (a) 23 MHz and (b) 30 MHz and 100% power hen the sample volume 




Table 2. 2: Examples of the 3dB beamwidths of transducer 707B calculating from 
the beam profiles shown in Figures 2.9-10 and the full dataset is included in 
Appendix 2. 
 









Peak positive 0.12 0.12 0.14 0.15 
Peak negative 0.13 0.13 0.16 0.14 
 
 
The contour maps of Figures 2.11 - 2.15 present the beam profile (in y direction with 
a step of 0.1mm in Figure 2.6) measured at different d pths (z direction with a step of 
5mm in Figure 2.6) for each transducer. The beam profile at the focal length is 
shown in Figure 2.9 (data from transducer 707B as an ex mple).  From these figures, 
the spatial distribution of the ultrasound energy during insonation is determined. The 
highest acoustic pressure appears in the focal zone. Th  depth close to the origin 




























































                              (a)                                                                (b)
Figure 2. 11: The acoustic pressure of (a) peak positive and (b) peak negative from 




































































                              (a)                                                                (b)
Figure 2. 12:  The acoustic pressure of (a) peak positive and (b) peak negative from 


































































                              (a)                                                                (b)
Figure 2. 13: The acoustic pressure of (a) peak positive and (b) peak negative from 







































































                              (a)                                                                (b)
Figure 2. 14: The acoustic pressure of (a) peak positive and (b) peak negative from 
































































                              (a)                                                                (b)
Figure 2. 15:  The acoustic pressure of (a) peak positive and (b) peak negative from 
transducer 708 (focal length=4.5mm) measured at different depths 
2.4.2 Measurement of the 3dB bandwidth  
The frequency dependence of the acoustic characterisa ion of the tissue mimicking 
material (TMM) in Chapter 3 and ultrasound contrast gents (Chapters 4-7) are the 
core of the research in this thesis. The frequency bandwidth of the signal from each 
of the transducers was measured to understand the energy distribution of each 
transducer in the frequency domain. Figure 2.16 show  the RF signal reflected from 
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the TPX reflector in (a) time domain and (b) frequency domain. The frequency 
spectrum is the FFT of the signal from the time domain and normalized to the peak 
of its spectrum. This is an example acquired from transducer 707B. 







































Figure 2. 16: The RF signal (a) in time domain and (b) frequency domain from 
transducer 707B (centre frequency 30MHz – manufacturer’s literature) reflected 
from the TPX reflector through the water path in response to 30MHz, 10%- power, 1 
cycle pulse.  
 
The measured 3dB bandwidth of each of the transducers at 10% power setting was 
calculated from their spectra and is presented in Table 2.3. This is the power setting 
and frequency range used in Chapter 3 for TMM characte isation. 
 
Table 2. 3: The 3dB bandwidth of the transducers at 10% power output  
 
Transducer model 710B 707B 704 711 
Measured 3dB band width (MHz) 12 - 25 17 - 31 20 - 40 27 - 47 
 
From Table 2.3, it can be seen that the measured 3dB bandwidths appear to be 
downshifted in frequency with respect to the nominal centre frequencies of the 
transducers (see Table 2.1). However, when a long cycle transmitting pulse was set 
in Engineering mode (mode allows more settings of parameters than default 
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settings), the peak of the corresponding spectrum appe red at the nominal central 
frequency.  Figure 2.17 shows the signals of four different numbers of cycles 
received by transducer 707B under Engineering mode and Figure 2.18 presents the 
corresponding frequency spectra. The longer the transmitting signal, the narrower the 
main lobe of spectrum. 





































































Figure 2. 17: The RF signals from the scanner reflected by the TPX reflector 
through the water path at time domain in response to 30MHz, 10%- power, 5/ 10/ 15/ 
25 cycle pulse transmitted by transducer 707B  
 



























Figure 2. 18: The spectra of the RF signals in response of the signal in Figure 2.17 
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There are 16 power settings accessible in RF mode encompassing 3%, 4%, 5%, 6%, 
8%, 10%, 13%, 16%, 20%, 25%, 32%, 40%, 50%, 63%, 79and 100%. Appendix 3 
listed the amplitude of the peak positive signal and peak negative signal at the power 
settings measured by the hydrophone. The calibrated peak negative pressure (PNP) 
and MI values are required for experiments in Chapters 3-7. 
 
Figure 2.19 shows the PNP dependent centre frequency of the spectra from the 
signals received by (a) hydrophone and (b) scanner, examples of these spectra 
acquired by transducer 710B are shown in Figures 2.20 - 2.21.  It can be seen that for 
each transducer, except transducer 704, with increasing PNP, the centre frequency 
shifts to lower frequencies. However, the fluctuation, e.g., frequency upshifts to 
higher frequencies from results of transducer 704, is likely to be caused by the 
variation in spectra around peak region. 
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711   (55MHz)
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711   (55MHz)
 
(a)                                                            (b) 
Figure 2. 19: The variation in centre frequency at a series of PNP, signals received 













































Figure 2. 20: The spectra of the signals received by the hydrophone at a series of 
power setting from transducer 710B (central frequency: 25 MHz) 
 
 









































Figure 2. 21: The spectra of the RF signals from the pulse-echo measurement at a 
series of power setting from transducer 710B (central frequency: 25 MHz) 
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2.4.3 Linearity of the system  
In Figure 2.22, the amplitude of peak negative signal (value read from the raw RF 
data in mV) received by the transducer at the sixteen power settings were plotted 
against the peak negative pressure values (calibrated data in Appendix 3 in MPa) 
acquired by the hydrophone at the same power settings for transducers 710B, 707B, 
704 and 711.  The goodness of fit by R2 is shown to be greater than 0.99 for the 
entire linear function fitting of all the curves. This linear relationship demonstrates 
insignificant nonlinearity of scanner itself. 
 
 














































       














































                           (a) 710B                                                        (b) 707B 















































      














































                                                 
(c) 704                                                       (d) 711 
 
Figure 2. 22: The comparison of signals received by each transducer and the 
hydrophone at different power settings       
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2.5 DISCUSSION  
This chapter measured the acoustic parameters of each tr nsducer of the high 
frequency ultrasound scanner Vevo770 including:  beam profile, 3dB bandwidth, 
characteristics of short and long transmitting pulses in time/frequency domain and 
peak negative pressures at different power settings. These datasets will be referred in 
the later chapters. Specifically, low power single cycle pulses are used in Chapter 3 
to measure the acoustical properties of TMM; low power short cycle pulses are used 
in Chapter 4 and 5 to measure the attenuation and backscatter of lipid shelled 
microbubbles (MBs); long cycle pulses for analyzing the subharmonic components 
of MBs are used in Chapter 6 and 7. The discussion focuses on the impacts of these 
signatures on the underlying selections of experimental parameters in the following 
chapters. 
2.5.1 Beam Profile  
Figure 2.9 shows the beam profiles of transducer 707B in M-mode at positions of 
maximum pressure amplitude. Overall uncertainties of ac ustic output measurements 
are mainly attributed to the uncertainties in hydroph ne sensitivity calibration. The 
acoustic pressure decreased when the power output was reduced from 100% to 10%. 
At low power output (10%) the output acoustic pressure was approximately 1MPa or 
above.  At lower frequencies at these acoustic pressu  commercial UCAs have 
been shown to rupture (if frequency=1MHz, then MI > 1 (Correas et al. 2001)). 
However, considering the high frequency range is far from the resonant frequency of 
these MBs, their behaviour will be studied in the following chapters.  
2.5.2 Focal position and focal zone 
Figures 2.11 – 2.15 show the spatial distribution of acoustic pressure. The maximum 
signal in the water was determined to be the position of the focus of the transducer. 
Curved transducers and lenses are two main methods for changing the directivity of 
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transducers as shown in Figure 2.23 (Wells 1977). Wells (Wells 1977) summarized 
the work of (O'Neil 1949) and (Fry and Dunn 1962) and showed that  
 
1) in Figure 2.23.a. the intensity at the centre of the curvature IR and the average 
intensity at the radiating surface I0 has an approximate relationship as   
 
                                                  IR/I0 = (kh)
2 = (2πh/λ)2                                                            (2.2) 
2)  in Figure 2.23.b 
                                                   F≈ R/(1-1/n)                                                  (2.3)      
    
where n is the refractive index n=c1/c2, c1 is the velocity in the lens and c2 is the 
velocity in the medium. The speed of sound in the propagating medium is included in 
the both equations (λ = v·t). Generally ultrasound scanners use the speed of sound in 
tissue 1540 m·s-1. However, the experiment used distilled water, the acoustic velocity 
of which is 1480 m·s-1 at 19.3oC (Bilaniuk and Wong 1993). The discrepancy 
between the speeds of sound is the main reason for the shift (± 0.5 mm from the 
nominal focal position) in position of maximum signal. Thus, the nominal focal 






















(b) The schematic geometry of a lens system 
Figure 2. 23: The schematic geometry of (a) a self-focusing radiator and (b) a lens 
system (Wells 1977) 
2.5.3 3dB bandwidth  
The sensitive frequency range of the transducer was measured as the 3dB bandwidth 
of the spectrum from a single cycle pulse. The signature of frequency spectrum is 
determined by the insonation signal driven by the transducer and the properties of the 
propagation medium.  In Chapter 3-7 where the frequency dependence of attenuation 
and the normalized backscatter are investigated for both TMM and UCAs, these 
calculations are performed over the 3dB frequency bandwidth of the transducers. 
Although the transducers function as both transmitter and receiver, the 3dB 
bandwidth instead of 6dB bandwidth is calculated. This is because 3dB bandwidth of 
each transducer is relatively narrow in which the en rgy mostly focuses and provides 
good signal to noise ratio. The overlapping frequency ranges of the five transducers 
enable the entire frequency bandwidth of 12 - 47 MHz (at 10% power) and 12 - 43 
MHz (at 3% power) to be available for the study. 
 
2.5.4 Characteristics of short and long transmittin g pulses  
Comparing the spectra of the short and long cycle signals in Figure 2.16 - 2.18, it 
was found that the peak of the spectrum from the long cycle signal occurs at the 
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nominal transmitting frequency of the signal. However, the peak of the broadband 
spectrum from a single cycle signal shifts to a lower frequency than the nominal 
transmitting frequency. The reason of this frequency shift of peak spectrum may be 
attributed to the variation of the waveform of the short cycle signal during 
propagation that increases nonlinearity of high frequency ultrasound. The density of 
the water varies with the propagation of the longitudinal wave in the underwater 
environment shown in Figure 2.24. Specifically, in the compression region (peak 
positive range)  the density and the pressure are elevat d, in the rarefaction region 
(peak negative range) these variables decrease with respect to the background 
(Zagzebski 1996).  The speed of sound is related to the density, thus the speed during 
the compressed cycle of the wave is higher than the value in the expansion cycle. If 
the waveform of the pulse distorts during the propagation like shown in Figure 1.6, 
this distortion generates more harmonics during the wave propagation. Additionally, 
the ultrasound propagating through the water is known to be nonlinear and the 
attenuation increases with frequency with a relationship of f 2 (Pinkerton 1949).  The 
nonlinearity may be more significant for the high frequency ultrasound due to the 













Figure 2. 24: The variation of pressure and density of the medium with the 
propagation of the sound wave (Zagzebski 1996)  
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2.5.5 Characteristics of transmitting signal of dif ferent powers 
Figure 2.19 presents the frequency spectra of the signal  received by the hydrophone 
and scanner at a series of power settings. At high power the frequency spectra shifts 
towards a lower frequency range indicating the nonli ear effect at high power is 
more prominent than at low power. With respect to the analysis above, high 
insonation pressure intensifies the distortion of the signal leading to nonlinearity by 
increasing the difference in the speed of sound betwe n the compressed medium and 
the rarefied medium. The differences between the frequency measured from the 
spectra obtained from the signal from the TPX reflector to those obtained from the 
hydrophone may be due to the double transit time of the ultrasound pulse through 
water experienced by the TPX reflector measurements. 
2.6 CONCLUSIONS  
This chapter describes the acoustic characterisation of the high frequency ultrasound 
scanner Vevo770 using five different transducers covering the range of 25 - 55MHz. 
This includes: 
 
1. The beam profile (the spatial distribution of the magnitude of pressure amplitude 
(positive and negative)) measurement using a 0.2mm me brane hydrophone.    
 
2. The 3dB frequency bandwidth measurement for eachof t e transducers at 1 cycle 
at 10% power output confirming the sensitive frequency range of the transducer. 
 
3. The impact of the acoustic pressure on the measur d centre frequency of each of 
the transducers. 
 
The objectivity of these measurements establishes the ettings with which this set-up 
will be operated in the following chapters. Furthermo e, an initial understanding of 






The acoustic speed and attenuation of a tissue-




The aim of this chapter is to characterise the speed of sound and attenuation of the 
IEC agar-based tissue mimicking material (TMM) over the frequency range 10 to 47 
MHz. Measurements were made using two independent systems, both employing 
broadband substitution techniques. The experimental method and MATLAB codes 
developed for TMM characterisation are fundamental for the calculations of 
ultrasound contrast agents in Chapters 4-7. Additionally, this TMM performed as a 
reference material for calculating contrast to tissue ratio in Chapters 5 and 7. The 
work in chapter 3 has been published in Ultrasound in Medicine in Biology, 2012 
and is included as in Appendix of this thesis. 
3.2 INTRODUCTION 
 
Ultrasound phantoms are passive devices which simulate the acoustic properties of 
the human body and enable the performance assessment of a  ultrasound system 
(AIUM 1995). In practice, variations of speed, impedance, scattering, absorption and 
attenuation affect the appearance of the pulse echosignal and provide information 
about the tissue structure. Thus, the knowledge of these parameters and their 
variation with frequency, temperature, amplitude, age nd pathology is important for 
us to understand and make the most efficient use of present and potential ultrasonic 




The phantoms are designed based on the specific function of the ultrasound scanner 
they are to test, e.g. TMM for measuring the attenuation and speed of sound of 
ultrasound scanners, blood mimicking fluid (BMF) and vessel mimicking tube 
(VMT) (Teirlinck et al. 1998) and string phantom for Doppler imaging (Culjat et al. 
2010).  In addition to the evaluation of attenuation, ther parameters like thermal 
conductivity, diffusivity tolerating high temperature for high-intensity focused 
ultrasound (HIFU) (e.g. hydrogel based TMM (King et al. 2007)) and elastic and 
mechanical properties (stiffness and stress relaxation) for elasticity imaging 
(Elastography) (e.g. gelatine gels  TMM (Hall et al. 1997)) can also be tested.  
 
The purpose of a Tissue Mimicking Material (TMM) is to closely mimic the speed of 
sound, attenuation and backscatter properties of soft ti sue in order to evaluate new 
signal or image-processing algorithms (Kofler and Madsen 2001, MacGillivray et al. 
2010) and to provide a reproducible method of assessing the image quality of 
diagnostic ultrasound (Browne et al. 2004, Shaw and Hekkenberg 2007). Various 
base materials have been used to produce either commercial or in-house TMM 
including agar, gelatine, n-propanol and oil (Duck 1990), urethane rubber, Zerdine®, 
condensed milk (Browne et al. 2003), magnesium silicate, open cell foam, 
polyacrylamide gel, polyurethane, polyvinyl alcohol (PVA), silicone polymer and 
organics (Culjat et al. 2010). Table 3.1 lists the different TMMs and their respective 














Table 3. 1: The speed of sound, attenuation and pros and cons of TMM (Culjat et al. 
2010) 
 



















1458-1520 0.85 temperature 
stability(0-
100oC) 
Incapability of sculpture 
or mould  

























Low α, highly toxic 














Difficulty in controlling 
freeze-thaw cycle 




To our knowledge there is no commercially available TMM for the quality 
assessment of high frequency ultrasound scanners (Moran et al. 2011). In addition, 
compared to low frequencies, there is little work to date that evaluates TMM at such 
frequencies. One gelatine-based tissue mimicking material with spherical glass 
scatterers has been characterised from 2 to 60 MHz (Bridal et al. 1996), the 
attenuation of which depended nonlinearly on the frequency. The propagation speed 
and attenuation coefficient of a phantom tissue-lik polymethylpentene was reported 
in the frequency range 20-70 MHz (Madsen et al. 2011). However at the same time, 
there is increasing demand for the development of a tissue mimicking phantom 
which is characteristic of both human and animal model tissue properties at high 
frequencies.  
 
The IEC agar-based TMM characterised in this chapter was developed as part of an 
International Electromechanical Commission project (IEC 2001, Zeqiri and Hodnett 
2010). The base ingredients of this TMM are water and glycerol. Agar is added to 
increase stiffness and its concentration, together with the glycerol, determines the 
speed of sound. Powders incorporating Al2O3 and SiC in different sizes are added to 
adjust the attenuation and scattering properties (Tirlinck 1997). It has been widely 
used, for example in flow phantom design (Ramnarine et al. 2001), in oesophagus 
phantoms (Inglis et al. 2006) and in breast phantoms (Cannon et al. 2011).  The 
acoustic properties of this agar-based TMM and their temperature and frequency 
dependence have previously been investigated over the frequency range 2.25 to 15 
MHz at an ambient temperature range of 10 to 35 oC (Browne et al. 2003) and at an 
ultrasound frequency range 17 - 23 MHz over a temperature range of 22 oC to 37 oC 
(Brewin et al. 2008). These authors showed that the sp ed of sound remained 
relatively constant with increasing frequency but that it increased with an increase in 
temperature while attenuation was shown to decrease with temperature. This TMM 
also showed acoustical stability over 2 years (Brewin et al. 2008) and exhibited a 
linear response of acoustic attenuation in the low frequency range 2-7 MHz (Browne 
et al. 2003), 6-15 MHz (Inglis et al. 2006) and 17-23 MHz (Brewin et al. 2008).  
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3.3 MATERIALS AND METHODS 
3.3.1 Manufacture of TMM  
The agar-based TMM used in this study was prepared following the method of 
Ramnarine et al.(Ramnarine et al. 2001), Browne et al. (Browne et al. 2003) and 
Brewin et al. (Brewin et al. 2008) using the ingredients described in Table 3.2. Due 
to the short focal length of the high frequency transducers (Table 2.1) thin slices of 
TMM were manufactured.  These were made by pouring a small volume of prepared 
TMM liquid at 46oC into PVC cylinder rings (inner diameter 4.8cm, 2mm height). 
Prior to pouring the TMM into the rings, a stretched layer of 14 – 16 µm thick Saran 
Wrap (SC Johnson Inc., Racine, USA) was glued to one rim of the ring. The TMM-
filled ring was then left on a flat surface to set.  Once the TMM was cooled to room 
temperature, before the upper layer of Saran Wrap ws stuck to the upper rim of the 
ring, approximately 0.2 ml of TMM preserving liquid (mixture of glycerol, water and 
disinfectant) was placed on the TMM and spread over th  surface to moisten it and 
ensure good acoustic coupling between the TMM and Saran Wrap. Enclosure of the 
TMM samples in Saran Wrap ensured that the glycerol did not leach from the TMM 
into the surrounding water-bath during measurements. Twelve TMM slices which 
varied in thickness between 2mm and 4mm were produced and were allowed to cool 
overnight.  These TMM samples will be referred to as TMM test cells (Figure 3.1). 
To account for the effect of the Saran Wrap, water test cells of the same dimensions 
were also produced, in which the TMM was replaced by istilled water. Two batches 
of TMM were manufactured following the same protocol to assess the 















Order Code and Manufacturer / 
Distributor Details 
Water 82.97%  
Glycerol 99% (pure) 11.21% 
(G7757) Sigma-Aldrich Company 
Ltd. The Old Brickyard, New Road, 
Gillingham, Dorset, UK 
Merck Agar-Agar technical 
(111925) 
3% 
(53648 5K) VWR International Ltd. 
Hunter Boulevard, Magna Park, 
Lutterworth, Leics, UK 
3µm Al2O3 Powder 0.95% 
Logitech Ltd. Erskine Road, Old 
Kilpatrick, Glasgow, Scotland 
0.3µm Al2O3 Powder 0.88% 
Logitech Ltd. Erskine Road, Old 
Kilpatrick, Glasgow, Scotland 
400 grain SiC Powder 0.53% 
Logitech Ltd. Erskine Road, Old 
Kilpatrick, Glasgow, Scotland 




(09621) (50%solution, diluted in-
house to 10%) Sigma-Aldrich 
Company Ltd. The Old Brickyard, 




Figure 3. 1: TMM test cells 
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3.3.2 Experimental set-up 
Measurement of the speed of sound and attenuation of the TMM were performed 
based on a broadband reflection substitution technique (AIUM 1995) using a 
Vevo770 pre-clinical ultrasound scanner (VisualSonics Inc., Toronto, Canada) and a 
scanning acoustic macroscope (SAM) system developed in-house in Dublin Institute 
of Technology (Cannon et al. 2011).  Using the broadband substitution technique, 
short duration, wideband transmitting pulses were us d to acquire the data on the 
position and magnitude of the received sound pulse with and without the sample 
between a pulse-echo transducer and a specular reflector (AIUM 1995). As described 
below the thickness of each sample at each acquisition was also calculated for 
measurements made using the Vevo 770 scanner. 
 
Figure 3.2 shows a schematic diagram of the experimental set-up. The TMM test cell 
was placed and scanned in a water bath of air-free and distilled water and a TPX 
reflector was mounted beneath the test cell as a reference reflector. Modelling clay 
(Plasticine, Flair, UK) was used to secure the position of the reflector and to offset 
the position of the TMM test cell from the referenc reflector.  A 3D-positioning 
system (VisualSonics Inc., Toronto, Canada) with a step size of 0.1 mm was used to 
adjust the position of the transducer and the test c ll.  The tank containing the TMM 
test cell was seated on a bench-mounted adjustable 2D (X, Y) rail system. The 
transducer was mounted on a Z positioning system. A physiological monitoring unit 
(VisualSonics Inc., Toronto, Canada) was used to measure the temperature of the 
water in real time.  All the measurements were performed at 21 oC± 1 oC. 
 
A Vevo770 pre-clinical ultrasound scanner and four transducers driven at 10% 
output power were used for the acoustic measurements. The corresponding peak 
negative pressures at focal position are in Appendix 3 as described in Chapter 2. The 
nominal centre frequencies, focal lengths and the measured 3dB bandwidth of each 
of the transducers are given in Table 2.1 and 2.2. The Vevo770 scanner was operated 
in RF mode. It was not possible to capture the RF data from the complete image 







Figure 3. 2:  Schematic diagram of the experimental set-up of Vevo 770 scanner  
 
3.3.3 Measurement of speed of sound and thickness o f TMM  
The thickness of TMM and the speed of sound were calculated from the return time 
intervals of the pulse echoes from the front and rear surfaces of the TMM test cell 
and from the surface of the TPX reflector. Equations 3.1, 3.2 and 3.3 were used to 
derive the speed of sound (Equation 3.4) and the thickness (Equation 3.5) of the 
TMM. Figure 3.3 illustrates these time intervals schematically. The symbols in 
equations 3.1-3.5 are defined in Table 3.3. The recorded temperature enabled the 









                                (a)                                           (b)                                     (c) 
Figure 3. 3: Diagram of the experiment and time intervals involved in calculations 
(not to scale) (a) TMM test cell, (b) Water test cell, (c) Water only.  Definition of 
















Table 3. 3: Definitions of the symbols involved in Equations 3.1 – 3.5 
 
TTMMUp Time required for ultrasound pulse to travel from the transducer to 
the upper surface of the Saran wrap of the TMM test c ll 
TTMMLw  Time required for ultrasound pulse to travel from the transducer to 
the lower surface of the Saran wrap through the TMM test cell 
TTMMR Time interval between the transducer and surface of the TPX 
reflector through the TMM test cell 
TWUp Time required for ultrasound pulse to travel from the transducer to 
the upper surface of the Saran wrap of the water test cell 
TWLw Time required for ultrasound pulse to travel from the transducer to 
the lower surface of the Saran wrap through the watr test cell 
TWR Time interval between the transducer and surface of the TPX 
reflector through the water test cell 
TR Time interval between the transducer and surface of the TPX 
reflector through the water only 
DTR Distance between the transducer and TPX reflector 
Vw Speed of sound in water 
VTMM Speed of sound in TMM 
Vs Speed of sound in Saran wrap 
dTMM Thickness of TMM in the TMM test cell 
 
 
In the experiment, the distance DTR between the transducer and TPX reflector was 
fixed (Figure 3.3. a, 3.3.b and 3.3. c) and was equal to  
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DTR = (TTMMUp + TTMMR - TTMMLw) ×Vw + [TTMMLw  - TTMMUp - (TR - TWR)] × VTMM + 
(TR - TWR) ×Vs                                                                                             (3. 1) 
 
DTR = (TWUp + TWR - TWLw) ×Vw + [TWLw - TWUp - (TR - TWR)] × Vw + (TR - TWR) 
×Vs                                                                                                               (3. 2) 
 
DTR  = TR × Vw                                                                                            (3. 3) 
 
After re-arrangement of the equations, the speed of sound VTMM and the thickness 
dTMM of TMM in the TMM test cell are given by:  
 
                        1 WR TMMRTMM W
TMMLw TMMUp WR R
T T
V V
T T T T
 −= +  − + − 
                                     (3. 4)       
                                         
                        dTMM = VTMM × [TTMMLw - TTMMUp – (TR-TWR)]                            (3. 5) 
 
For each measurement each TMM test cell sample was submerged in the water tank 
for a period of approximately 10 minutes for each measurement. The speed of sound 
of slice of TMM without the Saran Wrap was measured by transducer 710B over 50 
minutes as a comparison to show the effects of glycerol leaching from the TMM. 
3.3.4 Measurement of attenuation  
The attenuation was calculated by subtraction of the frequency spectra of the RF 
signals from the reflector with the TMM test cell from that with the water test cell in 
the path. The attenuation of TMM relative to water α  in the unit of 1−⋅ cmdB was 
calculated using Equation 3.6: 






−−=α                   (3. 6) 
 
where A(x, y, f) is the magnitude of the spectrum of the signal from the reflector with 
the TMM test cell in place (Fig 3.3.a), A0(x, y, f) is the magnitude of the spectrum of 
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the signal from the reflector with the water test cell in place (Fig3.3.b), and dTMM is 
the thickness of TMM in the TMM test cell.   
 
The attenuation of air-free distilled water is proportional to f 2 over the range 7.5 – 
67.5 MHz (Pinkerton 1949).  The attenuation in distilled water wα at 20 
oC is 
2.17×10-3 dB·cm-1 ·MHz-2 (Duck 1990) . 
                                 
The attenuation was calculated over the 3 dB bandwidth of each transducer. A 
polynomial curve fit was applied to the data using Equation 3.7, because the 
attenuation of water has been shown to be proportional to f 2 and the attenuation of 
TMM has been shown to vary linearly with frequency at low frequency range. 
Higher order terms, such as f 3 were excluded as their coefficients proved to be very 
small (10-5) compared with that of the lower order terms.  
 
                                2bfafwTMM +=+= ααα                                                    (3. 7) 
 
where TMMα  is the absolute attenuation of TMM, f is the frequency, and a and b are 
the coefficients of the polynomial function.  
3.3.5 Acquisition and analysis of acoustical data 
Twelve TMM test cells were measured at 3 independent positions by each 
transducer. For each TMM test cell, the raw RF dataof 5 lines (5 positions) from 500 
consecutive frames in 3 independent measurements were saved to the scanner and 
later transferred onto a PC and analysed using MATLAB. The angular separation 
between adjacent RF acquisition lines was approximately 0.3o and so the lines were 
assumed to be parallel and perpendicular to the TPXreflector. The water test cell 
was scanned in a similar manner.  For each position the mean and standard deviation 
of the thickness, speed of sound and attenuation were calculated. 
 
 65 
3.3.6 The speed of sound and attenuation using the SAM system    
The SAM system (Figure 3.4) used a broadband immersion transducer as both a 
transmitter and a receiver, which had frequency centred at 50 MHz with 1.27 cm 
focal length (V390-SU/RM; Olympus NDT Inc., Waltham, MA, USA). The 
measured 3dB bandwidth of the transducer used in the SAM system was 10 – 
33MHz.  For the SAM system, the same technique was employed for measuring the 
3dB bandwidth as was used for the Vevo770, but the refl ctor was a glass slide.  A 
pulser-receiver (Model 5052PR; Panametrics, Waltham, MA, USA) with in-house 
software developed in LabView (National Instruments, National Instruments 
Corporation, Austin, TX, USA) (Cannon et al. 2011) manipulated the transmitting 
and receiving signals. The transmitted ultrasound pulses were perpendicular to the 
surface of a glass slide at the focal plane of the transducer. A computer with a data 
acquisition card (PCI–5144; National Instruments) then acquired and saved the 
reflected, digitised (250 MS s-1) signals (Digitiser: National Instruments, Model PCI-
5114). Finally, the data was output to MATLAB for further calculations. A plastic 
washer of height 1.6 mm was attached on the glass side to form a space between the 
test cell and reflector. All acoustic measurements were performed in air saturated 
water at 20 oC± 1 oC. 
 
 
Figure 3. 4: Schematic diagram of the SAM system 
 
The experimental process of sample and reference measur ments were similar to 
those employed using the Vevo770 scanner.  However, when using the SAM system, 
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the complete RF signal from each line was collected.  For the measurements of one 
TMM test cell, 10 independent positions were scanned and 10 consecutive pulses at 
each position were recorded for data analysis. The attenuation was calculated using 
Equation 3.6.  The speed of sound of the TMM measured by the SAM system 
required a known thickness of TMM that was previously acquired from 
measurements using the Vevo 770 scanner. The speed of sound of the TMM, VTMM, 
was calculated using Equation 3.8 (AIUM 1995):  












=                                                    (3. 8) 
where dTMM is the known thickness of the TMM test cell measured by Vevo770 
scanner, Vw is the speed of sound in water and t∆  is the measured time shift between 
TTMMR and TWR.  
3.4 RESULTS 
3.4.1 Speed of sound and thickness 
The mean thickness values of each of the twelve TMM test cells measured by all the 
Vevo770 transducers are listed in Table 3.4 and show a maximum variation of 0.06 
mm.  
 
Table 3. 4:  The mean and standard deviation (in brackets) of the thickness of 12 








































Table 3.5 shows the measured TMM speed of sound and standard deviation. The 
mean values were found to be 1547.4 ± 1.4 m·s-1 and 1548.0 ± 6.1 m·s-1 measured by 
the Vevo 770 scanner and SAM system, respectively. Both results show good 
consistency and do not vary significantly over the frequency range 10 - 47 MHz.  
The acoustical properties from a second batch of 6 TMM test cells were also 
measured by the Vevo 770 scanner.  The measured speof sound was 1544.4 ± 1.0 
m·s-1.  
 
Figure 3.5 shows a typical time shift between TWR and TTMMR and the amplitude 
reduction of the reflected signal through the water test cell and TMM test cell in time 
domain. The two curves in Figure 3.6 show the corresponding spectra, the difference 




































reference signal through water test cell
attenuated signal through TMM test cell
 
Figure 3. 5: The signals reflected from the TPX reflector through the water test cell 
(reference) and through the TMM test cell in time domain 


















Spectrum of reference signal through water test cell
Spectrum of attenuated signal through TMM test cell
 
Figure 3. 6: The frequency spectra of the signals reflected from the TPX reflector 





Table 3. 5: The mean and standard deviation (in brackets) of speed of sound (m·s-1) 
of 12 TMM test cells measured by the four transducers of Vevo770 scanner and SAM 
system (standard deviation was calculated from the averaged results of 15 positions 
on each TMM test cell) 
 
Transducer 
Sample 710B 707B 704 711 
 
SAM 
1 1547.8 (0.5) 1547.6 (0.8) 1546.6 (4.1) 1546.9 (1.4) 1553.5 (2.7) 
2 1548.3 (0.6) 1548.4 (0.9) 1547.9 (3.0) 1547.9 (2.0) 1552.1 (2.5) 
3 1544.1 (1.5) 1545.7 (0.2) 1543.5 (0.4) 1547.2 (0.5) 1553.6 (2.4) 
4 1547.4 (1.1) 1546.6 (1.1) 1548.3 (1.6) 1547.9 (1.0) 1554.8 (2.5) 
5 1546.6 (1.6) 1547.0 (0.6) 1545.9 (2.0) 1546.6 (1.1) 1548.6 (5.6) 
6 1546.1 (0.4) 1545.8 (0.5) 1546.7 (1.5) 1546.4 (0.3) 1549.5 (2.8) 
7 1547.2 (0.4) 1547.0 (0.4) 1545.2 (1.5) 1547.4 (1.6) 1550.2 (2.5) 
8 1547.8 (0.7) 1547.9 (0.6) 1547.3 (1.7) 1548.8 (0.5) 1539.6 (5.3) 
9 1547.5 (0.5) 1547.8 (0.4) 1545.0 (1.3) 1548.3 (0.7) 1539.3 (3.3) 
10 1547.4 (0.2) 1549.0 (1.0) 1547.6 (1.8) 1548.1 (1.4) 1542.6 (3.3) 
11 1548.4 (0.5) 1550.2 (0.8) 1546.7 (2.7) 1548.1 (1.5) 1546.7 (3.0) 
12 1548.4 (0.6) 1551.2 (0.8) 1549.4 (2.0) 1548.7 (2.3) 1545.9 (3.3) 
 
Figure 3.7 shows the speed of sound results over 50 minutes of the unsealed TMM 
slice measured by transducer 710B over 50 minutes. The TMM sample was 
submerged in the water tank about 10 minutes for each measurement. The initial 
speed of sound is less than 1540 m·s-1and the value decreases about 15m·s-1 in the 






























Time (minute)  
Figure 3. 7:   Variation in the speed of sound (m·s–1) with time (minute) for unsealed 
TMM samples 
3.4.2 Attenuation as a function of frequency 
Figure 3.8 shows the attenuation of the two batches of TMM and demonstrates that 
the absolute attenuation in TMM increases with increasing frequency.  When the 
previous TMM attenuation values measured by other groups (Brewin et al. 2008, 
Browne et al. 2003, Inglis et al. 2006) were compensated for the attenuation of water, 
the polynomial function 0.40 f + 0.0076 f 2 was calculated to be the best-fit of all the 
relevant attenuation versus frequency data available for this TMM from 2 to 47MHz. 
This fitting curve is shown in Figure 3.9 with the previous attenuation results at the 
lower frequencies.  The mean attenuation and standard deviation obtained with each 
transducer and for both batches of TMM are presented in Figure 3.10.  The 
polynomial function fitting all the attenuation curves from batch 1 and batch 2, 
measured by transducers 710B, 707B, 704, 711 and the SAM system are listed in 







































TMM1 RMV710B (12 - 25 MHz)
TMM1 RMV707B (17 - 31 MHz)
TMM1 RMV704   (20 - 40 MHz)
TMM1 RMV711   (27 - 47 MHz)
TMM2 RMV710B (12 - 25 MHz)
TMM2 RMV707B (17 - 31 MHz)
TMM2 RMV704   (20 - 40 MHz)
TMM2 RMV711   (27 - 47 MHz)
TMM1 SAM         (10 - 33 MHz)
α = 0.40 f + 0.0076 f 2
 
 
Figure 3. 8: Attenuation of two batches of TMM as a function of frequency in the 
frequency range of 10-47 MHz measured by the Vevo770 scanner and SAM system, 




































Browne (2 - 7 MHz)
Inglis   (6 - 15 MHz)
Brewin (17 - 23 MHz)
α = 0.40 f + 0.0076 f 2
 
 
Figure 3. 9: The polynomial curve-fit of the entire attenuation data set (both batches 
of TMM measured using four high frequency transducers and SAM system and the 
attenuation (compensated for attenuation of water) of TMM in 2-7 MHz (Browne et 





















































































































Figure 3. 10: Mean and standard deviation attenuation values of the two batches of 










Table 3. 6:  The polynomial fit (α = a f + b f 2) of the attenuation of the two batches 
of TMM measured by Vevo 770 scanner and the SAM system 
 
Transducer 710B  707B 704 711 Combination SAM 
Batch 1 
 
 0.47 f + 
 0.00090 f 2  
0.40 f + 
0.0074 f 2 
0.43 f + 
0.0048 f 2 
0.45 f + 
0.0055 f 2 
0.39 f + 
0.0069 f 2 
0.32 f + 
0.011 f 2 
Batch 2  0.53 f + 
 0.00030 f 2  
0.50 f + 
0.0048 f 2 
0.46 f + 
0.0059 f 2 
0.48 f + 
0.0069 f 2 
0.39 f + 





This chapter reports for the first time acoustical measurements of the IEC agar-based 
TMM at ultrasound frequencies higher than those routinely used in clinical practice 
but at frequencies commonly used for preclinical imaging. We did not attempt to 
separate the attenuation into the separate components of absorption and scattering but 
measured the overall attenuation of the TMM. 
3.5.1 Sources of error 
The sources of error were discussed for the measurement of thickness, speed of 
sound and attenuation respectively. For speed of sound and thickness, initially the 
reason for choosing the sealed test sample was explained. Secondly, the influence of 
variation in speed of sound in water and variation in the thickness of TMM were 
discussed because these two quantities were used to calculate the speed of sound 
shown in Equation 3.4 and Equation 3.8, respectively.   For the attenuation 
measurement, there were four reflections as well as a double passage through the 
materials to take into consideration. The discussion detailing the magnitude of the 
uncertainty is most likely to be due to large uncertainties in the magnitude of the four 




3.5.1.1 Measurement of thickness and speed of sound  
 
In this study, the thickness of the TMM test cells was calculated using the RF data 
rather than by using mechanical callipers as the thin slices of TMM used in this study 
were easily compressed by the callipers. The small v riation in the measured 
thickness at different sites on individual TMM slices is likely due to slight variations 
in the flatness of surface of TMM.    
 
There are generally two approaches to test the thickness and speed of sound of a 
compressible and irregular shaped object using ultrasound.  The first is to test the 
unsealed object in its preserving liquid that requires a known speed of sound of the 
preserving liquid over the relevant ultrasound frequ ncy range. The second is to test 
the sealed object in water, since the acoustic properties of water have been 
extensively investigated across a wide ultrasound frequency range. Figure 3.7 shows 
the variation in speed of sound without wrapping or sealing. Brewin (Brewin et al. 
2008) also quantified the glycerol leaching time bytesting TMM with three 
thicknesses and showed that the speed of sound of a 7mm-thick TMM (the thinnest 
one) dropped from 1545 m·s-1  to 1525 m·s-1 in 40 minutes. The TMM samples in 
this experiment were approximate 2 mm, thus the thin piece increases the molecule 
interchange between the glycerol and water resulting in a faster reduction in speed of 
sound with time in water-bath.  
 
The method described in this chapter adopted the second approach of testing the 
sealed object in water. This method of measuring the speed of sound in the TMM is 
relative and based on the published data of absolute speed of sound values in water 
(Bilaniuk and Wong 1993) and described by AIUM (AIUM 1995). However Lubbers 
and Graaff (Lubbers and Graaff 1998) have suggested that the speed of sound 
measurements in water made by Del Grosso and Mader (Del Grosso and Mader 
1972) give more reproducible results. The discrepancy of speed of sound in pure 
water between the work of Del Grosso and Mader (DelGrosso and Mader 1972) and 
Bilaniuk and Wong (Bilaniuk and Wong 1993) between19 oC - 22 oC is smaller than 
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0.02 m·s-1 and therefore is smaller than the experimental error associated with this 
study.  
 
The measured mean speed of sound in TMM in this study is comparable to the 
previously measured value of the speed of sound in TMM at lower frequencies. The 
thickness dTMM used in the calculations of the SAM system was a me n thickness 
measured by the Vevo 770 scanner over 15 sites.  Unlike the measurements made 
using the Vevo 770 when individual thickness measurements were used for each 
sampling position, a mean slice thickness was used in the measurement of the SAM 
system. This mean slice thickness value may contribute to the variation in speed of 
sound measurements measured by the SAM system.  
 
3.5.1.2 Measurement of attenuation 
 
The reflections from the TMM test cell interfaces contributed to the uncertainty on 
the attenuation measurements. Based on the calculations of transmission coefficients 
of TMM and water,  
the amplitude transmission coefficient from water to TMM:  









                                                   (3.9) 
 
the amplitude transmission coefficient from TMM to water:  









                                                   (3.10) 
 
where the impedance of water is ZW = ρ watercwater, the speed of sound in water cwater 
= 1482.36 m·s-1 at 20oC, the density of water ρ water =1.00286×103 kg·m–3  (Kaye and 
Laby 1995). The impedance of TMM is ZTMM = ρ TMM cTMM, the measured speed of 
sound in TMM cTMM =1547.4 m·s
-1, the density of TMMρ TMM= (1.07±0.03) ×103 
kg· m–3 (Brewin et al 2008).  The total amplitude transmission coefficient back and 
forth is  
 
 77 



















T = 0.9942                                             (3.11) 
 
Consequently the transmission loss is constant and frequency invariant. However its 
influence on the measured attenuation of TMM does vary with frequency.  The 
intensity transmission loss in the unit of dB·cm-1·MHz-1 is  







                                                       (3.12) 
 
where f is the frequency, d is the thickness of TMM in cm. For a TMM sample of 
thickness 0.274cm, a theoretical uncertainty due to the four water-TMM boundaries 
was calculated to be less than 0.008 dB·cm-1·MHz-1 over the frequency range 12 - 47 
MHz and so laid within experimental error of the attenuation measurements. 
 
In addition, we have also quantified the uncertainties in the attenuation 
measurements due to the Saran Wrap interfaces on the test cells.  We performed two 
substitution technique experiments using similar methods to those described 
previously. In the first experiment, the frequency spectra from the TPX reflector with 
a TMM test cell in the ultrasound path was subtracted from the frequency spectra 
with the same TMM test cell uncovered i.e. without Saran Wrap. In the second 
substitution experiment the frequency spectra from the TPX reflector with and 
without a water test cell (water encased in Saran Wrap) were subtracted.  The 
difference between these two spectra was due to the diff rence in reflection 
coefficients at the Saran Wrap interfaces in these xperiments.  The maximum 
difference in these spectra was found to be less than 0.11 dB·cm-1·MHz-1, which is 
comparable to the standard deviation of the absolute attenuation value of ultrasound 
through TMM as shown in Figure 3.10. 
3.5.2 The assessment of the usefulness of the TMM 




In this chapter the acoustical properites of an IECagar-based TMM were measured 
from 21 - 47MHz to determine if such material has potential to be function as a 
suitable tissue mimic at high frequencies. We have shown that by combining all the 
data obtained from each of the transducers and the SAM system and including data at 
lower frequencies by other authors, a polynomial fit was applied to all the published 
data on this TMM from 2 – 47 MHz. The polynomial fit was found to be of the form 
0.40 f + 0.0076 f 2 and agreed well with the earlier measurements in the frequency 
range of 2 – 7 MHz (Browne et al. 2003) and 6 - 15 MHz (Inglis et al. 2006) and 17 - 
23 MHz (Brewin et al. 2008). Moreover from Table 3.5, it can be seen that the 
coefficients of the linear terms varied between 0.4 dB·cm-1·MHz-1 and 0.5 dB·cm-
1·MHz-1 for the four Vevo 770 transducers.  The coefficients of quadratic term are 
not negligible showing the nonlinear frequency dependence of the TMM attenuation. 
However, at frequencies less than 15MHz, this polynomial approximated a linear fit 
to the data in the form of 0.47 f + 0.32.  
 
In Figure 3.10 for all transducers, the attenuation of the second batch of TMM was 
shown to be higher than the first batch. The transducers 710B, 707B and 704 
demonstrated differences in mean attenuation of less than 3 dB· cm-1.   Note that the 
difference in mean attenuation between the two batches of TMM was found to be 
largest for the 711 transducer (highest frequency probe, 3dB bandwidth: 27-47MHz) 
with a maximum difference of 5 dB·cm-1 at higher frequencies. This large 
discrepancy may be attributed to the increasing nonli earity of TMM at higher 
frequencies. From the phantom manufacture point of view, the variation between 
batches can be relatively easy to see in the high frequency range thus challenges the 
phantom production of comparable acoustic properties at high frequencies. 
 
3.5.2.2 TMM for mimicking the properties of bio-tis sue at high 
frequencies 
 
As a primary step towards phantom manufacture at high frequencies, the TMM 
discussed in this chapter shows good reproducibility at high frequency and is 
consistent with the results from low-frequency acoustical characterisation results. 
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However, manufacturing the phantom that mimics the properties of tissue at high 
frequencies require acoustic data of bio-tissue at high frequencies. Published data on 
the acoustic properties of human and animal tissue at high frequency ultrasound (20 - 
70 MHz) is limited and concentrated in the region of vascular tissues (Lockwood et 
al. 1991, Saijo et al. 1998), blood (Treeby et al.), skin tissues (Huang et al. 2007, 
Moran et al. 1995) and bovine tissue (Maruvada et al. 2000).  Once data is published 
on the acoustical properties of soft tissue at high frequencies, the proportion of 




The measured speeds of sound of an IEC agar-based TMM measured by the Vevo 
770 scanner and SAM system were found to be 1547.4 ± 1.  m·s-1 and 1548.0 ± 6.1 
m·s-1.  These values are consistent with the results in earlier studies by Browne et al. 
(Browne et al. 2003) over the range 2.25 - 15 MHz and Brewin et al. (Brewin et al. 
2008) over the range 17 – 23 MHz.  The attenuation in agar-based TMM was shown 
to increase with increasing frequency and is comparable to previous results when it 
extrapolates to the low frequency range. However at higher frequencies, the 
relationship between attenuation and frequency was shown to be non-linear.  A 
unifying polynomial function 0.40 f + 0.0076 f 2 was derived both based on the data 
generated in this study and on previously published data and was shown to be able to 
estimate the attenuation of this agar-based TMM in the frequency range 2 – 47 MHz. 
This characterisation of the TMM at frequencies greater than 20 MHz allows this 
IEC agar-based TMM to be potentially used in high frequency applications.  
 
Furthermore, this work aids to develop the MATLAB codes that will be used for 








Chapter 4  
Development of the methodology for the acoustic 





This chapter aims to develop a reproducible experimental set-up and methodology to 
explore appropriate experimental parameters for studying the acoustic properties of 
ultrasound contrast agents (UCAs) over the frequency range 12 to 43 MHz. After 
introducing the background information of commercial UCAs used in this thesis, the 




This thesis employed 3 commercially available UCAs: two clinical UCAs Definity 
(Lantheus Medical Imaging, USA) and SonoVue (Bracco Group, Italy) and one 
preclinical UCA MicroMarker (untargeted) (Visualsonics, Canada). Their parameters 










Table 4. 1: The parameters of UCAs, *Definity (Lantheus Medical Imaging 2011), † 
SonoVue (Gorce et al. 2000, Schneider 1999), ‡Microa ker (Visualsonics 2012). 
 










C3F8 Phospholipids 1.1-3.3 µm 1.2×1010 
microspheres/ ml 
10 µL/kg 












and fatty acid 
2.3-2.9 µm 2×109 
microspheres/ ml 




The magnitude of the backscattered spectrum is determin d by the size, shape, 
number density and the elastic properties of the scatter materials (Insana et al. 1990).  
For sparsely and randomly distributed small spherical s atterers (e.g., air bubbles in 
water or fog droplets in air (Morse and Ingard 1986)), the diameter of which is much 
smaller than the wavelength and their relative incoherent backscattered intensity (De 
Jong 1993) at a distance r approximates to: 
 














sI is the backscattered intensity, 0I  is the incident intensity, n is the 
concentration, i.e., number of scatterers per unit volume, V is the occupied volume, k 
is the wave number, R is the radius of the spherical sc tter, kγ  is the compressibility 
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term, ργ  is the density term, r is the distance. From Equation 4.1, relative backscatter 
intensity has a linear relationship with the number of scatterers and it is proportional 
to diameter to the 6th power, which is equivalent to he square of the volume of the 
scatterer. Consequently, the variation in size distribution has a larger impact on the 
backscatter than concentration.  Equation 4.1 is applicable only for sparsely 
populated linear scatterers.  For a high concentration of scatterers, the magnitude of 
the scatter signal is not only dependent on the individual scatterer but also influenced 
by the interaction between the scatterers referred as multiple scattering (Stride and 
Saffari 2005).  
 
One aim of this chapter is to determine the concentration range where the attenuation 
and backscatter are linearly proportional to the number of MBs. It is this linear range 
of concentrations which contributes to linear scattering models for modelling studies 
which generally assume homogeneously and randomly distributed scatterers and no 
multi-scattering (Marsh et al. 1998). For in vitro experiments performed in this linear 
concentration range, a linear relationship with the interested parameters (e.g., 
attenuation or backscatter intensity) is ensured anthe occurrence of multiple 
scattering and shadow is avoided.  Additionally, this linear range of concentration 
(dose) is also important in in vivo experiments, as the measured changes in the 
amplitude of received signals are directly proportional to the variations in 
haemodynamic properties (Stapleton et al. 2009). For this thesis, one concentration 
in this linear range is experimentally selected to ensure adequate signals with 
sufficient signal to noise ratio (SNR) for the following experiments.   
 
The magnitude of acoustic pressure influences the oscillation of the microbubbles 
(MBs) and determines the amplitude and the spectral ontent of the received echoes. 
There is a balance that the pressure has to be sufficiently high to provide adequate 
SNR, and at the same time not destroy the MBs. Di solution can occur when MBs 
enter into a solution and includes three types: non-destructive diffusion (static), 
transient diffusion (acoustically driven) and destruc ion (rapid fragmentation) 
depending on the driving pressure and bubble size (Bouakaz et al. 2005, Porter et al. 




This chapter starts with the introduction of the prparation of UCAs (4.3), and the 
measurement of the size distribution (4.4). The acquisition format of the RF data is 
discussed in section 4.5. Acoustic measurements were measured at a series of 
concentrations of MBs to identify an appropriate range of concentration (4.6.1), in 
which the attenuation (4.6.2) and backscatter (4.6.3) vary linearly with number of 
MBs. Choosing one concentration in this range, the variation in attenuation and 
normalized backscatter power with incident pressure (4.7) and time (4.8) were 
measured to determine how the operating ultrasound parameters change the acoustic 
properties of MBs. As this chapter aims to develop method and experimental 
parameters, for each experiment the microbubble suspensions were tested only once 
unless otherwise stated. One measurement includes three continuous data 
acquisitions using one microbubble suspension.   
 
In this chapter, since the results from the first experiments dictate the parameters 
selected in the later experiments the methods, results and discussions are compiled 
together for each experiment. No separated sections are et for results. 
 
4.3 RECONSTITUTION OF UCAS  
 
Definity contains 1.5ml clear liquid per vial and is recommended to be stored at 4oC. 
The contrast agent is activated by rapid shaking for 45 seconds by a CAPMIX 
machine (ESPE, Seefeld, Germany).   
 
SonoVue is kept at room temperature and is reconstituted by injecting 5ml sodium 
chloride solution 9mg/ml (0.9%) into 25mg lyophilized powder then hand shaking 
vigorously for 20 seconds.  
 
MicroMarker (untargeted) is preserved at room temperature and is reconstituted by 
injecting 0.7 ml sodium chloride solution 9mg/ml (0.9%) into MicroMarker vial then 




After agitation, all MBs were left for 20 minutes for the surface bubbles on the 
suspension to disappear and to allow temperature of Definity to reach room 
temperature.  Two 19G needles were inserted into the vial of Definity and 
MicroMarker, one of which was connected to a 1ml syringe. The needle and syringe 
were used to draw-up the contrast agent while the or 19G needle was used to vent 
the vial. SonoVue was withdrawn from the vial using the syringe incorporated in the 
SonoVue contrast reconstitution kit. The MBs were transferred into 0.2ml PCR tube 
(Eppendorf, UK) for storage and to enable smaller quantities to be extracted using 
pipettes (Gilson, USA). The specific volume of extrac ion depends on the 
concentration required. The activated MBs in the vial were resuspended by gently 
inverting the vial for 10 seconds before measurements. The activated UCAs may be 
used up to 12 hours for Definity (Lantheus Medical Imaging 2011) , 6 hours for 
SonoVue (Bracco 2011) and 3 hours for MicroMarker (Visualsonics).  All the 
experiments of UCAs were completed within these time li its. 
 
4.4 SIZE DISTRIBUTION OF UCAS  
 
The size distribution of MBs was measured by a laser diffraction particle analyser 
named Mastersizer 2000 Hydro MU (Malvern Instruments L d, Malvern, UK).  
Optical microscope is also a common tool of sizing MBs (Sennoga et al. 2012) but 
not applied in this study because the sizing the int rested small MBs(< 2 µm) in 
Chapters 5-6 is limited by the resolution of microsc pe.  
 
The Malvern Mastersizer 2000 software (version 5.4) (Malvern Instruments Ltd, 
Malvern, UK) controlled the measurement, data generation and exportation of the 
data, and also allowed further calculation of curve fitting after data acquisition. The 
measurement used a standard operating procedure (SOP). A SOP was a pre-defined 
program in the software and consisted of laser alignment, background measurement, 
sample measurement and result output.  The original measurement and output result 
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was volume based.  Each sizing process defined in SOP consists of three 
measurements with 10 second-delay from one sample, then outputs one averaged 
size distribution curve automatically. 
 
The sizing performed by the Mastersizer 2000 is based on optical technology and 
detects the laser diffraction pattern from the scattering solution, then employs Mie 
scattering theory and based on an assumption of spherical particle generated a size 
distribution curve. Mie theory is a solution to Maxwell’s equation for modelling the 
scattering of generally spherical (both absorbing and non-absorbing) particles 
(Boliren and Huffman 1983). It has no particle geomtric size limitation, so it is 
widely used in particle sizing. 
 
Obscuration, refractive index (RI), absorption (imagin ry RI) and residual are the 
most critical parameters for measurements. Obscuration is a quantity indicating the 
loss of light energy after introducing the test sample, the value of which determines 
the appropriate concentration of sample required ensuri g sufficient sample present 
for sizing. As the size distribution of microbubble ranges from less than 1 µm to 10 
µm, the obscuration recommended is larger than 10% (Malvern Instruments Ltd. 
1999).  Refractive index (RI) and absorption (ABS) value are quantitative 
measurements of the energy change of light transmitted through the sample medium.  
The RI and ABS function as coefficients in Mie model to fit the measured diffraction 
data set. Residual is the difference between the measured data and fitting curve.  A 
value under 1% indicates a good fit (Malvern Instruments Ltd. 1999). If the residual 
is larger than 1%, RI and absorption values are not pr perly pre-defined in SOP and 
require adjustment to make the best fit of the measured data.    
 
RI and absorption values of the contrast agents under test are unknown. Guan and 
Matula have previously shown that the intensity of the scattered optical signal 
showed little difference between free bubble and encapsulated thin shelled bubble 
(thickness of the shell < 30 nm) (Guan and Matula 2004). The shell thickness of 
SonoVue was reported to be 4 nm (Hoff 2001) and 2.5 nm (Chetty et al. 2008). The 
shell of Definity is a phospholipid monolayer and its thickness ranged between 1 to 2 
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nm (Goertz et al. 2007).  Hence, the RI of the core gas was applied to the SOP and 
the resultant residual satisfied the requirements of being <1%.  RI of the gas of 
SonoVue SF6 was 1.00064 (Obriot et al. 1993) and approximately agreed with  
1.0007 applied in the measurement of (Sennoga et al. 2012). The values of RI are 
listed in Table 4.2.  
 
Table 4. 2: The RI and absorption of contrast agent samples, glass beads and water  






Definity SonoVue MicroMarker 
RI 1.33 1.52 1.0012* 1.0007 1.001 
 
Sennoga et al (2012) suggested that the absorption value for SonoVue was 0.01. This 
value produced residuals less than 1% and was used for all the UCAs sizing 
experiments. 
4.4.1 Calibration using standard glass microspheres  
Before sizing MBs, glass microspheres (QAS2002, Malvern instrument Ltd., 
Whitehouse scientific, UK) with known size 15-120 mµ (nom), weight 2.5g (nom) 
were used to calibrate Mastersizer.  
 
The size distribution of QAS 2002 glass microspheres ranges from 15 – 120 µm 
shown in Figure 4.1. Dv10, Dv50 and Dv90 give the size of particle below which 
10%, 50% and 90% of the sample population lies respectively. The values of Dv10, 
Dv50 and Dv90 of the mean measured data are 29.274 µm, 6.48 µm and 73.384 µm. 
Table 4.3 lists the median values and limits provided by the manufacturer. These 
comparisons of the measured particle size distribution with the reference size range 
from the manufacture clearly show that Mastersizer passed the general calibration.  
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Figure 4. 1: The size distribution of QAS 2002 glass microspheres 
 
Table 4. 3: Standard percentile of the glass microspheres QAS 2002
 
 Dv10 (µm) Dv50 (µm) Dv90 (µm) 
Lower limit 26.72 45.40 72.38 
Median values 28.43 46.8 77 
Upper limit 30.14 48.20 81.62 
 
 
As the diameter of the UCAs used in the following exp riments is less than 15µm, a 
compensated performance verification certificate was issued from the manufacturer 
using latex beads of three diameters (nominal 0.3 µm, 1 µm and 9 µm) given in 
Appendix 4.  All the above data certify Mastersizer 2000 functions properly 
particularly in the size range below 10 µm, i.e., the diameter range of MBs. 
4.4.2 Sizing the microbubble suspensions 
The SOP was initially built by inputting the RI of different UCAs in Table 4.2. 
Within the Mastersizer software, a general-purpose model with an assumption of 
irregular particle shape was used to fit the measured data and obtain the size 
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distribution curve. Although lipid MB are generally assumed to be spherical, the 
assumption of irregular particle shape was chosen due to the considerations: 1) 
automatic over-weighting factor on the detectors receiving small particles in 
spherical model 2) the surface roughness of shell leading to the light loss (Sennoga et 
al. 2012), and 3)  possible dissolutions of MBs causing a buckling state (non-
spherical geometry)  (Marmottant et al. 2005).  
 
MBs were added gradually until the required obscuration level was reached. Once 
the measurement was complete, the volume based size distribution curves were 
generated automatically. Using Mastersizer software, number based size distribution 
curves were derived from the volume based size distribution. Each sizing experiment 
took no more than 2 minutes and the total time of the UCAs sizing measurement was 
within the life time for UCAs as recommended by themanufacturer. 
 
Figure 4.2 shows the size distribution curve of (a) Definity, (b) SonoVue and (c) 
MicroMarker. For each contrast agent, the left panel shows the volume-based size 
distribution and the right panel shows the number density size distribution. Although 
the total volume of the bubbles larger than 4 µm is greater than those less than 4 µm, 





























































































































































Figure 4. 2: The native size distribution of microbubble: (a) Definity, (b) SonoVue 
and (c) MicroMarker. For each contrast agent, the left panel shows the volume-
based size distribution. The right panel shows the number density size distribution. 
 
 90 
4.5 THE ACQUISITION OF RF DATA  
 
Before introducing the experimental method of measuring the acoustic properties of 
the MBs, the RF data acquisition will be introduced first. Goertz stated that the time 
interval between adjacent measurements should be sufficiently long to allow 
independent sampling of signals (Goertz 2002). Based on the backscattered signal 
from the MB suspension, the acquired RF data was anlysed to determine 1) whether 
the RF data samples are independent. This was determined using an autocorrelation 
function and 2) whether the magnitude of the data acquired at different lines 
(different spatial positions) is of statistical equivalence using one-way ANOVA.  
 
The RF data from a pre-selected region of interest (ROI) was exported for analysis. 
The size of ROI was kept as small as possible to ensur  that the pressure within the 
ROI was approximately the same and to ensure that attenuation within the ROI 
would be kept to a minimum.  In these studies, the width of ROI is 1.5 ± 0.2mm and 
minimum length is 1 ± 0.2mm for each transducer.  
 
Pulse repetition frequency (PRF) and frame rate were unable to be adjusted in RF 
mode. However, the time required for digitising and saving selected RF signals 
indirectly controlled the PRF and frame rate by setting the number of frames, lines 
and acquisition/line in ROI. The maximal number of frames, lines and number of 
acquisitions are 1000, 100 and 20. 20000 is the upper limit of the product of these 
three quantities, i.e., no more than 20000 signals were able to be saved per capture.  
 
In this experiment, for RF data acquisition, the number of frames, lines and 
acquisitions/line were set at 100, 3 and 1. It took 4 seconds to save these 300 signals 
and approximate 13 ms between each acquisition. Three measurements of 100 
frames, each frame comprising 3 lines of RF data, i.e. 100 samplings × 9 groups 
(lines) were acquired. As an example, for each acquisition the magnitude of the 
backscattered signal over 3dB bandwidth of the spectra of 9 groups using Definity 




The autocorrelation function of the 900 samplings (100 samplings × 9 lines) is 
shown in Figure 4.3. An autocorrelation of 1 indicates a perfect correlation and the 
value of 0 means uncorrelated between the samplings. Within 50 samplings, the 
autocorrelation value approximates to 0 in Figure 4.3 and shows that the data saved 
in the defined format is independent. Thus each measur ment acquires backscattered 
echo from fresh MBs which have not been insonated an  no interference occur 
between the adjacent acquisitions.    
 
The box plot in Figure 4.4 shows the magnitude of the backscattered signal obtained 
from the 9 lines. The median (red line in the middle of the box) and the 25th and 75th 
percentile (top and bottom line of the box) of the samplings of each of the 9 lines are 
approximate the same (± 2dB). Symbol of + represents point beyond the whiskers. 
From the statistical analysis, the significance (P value) of the data between the 9 lines 
was calculated to be 0.62 indicating that there is no significant difference between 
the 9 lines, i.e., the RF data acquired at different positions (3 lines) is the statistically 
equivalent resulting from the homogeneous MB suspenion under the same 
insonation. Consequently for the remainder of this c apter, the RF data was acquired 
in this format (100 frames ×3 lines×1 acquisition) a d repeated 3 times. 
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Figure 4. 4: The comparison of the magnitude of the backscatter sp ctra at 9 lines. 
The three lines of the box represent the 25th, 50th (median) and 75th percentile 
sequentially and the symbol + represents point beyond the whiskers. 
4.6 THE VARIATION IN ATTENUATION AND NORMALIZED 
BACKSCATTER POWER AS A FUNCTION OF 
CONCENTRATION 
 
The acoustic properties, including attenuation and normalized backscatter power of 
the microbubble suspensions, were measured using the substitution method described 
in Chapter 3. Due to the limited volume (0.7 ml pervial) and cost (10 times higher 
than SonoVue) of MicroMarker, the acoustical data of MicroMarker was measured 
only by transducers 707B and 704 (section 4.6.2).  
4.6.1 Determination of tested concentration of MBs 
This section described the reasons for choosing a series of tested concentrations of 
MBs. Figure 4.5 shows the B-mode image from (a) lowconcentration 0.1× 106 
 
 93 
mbs/ml to (c) high concentration 10× 106 mbs/ml. The white horizontal line in each 
figure is the upper surface of the reflector. The white triangle symbol beside the scale 
indicates the focal position. Two horizontal figures are from the same tank of MBs 
and the only differences are the position of ROI and Gain values. The three figures 
on the left panel are used to show the influence of concentration on attenuation. With 
increasing concentration, the brightness of the signal from the reflector gradually 
reduces due to the attenuation. The three figures on the right panel are used to show 
the impact of concentration on backscattered signals from MBs. As a result of 
increasing concentration, the amplitude of backscatter signals increases first because 
of the increasing number of MBs then declines due to the attenuation in the path.  
 
               
(a) Low concentration (0.1× 106 mbs/ml) (Gain: -2dB (left), 23dB (right)) 
 
                
(b) Medium concentration (0.8× 106 mbs/ml) (Gain: -2dB (left), 18dB (right)) 
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(c) High concentration (10× 106 mbs/ml) (Gain: -2dB (left), 31dB (right)) 
 
Figure 4. 5: Examples of B-mode image of reflected signal from reflector and 
backscatter signals from microbubble suspension at (a) low, (b) medium and (c) high 
concentration acquired by transducer 707B, white triangle indicates the focus 
(12.7mm in this case) on the right scale (accuracy: 0.1mm), ROI size (red box): 
1mm×1.5mm. 
 
The recommended concentrations of Definity, SonoVue and MicroMarker, in a unit 
of mbs/ml, for practical applications (shown in the last column of Table 4.5) are 
calculated based on the physiological parameters of human and mice (Janssen and 
Smits 2002) shown in Table 4.4, the maximum number of MBs within the vial after 
reconstitution and the recommended dosing regime from the manufacturer shown in  
Table 4.5. A series of test concentrations were chosen around these recommended 
concentrations and listed in Table 4.6. MBs were diluted in air saturated distilled 
water for the measurement.  
 
Table 4. 4: Physiological parameters of human and mice 
Human Mice 
Weight Blood volume Weight Blood volume 




Table 4. 5: The maximum concentration from manufacturer, recommended bolus 
dose and *their corresponding concentration in a unit of mbs/ml using the 
parameters of human (Table 4.4) for calculating theconcentration of Definity and 













10 µL/kg 1.6×106 mbs/ml 
SonoVue® 2-5×108 
microspheres /ml 











Table 4. 6: The tested concentration and dilution rate of Definity, SonoVue and 
MicroMarker 
Definity 
 (×106 mbs/ml) 0.01 0.075 0.15 0.3 0.6 1.2 1.6 2.4 
Dilution rate 1:320000 1:160000 1:80000 1:40000 1:20000 1:10000 1:7500 1:5000 
 
SonoVue  
(×106 mbs/ml) 0.1 0.2 0.4 0.8 1.6 4.9 6.4 10 
Dilution rate 1:5000 1:2500 1:1250 1:625 1:312.5 1:102 1:78 1:50 
 
MicroMarker  
(×106 mbs/ml) 0.1 0.2 0.4 0.8 1.6 4.9 6.4 10 
Dilution rate 1:20000 1:10000 1:5000 1:2500 1:1250 1:408 1:312.5 1:200 
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4.6.2  The concentration dependent attenuation meas urement 
The experimental apparatus for measuring attenuation were assembled as shown in 
Figure 4.6. A water tank (7cm-diameter, 4cm-height) was placed on a magnetic 
stirrer (RCT basic, IKA, US) with a magnetic bar (3mm-OD, 1cm-length) for 
ensuring a homogeneous suspension. A transducer was placed perpendicular to the 
TPX reflector which was positioned at the bottom of the tank, and the transmitting 
power was set at 10%-power, the corresponding peak n gative pressures are given in 
Appendix 3. MBs, at a known concentration, were diluted into the water tank and 
stirred for one minute at a speed of 430 rpm before measurement. The schematic 
position of the ROI and the focus for the attenuation measurement are shown in 
Figure 4.7 and its corresponding figures from the scanner are presented in Figure 4.8. 
 










                         Figure 4. 6: Schematic of experimental set-up 
 
The attenuation is measured as the amplitude reduction of the ultrasound signal, 
which has propagated through the diluted microbubble suspension, compared to the 
same signal propagated through the reference water medium. The attenuation 
coefficient was calculated by subtraction of the frquency spectra of the RF signals 
from the TPX reflector through the microbubble suspension from the RF signals 
from the TPX reflector through water. The attenuation coefficient α in the unit of 
dBcm-1 was calculated using the Equation 4.2 








−=α                                                           (4. 2) 
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where I(0) is the magnitude of the power spectrum of the signal from the reflector 
with the water in the tank (Figure 4.7.a), I(d) is the magnitude of the power spectrum 
of the signal from the reflector with the MBs in the tank (Figure 4.7.b), and d is the 
distance from the transducer to the upper surface of the TPX reflector. D is the 
distance reading from the RF raw data of the scanner which assumes speed of sound 
is 1540 m·s-1. The speed of sound Vwater is from the published data (Bilaniuk and 
Wong 1993) at a specific temperature. The actual distance d between transducer and 




           (a) Water in the tank            (b) Microbubble suspension in the tank 
Figure 4. 7: Schematic of attenuation measurement showing the position of focus 
and ROI 
 
At each concentration, the attenuation of the contrast agent suspensions was 













           
 
             (a) Water in the tank                 (b) Microbubble suspension in the tank 
Figure 4. 8: The screen capture of the attenuation measurement corresponding to 
Figure 4.7. Examples acquired by transducer 710B, the red box is ROI (size: 
1.2mm×1.7mm) and white triangle on the right side of scale indicates the position of 
the focus (15 mm in this case) 
 
The attenuation (Figure 4.9 - 4.12) of ultrasound through suspensions of Definity, 
SonoVue and MicroMarker (only measured by transducer 707B and 704) increase 
with increasing concentration measured by transducers 710B, 707B, 704 and 711 at 
10% power. The inset in each figure shows the attenuation data as a function of 
concentration up to 10×106 MBs/ml.  Attenuation varies linearly with concentration 
(at concentrations less than 3 × 106 mbs/ml) with R2 shown to be greater than 0.99 







































Figure 4. 9: Attenuation of Definity and SonoVue as a function of concentration 
measured by transducer 710B (3dB bandwidth: 12-25 MHz) 
 

































Figure 4. 10:  Attenuation of Definity, SonoVue and MicroMarker as a function of 
concentration measured by transducer 707B (3dB bandwidth: 17-31MHz) 
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Figure 4. 11: Attenuation of Definity, SonoVue and MicroMarker as a function of 
concentration measured by transducer 704 (3dB bandwidth: 18-32MHz) 
 




































Figure 4. 12:  Attenuation of Definity and SonoVue as a function of concentration 
measured by transducer 711 (3dB bandwidth: 27-47MHz) 
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4.6.3 The concentration dependence of normalized ba ckscatter power  
The normalised backscatter power (NBS) was calculated by normalizing backscatter 
power to a reference measurement to make the measurement independent of 
transducer properties. Previous groups have analysed six methods of processing the 
integrated backscatter signal in time and frequency domain and no significant 
difference was shown using myocardial tissue data (Rijsterborgh et al. 1993). The 
study regarded the integration of the backscattered sp ctrum over the 6dB bandwidth 
of the transducer as a gold standard. Other published calculations of the backscatter 
power include the root mean square (RMS) backscatter coustic pressure (Pa) (Butler 
et al. 2008) and mean backscatter power (dB) over the sampling points (Moran et al. 
2002).  
 
The calculation of NBS in this chapter is based on the  ‘gold standard’ from 
(Rijsterborgh et al. 1993) and normalized the mean squared acoustic power of the 
backscattered signal from the diluted microbubble suspension to the reflected signal 
from the reflector at the focus of the transducer in the microbubble suspension 
(Equation 4.3).  
 





                           (4. 3) 
 
To avoid saturation of the amplifier electronics, the gain settings for the reference 
measurement were lower than that of diluted microbubble suspension backscatter 
measurements. This difference in gain settings was taken into consideration in the 
subsequent calculations.   
 
For each concentration, the NBS of the contrast agent suspension was integrated and 



















              Figure 4. 13: Schematic of normalized backscatter power measurement  
 
                              
 
(a) Reference (Gain=-2dB)            (b) Backscattered signal from MBs (Gain= 23 dB)      
      
Figure 4. 14: The screen capture of the NBS measurement corresponding to Figure 
4.13 The red box is ROI and white triangle on the right side of scale indicates the 
position of the focus. Examples acquired by transducer 710B, the red box is ROI 
(size: 1.2mm×1.7mm) and white triangle on the right side of scale indicates the 
position of the focus (15 mm in this case) 
 
Figure 4.15 - 4.18 show NBS of ultrasound through suspensions of Definity, 
SonoVue and MicroMarker increase with increasing concentration measured by 
transducers 710B, 707B, 704 and 711 at 10% output power. NBS approximates a 
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linear relationship with concentrations (at concentrations less than 3 × 106 mbs/ml) 
with R2 shown to be greater than 0.99 for all fits.   
 
The insonating frequency of the testing transducers is much higher than the 
published resonance frequency of Definity (8 - 12 MHz) (Goertz et al. 2007) and 
SonoVue (1 - 3 MHz ) (Gorce et al. 2000). In the same range of microbubble 
concentrations, the three UCAs produce comparable attenuation and normalized 
backscatter power responses. The transducer 711 that transmits the highest frequency 
ultrasound (3dB bandwidth 27-47MHz, the furthest from the resonance frequency) 
shows the lowest backscattered power and attenuatio in Figure 4.18. The largest 
difference in normalized backscatter power between D finity and SonoVue is from 
the result of transducer 711.  
 
          












































Figure 4. 15: Normalized backscatter power of Definity and SonoVue varied with 
concentration measured by transducer 710B (3dB bandwidth: 12-25 MHz) 
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Figure 4. 16: Normalized backscatter power of Definity, SonoVue and MicroMarker 
varied with concentration measured by transducer 707B (3dB bandwidth: 17-
31MHz) 











































Figure 4. 17: Normalized backscatter power of Definity, SonoVue and MicroMarker 
varied with concentration measured by transducer 704 (3dB bandwidth: 18-32MHz) 
 
 105 
        











































Figure 4. 18:  Normalized backscatter power of Definity and SonoVue varied with 
concentration measured by transducer 711 (3dB bandwidth: 27-47MHz) 
 
In summary, any concentration of tested MBs below 3 × 106 mbs/ml can be regarded 
as a suitable concentration for future experiments, as the attenuation and NBS 
demonstrate a linear relationship with the number of MBs.  In this chapter, 
concentrations of 0.8× 106 mbs/ml and 1.6× 106 mbs/ml are used in the following 
experiments and 0.8× 106 mbs/ml is used in Chapters 5-7.  
 
4.7 THE PRESSURE DEPENDENCE OF ATTENUATION AND 
NBS 
The acoustic pressure determines the amplitude of oscillation of MBs. Specifically, 
at low incident pressure, in a non-destructive environment the contrast microbubble 
can exhibit a prolonged enhancement period.  At high incident pressure, the MBs are 
forced to collapse and produce a rapid and short enhancement. Some perfusion 
studies rely upon the interplay of two different acoustic pressure pulse transmission, 
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i.e., power modulation. Moreover drug-delivery studies use high pressures to cause 
the shells of drug- or gene-loaded MBs to collapse rel asing a high gene- or drug-
load to specific sites (Unger et al. 2001). Therefor  it is important to assess MB 
behaviour at a range of acoustic pressures. A large number of studies is available at 
lower frequencies relevant for human diagnostic equipment, but not at the 
frequencies investigated here.  
 
In this section, the attenuation and NBS of Definity and SonoVue suspensions were 
measured at transmitted powers from low (3%) to high (100%) using a concentration 
of 1.6×106 mbs/ml, which was determined from Section 4.7 as a mid-point 
concentration at which attenuation and backscatter varied linearly as a function of 
concentration. In this experiment for each power, the attenuation and NBS of the 
microbubble suspensions was integrated and averaged over the 3dB bandwidth of the 
power spectra, respectively. Only transducer 707B was used because 707B shows the 
widest range of pressure (peak negative values (PNP) listed in Appendix 3) among 
the four tested transducers and its central frequency 30 MHz was in the middle of the 
frequency range of all the transducers. The experiment was completed once in one 
tank of MBs using one-cycle pulse over a period of 30 minutes. This pressure 
dependence experiment aimed to understand the trendof how attenuation and NBS 
varied with pressure and estimate a suitable pressu range for studies described in 
chapter 5 to measure the attenuation and contrast to tissue ratio under a non-
destructive experimental environment.  
 
Figure 4.19 shows the signal reflected from the TPX reflector through the water and 
microbubble suspension in the time domain and frequency domain. The difference of 
the spectra in Figure 4.19 (b) is the attenuation as a function of frequency over twice 






























Reflected signal through water
Attenuated signal through microbubble suspension





















Spectrum of reflected signal through water
Spectrum of attenuated signal through microbubble suspension
 
       (a)                                                           (b) 
Figure 4. 19: The reflected ultrasound signals and their associated spectra reflected 
from the TPX reflector through the water (reference) and through the microbubble 
suspension in (a) time domain and (b) frequency domain 
 
From Figure 4.20, it can be seen that the attenuation decreases with increasing power 
settings. However, for powers below 8% power setting (the first 5 points on the PNP-
axis), the attenuation curves of Definity and SonoVue stay approximately horizontal 
indicating a weak relationship between attenuation and pressure below 0.95 MPa 
(8%-power of transducer 707B).  
 
The NBS is up to 8 dB higher at 3% power (the first PNP) than the 100% power (the 
last PNP) for Definity shown in Figure 4.21 (a) compared to a difference of 5dB for 
SonoVue in Figure 4.21 (b).  At higher transmitting power, MBs oscillate in larger 
amplitude producing larger backscatter cross section, but also have a high possibility 
to be driven to diffuse and disrupt, thus the total number of scattering particles may 
reduce and the size distribution may change. For this reason, both the attenuation and 
NBS decrease with increasing power.  
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(a) Definity                                              (b) SonoVue 
Figure 4. 20:  The variation in the mean attenuation of (a) Definity and (b) SonoVue 
with PNP measured by transducer 707B    
 




























































(a) Definity                                              (b) SonoVue 
Figure 4. 21: The variation in the NBS of (a) Definity and (b) SonoVue with PNP 
measured by transducer 707B  
 
Note that the experiment in Figure 4.20-4.21 was completed in one tank of MBs in 
30 minutes.  Over this period of time, the natural diffusion of MBs may alter the 
acoustic response and the destruction of MBs may accumulate in the sequent 
measurements. Time and the different pressures may be additional factors to be 
considered, so the influence of time is further discussed in section 4.9 using one 
pressure per experiment. Additionally, the relationship between attenuation a d 
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pressure could be further investigated by fast-time pressure dependent measurements 
as previously described (Tang et al. 2005). However, because of the long time-
interval limitation of manual operation in setting varying pressure during the 
experiment, this work can not be accomplished using this scanner. 
 
4.8 THE VARIATION OF ATTENUATION AND BACKSCATTER 
WITH TIME  
 
The behaviour of the MBs over time is also of interest, as this may reveal the 
occurrence of acoustic driven diffusion and rapid fragmentation at various pressures. 
This section includes two experiments. The first one is the attenuation measurements 
obtained by transducer 707B at four power settings 4%, 10%, 50% and 100% 
acquired over a period of 15 minutes intermittent scanning. The second experiment is 
measurements of normalized backscatter intensity usng 4 transducers 710B, 707B, 
704 and 711 over 30 minutes intermittent and continuous scanning. 
 
In the first experiment, the attenuation measurements were obtained 4 times 
intermittently by transducer 707B over 15 minutes with 5-minute interval between 
scans. Four power settings 4%, 10%, 50% and 100% were used in each independent 
test.  In Figure 4.22, the frequency dependent attenuation curves at 4%-power are 
stable over 15 minute because the attenuation curves overlap, whereas the 
attenuation curves at other power settings drop gradually at sequential time points 
showing attenuation decreases with time. Higher power gives a more pronounced 
decrease of attenuation for each UCA seen from one c lumn of Figure 4.22. The 
attenuation of Definity measured at 10%, 50% and 100% presents similar values 
around 3.5-3.75dB·cm-1 at 17MHz while the general trend of attenuation with 
frequency is steeper at 100% power than that at 10%power setting. However, for 
SonoVue, the attenuation curve of the initial measurement drops with increasing 


































      




























































    




























































     






























































      































Figure 4. 22: The attenuation of ultrasound through Definity (left panel) and 
SonoVue (right panel) measured suspensions by transducer 707B at the power 
setting (a) 4%, (b) 10%, (c)50% and (d) 100%  for 15 minutes 
  
The second experiment studied the influence of continuous insonation over 30 
minute by calculating the normalized backscatter intensity at a low pressure (10% 
transmitted power). A flow chart in Figure 4.23 shows this process. The continuous 
scan was defined as a process of obtaining data from one ta k of Definity (or 
SonoVue) microbubble suspensions at a concentration of 0.8 × 106 mbs/ml every 2 
minutes for 30 minutes using transducers 710B, 707B, 704 and 711. Between the 
adjacent data acquisition every 2 minute, the scanner continued to transmit 
ultrasound. As control groups, the intermittent scan using a new tank of 
microbubble suspensions were acquired for 30 minutes with 2-minute interval for 
Definity and 4-minute interval for SonoVue. The reason of choosing 4-minute 
interval for SonoVue is based on the previous results of Definity as no obvious 
difference between the intermittent and continuous scan is found from Definity result 
measured by transducer 704 and 711, 4-minute interval was applied to reduce the 
time exposure to ultrasound in the intermittent scan. The microbubble suspensions 
were stirred continuously over the entire measurements.  
 
The backscatter intensity was normalized to the initial value of each group. NBS is 
not calculated because it requires the data of attenuat d signal from the reflector, the 
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measurement of which extends the exposure time to ultrasound. In this way, the 
ultrasound exposure time can be reduced. An exponent function of ceay bx +⋅= −  
(Smith et al. 2007) was fitted to the result and the correlation coefficient R2 was 
calculated. 
 




                                                   (a) 






Figure 4. 23: Flow chart of continuous scan and intermittent scan, DA indicates 
data acquisition. For intermittent scan, the time interval between measurements is 2 
minutes for Definity and 4 minutes for SonoVue leading to different times of 
measurements in 30 minutes 
 
The influence of continuous insonation was studied at 10% transmitting power using 
Definity and SonoVue shown in Figure 4.24. The attenuation from intermittent scans 
decreases with time. The correlation coefficient R2 of an exponent function of 
ceay bx +⋅= −  were larger than 0.97 for all fittings.  
 
The normalized backscatter intensities of continuous and intermittent scan overlap at 
1 because of self-normalization. This does not mean th t the absolute values of the 
first backscatter measurement are the same. This presentation format only focuses on 






































    

































(a) 710B (3dB bandwidth: 12-25MHz) 
 



































    

































(b) 707B (3dB bandwidth: 30MHz) 
 

































































    
                                       (c) 704 (3dB bandwidth: 20-40MHz) 
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(d) 711 (3dB bandwidth: 27-47MHz) 
Figure 4. 24: Normalized backscatter intensity of Definity (left panel) and SonoVue 
(right panel) measured by 710B (a), 707B (b), 704 (c) and 711 (d) 
 
In Figure 4.24, the largest difference between the continuous scan and intermittent 
scan is from transducer 710B (Figure 4.24 (a)). Thereasons include the transmitting 
peak negative pressure of 710B at 10% power setting is higher than two transducers 
704 and 711 and its 3dB bandwidth is closest to the resonant frequency of Definity 
and SonoVue compared with other transducers. One interesting point is the curve of 
intermittent scan is steeper than the curve of continuous scan. The only difference 
between continuous and intermittent scan is the exposure time to ultrasound. On one 
side, the intermittent scan always drives fresh MBs into the insonation plane and 
reflects the natural lifetime of MBs with time if the insonation is non-destructive. On 
the other side, the receiving signals from continuous scan come from MBs of various 
stages: fresh, oscillated and disrupted. To some ext nt, the difference between the 
two curves is an indicator as to whether the insonati  pressure destroys MBs. For 
this case, the large difference of the two curves indicates the pressure from 
transducer 710B may disrupt MBs. The possible reason of the low gradient from 
continuous scan compared to the intermittent scan my be due to the low backscatter 
signal from the initial measurement and further continuous destruction. Other 
possible reasons may be attributed to gas release from the encapsulated bubbles (de 
Jong et al. 2009).  It is known that theoretically free small bubbles resonate at high 
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frequency, though they survive very short periods of time (few microseconds). 
Figure 4.25 shows the simulation of the resonance frequency of free and 
encapsulated MBs using the equation and parameters of encapsulated SonoVue 
bubbles (Goertz et al. 2007, Gorce et al. 2000). The detailed equation and parameters 
can be found in Chapter 5. Continuous scanning exert d energy on the bubble more 
frequently and was able to capture the echo from free bubbles. Thus, the continuous 
scan may produce higher backscatter than the intermit nt scan. When the insonating 
frequency is removed from the resonance frequency of the MBs and transmitting 
pressure is low (case for transducer 704 and 711), little gas leases from the MBs 
producing no significant changes on the backscatter curves.  
 


























undamped resonance frequency of free bubble
damped resonance frequency of encapsulated bubble
 
Figure 4. 25: The simulation of the resonance frequency of free MB and 
encapsulated SonoVue MBs 
 
4.9 DISCUSSION 
The reconstitution and sizing process of UCAs detailed in this chapter are used in the 
experiments of the following chapters 5-7.   
 
Through the concentration dependent experiment of attenuation and NBS, a linear 
range was found to ensure the attenuation varied linearly with number of MBs and 
 
 116 
NBS varied linearly with the number of MBs. Within this range, a concentration of 
0.8×106 mbs/ml is determined to be used in the following chapters.  
 
The variation in attenuation and NBS measured with increasing power showed that 
the MBs might be disrupted at high power, but the accumulated influence of higher 
power and time cannot be excluded because the experiments were completed in one 
sample. Thus, independent MB attenuation measuring at 4%, 10%, 50% and 100% - 
transmitting power over 15 minutes were made and only the power as low as 4% 
showed a stable attenuation curve. Additionally, the continuous and intermittent 
experiments measured at 10% power over 30 minutes also suggested possible MB 
destruction. All these indicate lower powers less than 4%, e.g. 3% would be suitable 
for prospective non-destructive experiments.  
4.10 CONCLUSION 
This chapter provides a set of preparations for measuring UCAs in the following 
experiments: UCA reconstitutions, size distribution measurement, and format of RF 
data acquisition. More importantly, the concentration of 0.8×106 mbs/ml and PNP in 
response to 3% power (minimal power out of the scanner) are determined to be used 














    
Chapter 5 
The attenuation and contrast to tissue ratio of thr ee 




The aim of this chapter is to compare the fundamental acoustic performance of 
Definity, SonoVue and MicroMarker as a function of size over the frequency range 
12 - 43 MHz at 20± 1oC.  The values of measured attenuation are compared with 
those published previously and guide the choice of shell properties for computer 
simulation in the high frequency range. Based on the estimated resonant diameter 
from these simulation results, by a process of decantation, two subpopulations of the 
native microbubbles (MBs) are formed with differing size distributions. The analysis 
addresses the questions: 1. how the variation in size d stribution and concentration 
alter the fundamental acoustic response at high ultrasound frequencies and 2. the 
potential impacts  of size distribution on the improvement of the preclinical 
applications. The subsequent subharmonic responses of these subpopulations are 
discussed in Chapter 6.  
5.2. INTRODUCTION 
 
In previous in vivo studies, the backscatter response and the duration of e hancement 
of Definity were characterised in mice at 40 MHz using 3.5 MPa peak negative 
pressure (Sirsi et al. 2010) and it was found that large Definity MBs (4-5 and 6-8 µm 
diameter) had longer persistence and stronger contrast enhancement than small MBs 
(1-2 µm diameter). It also concluded that the dissolution of the gas core was the 
dominant mechanism of contrast decay and that this mechanism was larger than the 
filtration and removal of the UCAs by macrophages in the lung, liver and spleen. The 
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concentration dependent attenuation and backscatter properties of Defintiy at 30 
MHz were investigated both in vivo and in vitro and the results suggested that doses 
between 10 and 60 µL ·kg-1 produced a linear increase in peak enhancement and 
these doses were recommended for quantitative contrast flow studies in mice 
(Stapleton et al. 2009).  
 
For in vitro experiments studying the fundamental acoustic response of UCAs, the 
attenuation of UCAs has been previously studied: Definity ((Goertz et al. 2007) over 
12-29 MHz and (Faez et al. 2011) over  5-15 MHz), SonoVue ( (Gorce et al. 2000) 
over 0.8-10MHz) and MicroMarker ( (Huo et al. 2010) over 18-25 MHz). Data based 
on these results are used to calculate the shell properties (listed in Table 5.2) and 
support the simulation study of MBs dynamics. Mean backscatter power and 
attenuation of surfactant encapsulated Sonazoid (Nycomed; Oslo, Norway), Definity, 
SonoVue and albumin shelled Optison (Mallinckrodt; Hennef, Germany) were 
measured at 30 MHz as a function of concentration and time (Moran et al. 2005, 
Moran et al. 2002). The concentration range of 104 to 106 MBs·ml-1 was found to 
present a linear relationship with mean backscatter power. 
  
The literature has demonstrated that alteration of the MBs size distribution 
effectively changes the fundamental (Sirsi et al. 2010) and harmonic response 
(Cheung et al. 2008, Goertz et al. 2003) at high ultrasound frequencies. However, 
little work has been done on investigating the acoustic response of selective size 
distributions of MBs. Between the UCAs measured by various experiment set-ups, 
differences in shell, gas and size distribution of MBs exists and the differences in 
experimental methods cannot be excluded as having an effect on the acoustic 
response. Consequently, it is not clear which factor or factors predominantly 
influence the fundamental and subharmonic performance of MBs at high frequency.  
This chapter aims to address the effect of size distribution on the fundamental 
response of different-sized subpopulations and the following Chapter 6 studies the 
subharmonic response from these subpopulations. 
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5.3 MATERIALS AND METHODS 
5.3.1 UCAs preparation  
Reconstitution and sizing of UCAs were described in chapter 4 and referred as 
‘native MB population’. As the pre-reconstitution temperature of Definity influences 
the acoustic properties (Helfield et al. 2012), Definity was left 15 minutes at room 
temperature before activation. Based on the maximum concentration (Table 4.1) 
from the manufacturer’s published literature, MBs in d fferent dilutions (Table 5.1) 
were diluted in air saturated distilled water to reach the same concentration of 
0.8×106 MBs·ml-1 and stirred for one minute at a speed of 430 rpm before 
measurement. This concentration lies in the range of concentrations in which 
attenuation of Definity, SonoVue and MicroMarker varies linearly as shown in 
Chapter 4.  
 
Table 5. 1: The dilution of Definity, SonoVue and MicroMarker 
 
Name Definity SonoVue MicroMarker 
Dilution 1:15000 1:625 1:2500 
 
5.3.2 Microbubble size distribution manipulation by  decantation 
The MBs were sub-divided into 2 subpopulations, referr d to as large MBs and small 
MBs. This was achieved using the method of decantatio  that has been shown to be a 
simple method to alter the size distribution of MBs (Goertz et al. 2007, Gorce et al. 
2000).  The boundary between large and small MBs derives from the considerations 
of separating the MB population into MBs resonating above the lower limit of the 
testing frequency, i.e., 12 MHz. Applying de Jong’s model, the simulation of 
scattering cross-section σs (r, f) in Equation 5.1 (Equation 1 in (de Jong et al. 1992)) 
and resonance frequency fres in Equation 5.2 (Equation 7 in (Goertz et al. 2007)) can 
 
 120 
be used to determine the boundary of dividing the MBs population. The shell 
properties of the three UCAs used in the simulation are listed in Table 5.2. 
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=                                      (5.1) 
The resonance frequency corresponds to the MBs oscillating to a maximum 
scattering cross-section.  
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+=  is the resonance frequency of encapsulated bubble,  
the total damping totalδ  consists of radiation, viscosity and shell friction damping  
 















r: radius of bubble, Sf is shell friction = 48 ∈sπµ , Sp is shell stiffness = 6Gs∈, sµ : 
shell viscosity, Gs: shell elastic modulus, ∈ is the thickness of the shell,                                                                                                                              
γ is the polytropic exponent (Definity: 1.06 (Goertz et al. 2007), SonoVue: 1.095 








                       
Table 5. 2: The shell stiffness Sp and friction Sf of the three UCAs 
 
UCAs Frequency range Sp (N·m
-1) Sf (×10
-6 kg·s-1) Reference 
Definity 12 – 28 MHz 1.71±0.24 0.015±0.015 (Goertz e  al. 2007) 
SonoVue 0.8 – 3 MHz 1.1 0.27 (Gorce et al. 2000) 
MicroMarker 18 – 25 MHz 10.3* 0.15* (Helfield et al. 2012) 
 
* Shell elasticity χ = 5.15 N·m-1and shell viscosity κs = 3×10
-9 kg·s-1 (Helfield et al. 
2012) referred from (Huo et al. 2010), Sp = 2 χ, Sf = 16π κs (Doinikov and Bouakaz 
2011) 
 
The resonance frequencies of Definity, SonoVue and MicroMarker as a function of 
MB diameter are plotted in Figure 5.1. The critical size, defined as the size below 
which the encapsulated MBs would never resonant (Khismatullin 2004), when 
insonated at 12 MHz are found to be 0.5µm for Definity, 1.5 µm  for SonoVue and 1 
µm for Micromarker. Above the critical size MBs with less than 1.7 µm-diameter 
(Definity) and 3.1 µm-diameter (MicroMarker) resonate at frequencies higher than 
12 MHz, while no SonoVue MBs were found to resonate within this frequency 
range. A boundary of 2µm diameter was chosen as a compromise to divide the 
populations of Definity and SonoVue into large and small MBs. The reason is that 
below this diameter includes the Definity MBs capable of resonating above 12 MHz 
and SonoVue MBs approximately giving the peak of acoustic response. 
MicroMarker was not decanted for comparison due to over 80% MBs of its native 










































Figure 5. 1: The resonance frequency as a function of diameter for Definity, 
SonoVue and MicroMarker (derived from Equation 7 in (Goertz et al. 2007) using de 
Jong’s model). The shell parameters of the three UCAs used in the simulation of 
resonance frequency are listed in Table 5.2.The bluline at 12MHz is the lower end 
of the testing frequency range in this study 
 
The estimated decantation time for acquiring MBs of a specific diameter is based 
upon Stokes’ equation (Equation 5.3) (Equation 12 in (Goertz et al. 2007)), the 
principal of which is based upon the varying times of different-sized MBs floating a 
certain height. The height is determined by the requir d volume and the shape of the 
container used for decantation. 










≅                                                    (5.3) 
 
where t is the floating time, d is the distance of rising, lµ is the viscosity of liquid, r 
is the radius of bubble, g is the gravitational force and lρ is the  density of liquid. 
 
In this study 0.5ml Definity and 2ml SonoVue decanted MBs were selected to ensure 
the measurement of one UCA coming from the same vial at the required 
concentration, which corresponds to target rising heig t of 1.1cm for Definity and 
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1.6cm SonoVue using the original inverted vials as decanting containers. Figure 5.2 
shows the varying time for MBs of diameter between 0.8 and 8 µm to float a 1.1 and 
1.6 cm – in water. It can be seen that a period of approximately 1-hour for Definity 
and 2-hour for SonoVue is sufficient for MBs larger than 2µm to float the rising 
height.  






























Figure 5. 2: The time for MBs in a diameter of 0.8-8 µm to float a 1.1 cm and 1.6cm-
distance using Stokes’ equation 
 
Consequently 0.5ml of 1-hour decanted Definity and 2ml of 2-hour decanted 
SonoVue MBs were acquired in this study. For a detailed process of handling 
decantation, the original vials with reconstituted UCAs were inverted and stood at 
room temperature. After the certain period of time (1 hour for Definity and 2 hour for 
SonoVue), two 19G needles were inserted into the vial and the position of vial was 
kept inverted during this process. One needle was fully inserted for venting the gas. 
The head of the other needle was just inserted into the rubber stopper of vial allowing 
extraction of the required volume (0.5ml for Definity and 2ml for SonoVue). By 
collection of the decanted volume of UCAs allows separation of the MBs that are 
less than 2µm-diameter. MBs less than 2µm in diameter will be called ‘small MBs’ . 
The remainder will be called ‘large MBs’  and are from the native solution after 
removal of the small MBs. The detailed manipulation of decantation is given in 
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(Goertz et al. 2007). Same dilution was employed in each subpopulation pre- and 
post-decantation for the acoustic measurements. 
 
The size distribution of Definity, SonoVue and MicroMarker MBs was measured by 
a Mastersizer 2000 Hydro MU and followed the protocl in Chapter 4. Mastersizer 
does not output the concentration directly, but the value can be calculated using the 
measured volume based size distribution data and assuming that the MBs are 
spherical. Based on a known volume of the suspension, the concentration can be 
acquired by calculating the total number of MBs from the measured volume and the 
volume of individual MBs at the measured diameter. 
5.3.3 The measurement of attenuation and contrast t o tissue ratio  
The measurement of the attenuation was detailed in Chapter 4. The backscatter 
capacity of UCAs were evaluated using the contrast to tissue ratio (CTR) defined in 
Equation 5.4, which was calculated by normalizing the mean squared acoustic power 
of the backscattered signal from the MB suspension to the mean squared acoustic 
power of the backscattered signal of a tissue mimicking material (TMM) (Sun et al. 
2012) placed at the focus of the transducer as shown in Figure 5.3. The backscattered 
power was calculated from the power spectra of the signal in frequency domain and 
integrated over the 3dB bandwidth of the transducer. Because the backscattered 
TMM signal was measured in water, the backscatter of the MBs suspension was 
compensated by the attenuation of the ultrasound (α) through the MBs suspension 
between the transducer and the upper surface of ROI (dup).  
 






























(a) Backscattered signal from MB suspension    (b) Backscattered signal from TMM 
Figure 5. 3: Schematic of CTR experimental set-up 
 
Each experiment was repeated three times and 900 indepe dent samples (300 
consecutive frames on 3 lines) in ROI were colleted p r experiment. 
 
The power spectra of the backscattered signals from two TMM samples at three 
positions per TMM were measured and the averaged spctra over the 3dB bandwidth 
of each transducer were calculated and shown in Table 5.3.  These values were used 
as the denominator for the CTR calculation in Equation 5.4.  
 
Table 5. 3: The mean backscatter value from TMM samples over the 3dB bandwidth 
of the four transducers 
Transducers 710B 707B 704 711 
TMM BS (dB) 30.2068 ± 
0.9915 
31.9763    ± 
0.9776 
30.8297   ± 
0.9928 
28.9287   ± 
0.9061 
5.3.4 Determination of transmitting pressure 
For the attenuation and CTR measurement, the transmitting peak negative pressures 
(PNP) were set at 0.56 MPa for transducer 710B and 707B (MI=0.16 at 12 MHz 
frequency). For transducers 704 and 711, the PNP was selected at 0.58 MPa 
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(MI=0.09 at 43 MHz frequency) to approximate a comparable PNP output similar to 
that exhibited by transducers 710B and 707B. The measur ment of the acoustic 
pressure from the four transducers can be found in Chapter 2 and values listed in 
Table 5.4 are selected from Appendix 3.  
 
Table 5. 4: Characteristics of four high frequency transducers.  The central 
frequency and focal length measurements are defined by manufacturer’s literature. 
The PNP (measured by a membrane hydrophone) and 3dB bandwidth (measured 
from the frequency spectrum) in response to the specific output power setting of each 
transducer.  
 
Transducer model RMV 710B 707B 704 711 
Central frequency (MHz) 25 30 40 55 
Focal length  (mm) 15 12.7 6 6 
Power 3% 3% 13% 50% 
PNP (MPa) 0.56 0.56 0.58 0.58 
Measured 3dB band width (MHz) 12 - 25 17 - 31 18 - 32 24 - 43 
5.4 RESULTS 
5.4.1 Scattering cross-section of the three UCAs ba sed on simulation 
results 
Figure 5.4 shows the scattering cross-section of the three UCAs for different sizes in 
the vicinity of the estimated resonance diameters.  In the frequency range 12- 43 
MHz of this study, the peak of the scattering cross-section of the resonant Definity 
(0.7-1.7µm) and MicroMarker (1.3-3.1µm) MBs is comparable to that of the larger 
MBs (e.g. 8µm diameter MBs). The small MBs below the resonant diameter 
contribute negligibly to the scattering. The scattering cross-sections of the large MBs 






































(a) Definity  






































































Figure 5. 4: The simulation of scattering cross section σsc of (a) Defintiy, (b) 
SonoVue and (c) MicroMarker as a function of frequency at different diameters  
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5.4.2 Size distribution of MBs and variation in con centration pre- and 
post- decantation  
Figure 5.5 shows the volume based size distribution of Definity, SonoVue and 
MicroMarker. The two percentages in the legend of De inity and SonoVue are the 
percentages of the native population that lie below and above 2 µm (the boundary). It 
can be seen that the small MBs are successfully remov d via decantation, however a 
certain number of small MBs still exist in the large MBs population. The reason for 
presenting volume based size distribution is because Gorce et al (2000) showed a 
good correlation between volume fraction and mean echogenicity efficacy of 
SonoVue rather than MB absolute number in the frequency range 1-10 MHz.   



















Native MB (34.72%, 65.28%)
Small MB  (95.01%, 4.99%)
Large MB  (27.51%, 72.49%)
 
(a) Definity 


















Native MB (10.72%, 89.28%)
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Figure 5. 5: The volume based size distribution of 3 populations f (a) Definity, (b) 
SonoVue and 1 population of (c) MicroMarker. The 2 percentages in the legend of 
Definity and SonoVue are the percentages below and above 2 µm.  
 
Table 5.5 shows the variation in calculated concentration of the decanted two 
subpopulations compared with the native population. For both Definity and 
SonoVue, the concentration of small MBs population was found to decrease while 
the concentration of the large MBs was found to increase after decantation.    
 
Table 5. 5:  The relative percentage of concentration of small and large MBs 
compared with the native population, where negative and positive numbers indicate 
decrease and increase in concentration respectively.  
 
 Small MBs (%) Large MBs (%) 
Definity - 5.92 ± 0.74 8.12 ± 12.72 
SonoVue -23.05 ± 10.62 72.09 ± 11.74 
5.4.3 The frequency-dependent attenuation of UCAs s uspensions  
Figure 5.6 shows the attenuation (dB·cm-1) as a function of frequency of the three 
UCAs. From the data collected in this study over the frequency range (12-43 MHz) 
the attenuation decreases with increasing frequency for native (a) Definity, (b) 
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SonoVue and (c) MicroMarker. The variation in attenuation from MicroMarker is the 
smallest and less than 2dB·cm-1 in amplitude over the frequency range of 12-43 
MHz. The results are in good agreement with the published data of Definity (Goertz 
et al. 2007) and SonoVue (Gorce et al. 2000). The attenuation curve of MicroMarker 
has not previously been published.  The attenuation curves focus on the comparison 
between the data acquired in this thesis and the published data at different 
frequencies. Thus, the attenuation results of the subpopulations are not presented in 
this thesis. 
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Figure 5. 6: Frequency dependent attenuation of native UCAs measur d by 4 
transducers over their 3dB bandwidths. (a) The attenuation of Definity is compared 
with the experimental results of Goertz (2007); (b) the attenuation of SonoVue is 
compared with the results of Gorce (2000), the concentration of Gorce’s experiment 
is 1:2000 therefore the attenuation is corrected by multiplying 3.2 as we use 1:625 
dilution; (c) MicroMarker. Insets in (a) and (b) zoom in the attenuation at high 
frequencies and use to compare with (c). 
5.4.4 CTR 
Figure 5.7 shows the CTR of SonoVue and Definity at the three populations and 
native MicroMarker measured by the four transducers. As the CTR is a normalized 
result to the backscattered TMM, a value of which closer to zero indicates a higher 
backscatter capability from MB suspension.  The CTR of each UCA decreases more 
than 5dB from the result of transducer 710B (12-25 MHz) to 711 (24 - 43MHz). The 
CTR measured by transducer 707B and 704 is comparable due to their similar 
driving frequency range and PNP. For each subpopulation of Definity and SonoVue, 
the large MB population produces the highest CTR.  Despite the differences in gases, 
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shells and size distributions between the agents, when measured using the same 
transducer the magnitude of the CTR of each of the t r e native UCAs is 
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Figure 5. 7: The CTR of small, native and large populations of Definity and 
SonoVue and of native MicroMarker measured by the 4 transducers over their 3dB 
bandwidths, the error bars were calculated from the three independent 
measurements  
5.5 DISCUSSION 
5.5.1 The influence of decantation  
In addition to the altered size distributions of Definity and SonoVue through 
decantation shown in Figure 5.5, in Table 5.5 it is shown that concentration 
decreases in the small MB population whereas increases in the large MB population 
compared with the native population. The resultant i fluence on CTR of 
subpopulations is discussed in the discussion of CTR in section 5.5.4. 
 
In this study, decantation was chosen to alter the siz distribution of MBs and its 
advantages over other methods such as filtration (Cheung et al. 2008, de Jong et al. 
1992) or centrifugation (Feshitan et al. 2009) include 1) no compression force 
applied, 2) no limitation of size required during these processes and 3) simplified 
concentration variation for preclinical injections. Talu et al (Talu et al. 2008) and 
Barrack and Stride (Barrack and Stride 2009) have showed the destruction of MBs 
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using narrow gauged needles (0.241mm-diameter for 25G, 0.159mm-diameter for 
30G needle). MBs which have either been passed throug  a filter of diameter 
generally ranging between 1 and 10 µm or experienced the centrifugal force are 
likely to be destroyed. Another drawback of using a filter is selection of MB size is 
directly restricted by the filter pore size from the manufacturer. Additionally, both 
filtration and centrifugation introduce pre-dilution before practical application. 
Specifically, MBs usually require high dilution (>1:1000), to allow sufficient space 
to isolate MBs in centrifugation, and to avoid clogging in filtration pores. However, 
in vivo applications especially small animal injections require limited injection 
volume (100µl for mice (Foster et al. 2011)) and higher concentration (e.g. 
MicroMarker 1×107 MBs in 50 µl per injection) than the physics experiment 
requirements in vitro (e.g., 0.8×106 MBs/ml applied in this study), the pre-dilution is 
irreversible and may hinder the underlying practical application. The only limitation 
of decantation is the time required to separate out the different sized MBs.  
5.5.2 The influence of pressure on the attenuation measurement  
Transmitting pressure for the acoustic measurement is set at 0.56 MPa (MI=0.16 at 
12 MHz frequency) and 0.58 MPa (MI=0.09 at 43 MHz frequency). Small, 
individual Definity and MicroMarker MBs (< 2 µm) were found to be preferentially 
disrupted at 25MHz and acoustic PNP ranging from 0.2-1 MPa (Helfield et al. 2012), 
i.e., lower PNP than that used in this study. However, in this study the attenuation of 
ultrasound through the native Definity suspension did not vary with time over 15 
minutes at 4% power (PNP=0.67 MPa)  (Chapter 4.8). This indicates that the applied 
PNP does not destroy the MB suspension over the measur ment period. Note that in 
the published attenuation experiments, Goertz (2007) used 25 kPa over the frequency 
range 12-29MHz (maximal MI = 0.007) and Gorce (2000) used 10 kPa over the 
frequency range 0.8-10MHz (maximal MI = 0.011) as transmitting pressure to 
approach a small oscillation of MBs. The attenuation acquired at higher PNP in this 
study shows similarity in magnitude with these published data.  This implies that the 
attenuation of Definity and SonoVue display a low sensitivity to pressure at these 
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low non-destructive pressures over the frequency range of 12-43 MHz. However, 
further investigations of pressure dependence are required to prove this hypothesis. 
5.5.3 The limitation of simulation of resonance fre quency 
The attenuation values of native Definity (Figure 5.6.a) and SonoVue (Figure 5.6.b) 
measured over 12 - 43MHz are consistent with published results at similar dilution 
ratios. The measurement of attenuation is used to de ermine the shell stiffness and 
friction (de Jong et al. 1992, Goertz et al. 2007), the good agreement of the measured 
attenuation at high frequencies with the published r sults indicates the shell 
properties in Table 5.2 are appropriate to be used in the simulation of resonance 
frequency in Figure 5.1. However, the equations for the calculation of resonance 
frequency are derived from small scale linear oscillations of encapsulated MBs, and 
the shell parameters in Table 5.2 are derived at different frequencies compared to the 
range of interest in this study, hence it is possible that the values of shell parameters 
may not be entirely accurate. For example, 1µm SonoVue was found to resonate at 
21 MHz (Bouakaz and de Jong 2007) while in Figure 5.1, 1 µm  SonoVue was even 
below the critical size. In addition, the literature is not conclusive on the MB 
theoretical behaviour at any frequency range. However, the accuracy of the 
calculation of the resonant frequency is not an absolute requirement for this work. 
An approximate figure for the sizes of resonating and non-resonating MBs is 
possible to attain using the existing theory, and as shown by the results we consider 
that this is an acceptable means of guiding size fractionation.   
5.5.4 The impact of decantation on CTR  
For each UCA, the CTR of the native population lay between the response from the 
small and large MB populations with the largest CTR measured in the large MB 
population. An in vivo study at 40 MHz showed that Definity (4-5 µm-diameter, 6-8 
µm-diameter) had a higher mean video intensity than Definity (1-2 µm-diameter) 
indicating that large MBs contributed predominately to the fundamental response 
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(Sirsi et al. 2010). This can also be supported by Figure 5.4.  For each UCA, MBs at 
resonance and of diameters larger than resonance contribute most to the scattering 
while small MBs below the resonant diameter are acoustically undetectable. 
However, it should be noted that in this study, theD finity MBs in the small 
subpopulation are resonant MBs (<1.7 µm-diameter) above 12MHz. The low CTR 
from the small resonant MBs suggests that at high frequency the large off-resonance 
MBs are more suitable for enhancing the fundamental acoustic response than small 
resonant MBs, although the influence of decreasing concentration of small Definity 
MBs after decantation cannot be completely excluded. An improvement of 20dB in 
CTR of SonoVue large MBs over small MBs also supports this conclusion. Hence 
decantation performs an effective method for CTR enhancement by increasing the 
absolute number of large MBs in a limited volume, which is particularly useful for 
practical in vivo preclinical injection regimes where the injected volume is often 
limited.  
5.5.5 Comparison of three lipid UCAs and considerat ions of their 
preclinical applications 
At the same concentration, the attenuation and CTR of the three native UCAs are 
found to be comparable measured by transducers 710B, 7 7B and 704 shown in 
Figure 5.6 and 5.7. From the results of transducer 711, MicroMarker presents 2dB 
increase in CTR and a large attenuation of approximate 0.5-1dB·cm-1 at 30-43 MHz 
in comparison to native Definity and SonoVue. This indicates an advantage of using 
MicroMarker at frequencies higher than 30MHz. From the practical application point 
of view, at frequencies below 30MHz not only Definity but also, SonoVue may also 
be used preclinically at similar MB concentrations as MicroMarker. For instance, the 
recommended bolus injection of MicroMarker is 1×107 mbs per 50µl (1:10 dilution) 
for mice cardiovascular, kidney and liver imaging and 1×108 mbs per 50µl for 
tumors, retina and hind limb imaging, respectively (Visualsonics, 2012). Assuming 
an injection of 50 µl UCAs of 1×107 mbs, the dilution changes to 1:60 for native 
Definity and 1:2.5 for native SonoVue UCAs. However, for 1×108 mbs per 50 µl, 
native SonoVue faces the dilemma of low concentration within limited injected 
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volume (100 µl). As discussed the advantages of decanted large MBs for CTR 
enhancement, the increasing concentration of large MBs may aid enhancement in 
preclinical injections. Using SonoVue for in vivo practical application requires 
further studies.  
5.6 CONCLUSION 
 
There are 2 main conclusions from this chapter  
 
- From the measurement of attenuation and CTR of Definity, SonoVue and 
MicroMarker at high frequency from 12 to 43 MHz using a PNP of 0.56MPa/ 
0.58MPa, the acoustic characterisation of the three native UCAs are comparable at 
same number concentration below 30MHz, though their size distributions and 
encapsulated gases and shells are significantly different. Above 30MHz, native 
MicroMarker produces higher values of attenuation and CTR compared with native 
Definity and SonoVue.  
 
- From the CTR comparison of subpopulations of Definity and SonoVue, altering the 
size distribution and concentration through decantation enables further enhancement 
for specific applications and may take full advantage of the imaging capabilities of 
the scanner. In addition to Definity and MicroMarker, SonoVue may also be suitable 
for preclinical application using an appropriate dilution and using large decanted 



















This chapter aims to investigate the subharmonic response of three lipid shelled 
ultrasound contrast agents (UCAs) Definity, SonoVue and MicroMarker by 
simulation in conjunction with experimental data.  Firstly, simulations of 
subharmonic to fundamental ratio (SFR) of individual microbubble (MB) were 
performed and the influence of insonating parameters was studied. Secondly, the 
experimental data of the three UCAs were acquired using a 25-cycle, 668kPa peak 
negative pressure (PNP), 25MHz ultrasound pulse undr Engineering mode. Thirdly, 





Harmonic imaging exploits the nonlinear properties of UCAs and specifically the 
2nd harmonic.  However broadband transducers that can receive the 2nd harmonic 
signals at high frequencies remain a manufacturing challenge. Additionally, tissue 
itself displays the 2nd harmonic properties when driven at high power and high 
frequency reducing the contrast to tissue ratio at the second harmonic. The 
generation of subharmonic is a unique property of MBs as tissue emits no 
subharmonic signal. Thus detecting the subharmonic signal improves contrast 
enhancement although spatial resolution is compromised (de Jong et al. 2000, 
Shankar et al. 1998).  
 
 139 
The onset pressure for subharmonic generation of a free bubble was previously found 
to be lowest at a driving frequency equal to twice th  MB’s resonance frequency (de 
Jong et al. 2000, Eller and Flynn 1969, Forsberg et al. 2000) and this threshold was 
shown to be lower than the MB destruction threshold (Chomas et al. 2002).  For MB 
resonating at the insonation frequency, the pressur th eshold for producing 
subharmonic was found to be higher than the destruction threshold from the optical 
experiment using a lipid MB MP1950 (Mallinckrodt, Inc., St. Louis, MO) at 
2.25MHz (Chomas et al. 2002).  An experiment using polymer shell MB SHU563A 
(Schering, Germany) also showed that the generation of sub- and ultra-harmonics 
linked to the destruction of MBs (Uhlendorf and Hoffmann 1994). However, 
subharmonic emissions have also been measured at low pressure, e.g., subharmonic 
threshold of SonoVue is 34.7kPa at 3.3MHz and 26.4kPa at 5MHz (Biagi et al. 
2007), pressure for stable subharmonic response of albumin encapsulated Infoson 
(other name marketed in US is Albunex) is 50-100kPa at 2.25MHz (Lotsberg et al. 
1996). The generation of subharmonic was shown to undergo three stages: 
occurrence, growth and saturation at 2 MHz (Shi et al. 1999). The subharmonic is 
insignificant at very low insonation pressures and starts to increase after the 
insonation pressure exceeds a certain threshold then gradually grows with increasing 
pressure. Within this growth stage before MBs are destroyed, the subharmonic 
signals may be extracted and useful for imaging purposes owing to the unique 
subharmonic generation by MBs and consequently highsubharmonic signal to noise 
ratio. With a further elevation of the pressure, the subharmonic signals enter into the 
phase of saturation then the signal-to-noise ratio will be greatly reduced due to the 
destruction of MBs (Shi et al. 1999).  
 
Cheung et al. (2008) compared the SFR of Definity in three populations (5 µm 
filtered, 1.2 µm filtered and native) in the frequency range 20-40MHz and validated 
the hypothesis that off-resonance MBs with diameters less than 5 µm were 
responsible for the subharmonic signal when insonated at their 2nd harmonic 
frequency. Additionally, the diameters of MBs that generate subharmonic at driving 
frequencies of 20 MHz and 30 MHz were simulated andwere shown to be larger 
than the diameter of MBs which generate 2nd harmonic which is associated with the 
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resonant MBs (Goertz et al. 2003). In other words, at both high and low frequencies, 
not the resonant MBs, but larger MBs resonating at half of the driving frequency 
predominately produce subharmonic echoes.  
 
For other in vitro studies of subharmonics conducted at high frequency, Helfield et al 
(2012a) showed a variation in subharmonic response of 5 types of individual 
phospholipid-encapsulated MBs (<3 µm) associated with different shell structures 
using an optical-acoustic setup operating at 25MHz and 0.02-1.2 MPa. Among the 5 
types of MBs, MicroMarker was shown to produce the highest and most consistent 
subharmonic response. Although MBs of various micro-st uctural heterogeneities 
produce different nonlinear responses in terms of active size and amplitude, no clear 
relationship was indicated between these factors.  The subharmonic of individual 
MicroMarker targeted MBs bound on gelatin were studied as a function of pressure 
and size at 30 MHz (Sprague et al. 2010). The pressu  threshold for emitting 
subharmonics was found to be 110 kPa and MBs smaller than 1.7 µm in diameter 
were disrupted in the pressure range 0.4-1 MPa showing phenomena of rapid 
dissolving and/or detaching from the bounded surface. 
 
In vivo subharmonic contrast intravascular ultrasound (IVUS) imaging (transmitted 
at 30 MHz and 40 MHz, received at 15MHz and 20MHz respectively) was found to 
be feasible using atherosclerotic rabbit aorta for improvement of vessel lumen 
boundary detection and vasa vasorum imaging (Goertz et al. 2006, Goertz et al. 
2007).  The subharmonic signature of MicroMarker (exposure to 30MHz signal of 
magnitude 1MPa, detection at 15MHz) in the mice renal cortex as a function of 
concentration was measured in the context of microvascular flow imaging (Stapleton 
et al. 2007). The recommended dose range was found to lie between 0 and 300µL 
·kg-1 (i.e., 0 to 10 million MBs per mL of blood), as in this concentration range the 
average enhancement and integrated enhancement of the agent increased linearly.  
 
The above literature reviews the generation and properties of the subharmonic 
response of the UCAs at low frequencies and the limited signature of subharmonics 
(bulk Definity suspension (Cheung et al., 2008) and small individual Definity and 
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MicroMarker (<3µm) (Helfield et al, 2012a)) at high frequencies. The subharmonic 
studies of another common UCA SonoVue have not been published and its 
feasibility for subharmonic application remains unclear. As described in Chapter 5, 
altering the size distribution of commercially available UCAs enables further 
enhancement for fundamental applications. In a similar manner, the size distribution 
for improving high frequency subharmonic application is worthy of investigation. 
Additionally, to date no comparison has been made between the bulk experimental 
data and the suharmonic modelling of individual MB.  
 
In this chapter, the simulation is firstly performed to analyse the impact of frequency, 
pressure and pulse length (number of cycle) on the subharmonic properties of 
individual MB. Secondly, the experimental subarmonic data of three native UCAs is 
discussed and the discrepancy with the simulation results is explored. Thirdly, the 
potential improvement of the subharmonic application by changing the size 
distribution of commercially UCAs is discussed using the subpopulations described 
in Chapter 5. All these are suggested to contribute to the benefit of using MB 
subharmonic technique at high frequencies than other harmonic alternatives owing to 
its advantage of minimal subharmonic generation from tissue. 
 
6.3 METHOD AND MATERIALS 
6.3.1 Simulation of the scattered signal of individ ual MB 
The simulation uses an open source and free downloaded toolbox BUBBLESSIM in 
MATLAB developed by Lars Hoff from The Norwegian University of Science and 
Technology. This toolbox simulates the dynamic oscillation of MBs and outputs the 
scattered signal by inputting the parameters of model, MB, ultrasound and 
environment. Figure 6.1 shows the interface of the toolbox and Table 6.1 lists the 
main options employed in the simulation. The current version of the BUBBLESIM 
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toolbox is only capable of processing one simulation each time after inputting the 
parameters. The MATLAB codes developed by Dr. David Thomas and Dr. Padraig 
Looney (Medical Physics, The University of Edinburgh) (Looney 2011, Thomas 




Figure 6. 1: The interface of BUBBLESIM Toolbox providing the option of model 












Table 6. 1: Selections of model and key parameters 
 




Simulation Model 1. Rayleigh-Plesset (R-P) 
2. Trilling 
3. Keller-Miksis (K-M) 
4. Modified R-P with  






3. Thermal damping pulse frequency 






1. Runge - Kutta 4-5 order (ODE45)  
2. Stiff variable order (ODE 15s) 
ODE 15s  
 
 
Amongst the four models, the main reason for choosing the Keller–Miksis model is 
that this model takes into consideration radiation damping and large amplitude 
oscillations (Doinikov and Bouakaz 2011, Keller and Miksis 1980), despite this it 
suffers a risk of numerical instability (Andersen ad Jensen 2009). The equation of 
Keller-Miksis model is: 
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PG0= P0 – Pv + 2σ/R0 is the pressure of gas in the MB at equilibrium status, P0 is the 
hydrostatic pressure at rest, Pv is the vapour pressure in the MB, 2σ/R0 is Laplace 
pressure and σ is the surface tension, Pac (t) is the driving pressure. 
 
Parameters of MBs: 
 R is the instantaneous radius of MB, R& =dR/dt is the speed of MB wall, R&& = d2R/dt2,  
R0 is the rest radius, κ is the polytropic exponent of gas also the ratio of specific heat 
of gas. 
 
Parameters of liquid: 
c is the speed of sound, ηL is the dynamic viscosity, ρL is the density 
 
The determination of whether the thermal damping is considered isothermal or 
adiabatic is estimated by the Peclet number Pe = R0
2ω/Dth, where Dth is the thermal 
diffusivity of gas and ω is the angular frequency (Doinikov and Bouakaz 2011). If Pe 
>>1, κ = γ and adiabatic is applied. If not, κ =1, i.e., the thermal damping is 
approximately isothermal (Doinikov and Bouakaz 2011). Note that the polytropic 
exponents of gas used in the published work are close t  1 (Definity: 1.06 (Goertz et 
al. 2007), SonoVue: 1.095 (Marmottant et al. 2005) and MicroMarker: 1.045 
(Helfield et al. 2012)). Thus, isothermal was used as thermal damping.   
ODE 15s and ODE 45 are two numerical solvers in MATL B and are suitable for 
solving stiff and non-stiff ordinary differential equations, respectively. The solution 
deriving from stiff differential equation is numerically stable only within a small 
time-scale. The main principle in determining the type of equation is whether the 
equation includes certain terms resulting in a solution with rapid variation. Due to the 
consideration of rapid variation of the solution introduced by the large oscillation, the 
dynamic oscillation system may become stiff. Thus, ODE 15s was chosen. 
 
The relevant parameters of the MBs are listed in Table 6.2. Although the shell 
parameters may be both frequency  and size dependent (Faez et al. 2011), there is 
limited published data on this variation.  However, such variation in shell parameters 
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is potentially one of the reasons in explaining the discrepancy between the 
experimental data and simulation results, but no further quantified explorations of 
their influence are discussed in this thesis.  
 
Table 6. 2:  The shell elastic modulus Gs (MPa), viscosity ηs (Pa·S) and shell 
thickness ε (nm) of the three UCAs. Based on the parameters in Table 5.2, using 
εεχ 6S3G ps == , πεεκη 48S3 fss == , Gs and ηs can be converted from shell 
surface elasticity χ, stiffness Sp, surface viscosity κs and friction Sf (Doinikov and 
Bouakaz 2011). 
 
UCAs Gs (MPa) ηs (Pa·S) ε (nm) 
Definity 190 0.07 1.5  
SonoVue 61 0.597 3  
MicroMarker  572 0.33 3  
 
 
The insonating parameters used in the simulations are listed in Table 6.3. The 
diameter of simulated individual MBs ranges from 0.5 to 8 µm.  
 
 
Table 6. 3: Parameters of ultrasound applied in the simulations, the selective values 
are based on the parameters of Vevo770 scanner except the pressures  
 












6.3.2 Comparison of the measured data and the simul ation results  
Based on the simulation, the backscattered signal from specific sized MBs can be 
obtained at each diameter in response to the measured diameter from the Mastersizer 
data. This backscattered signal was filtered using a  elliptic filter with 2MHz 
bandwidth in the fundamental and subharmonic frequency to form the fundamental 
and subharmonic components, respectively. The output volume based size 
distributions from the Mastersizer are presented in the format of a relative percentage 
at each diameter. Here the volume based size distribution curve is used because of its 
better correlation with the backscattered signal thn number based size distribution 
curve (Gorce et al. 2000). These percentages are used a  weighting factor and 
determine the various contributions of MBs at different diameters to the fundamental 
and subharmonic components of the backscattered signal. The SFR of a group of 
MBs from the simulation is calculated using Equation 6.2. 
 









10log10                                     (6.2) 
 
where weighti is the weighting factor, subharmonici and fundamentali are the 
components of the subharmonic and fundamental backsc ttered signal at each 
diameter i, respectively. These three variables of all the diameters compose thre  row 
vectors, whereas number is the total number of testing MBs, i.e., a sc lar quantity 
and can be cancelled out from the numerator and denominator. The only assumption 
in this equation is that the concentration of the MBs suspension is sufficiently low 
and no multiple scattering occurs. Under this assumption of low concentration, the 
SFR becomes independent of concentration. 
6.3.3 Experimental measurement of the SFR   
The subharmonic components were extracted from the backscattered signal acquired 
in the same manner as shown in Figure 5.3.a in Chapter 5. The concentration and 
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acquisition of the different sized subpopulations is the same as described in Chapter 
5. The calculation of the SFR uses Equation 6.3, 
 







10log                                                  (6.3) 
where the numerator and enominator are the power spectra of backscattered signal 
integrated over the 2 MHz bandwidth of the transmitting frequency and subharmonic 
frequency, respectively. This calculation of SFR over the 2MHz bandwidth 
approximates the difference between the fundamental pe k and subharmonic peak. 
For transducer 710B these values are 25MHz and 12.5MHz respectively.  
 
In these experiments, the SFR was only measured using transducer 710B  
(transmitting signals: 25MHz frequency, 25 cycles, 668 kPa PNP). 
The reason is due to the following considerations: 
 
 - one PNP, the experiment used the lowest PNP 0.67MPa (lowest power), the other 
15 discrete power outputs are have higher PNP and likely to increase MB destruction 
 
- the subharmonic peak is discernible from the spectrum using 25 cycle signal, a 1-
cycle pulse  did not produce a subharmonic peak as shown in Figure 6.13.  Only 25-
cycle signal was applied in this study to present the SFR 'confidently'. 
 
Another experiment was performed to test the concentration independence of SFR by 
measuring the SFR of SonoVue at a series of doubling dilutions: (1: 312.5/ 1:625/ 
1:1250) at three populations (same dilutions as described in Chapter 5, the dilution of 
1: 625 corresponds to 0.8×106 mbs/ml). For each concentration and subpopulation, 





6.4.1 The comparison of backscattered signal from T MM and UCAs 
Figure 6.2 shows the backscattered signal from TMM in (a) B-mode images and in 
(b) frequency domain measured by transducer 710B (25-cycle, 25 MHz, 100% power 
in response to 2.77 MPa-PNP). There is no subharmonic peak at half the transmitting 
frequency 12.5MHz at 100% power. Because nonlinearity increases with increasing 
power, no backscattered response of TMM at 12.5MHz under low power is expected. 
In comparison with this response in the subharmonic frequency range, Figure 6.3 
shows the spectrum of the backscattered signal fromMicroMarker MBs using the 
same transmitting parameters except the power is set to 3% in response to a PNP of 
0.67MPa. A peak can be seen at 12.5 MHz. The difference of the backscattered 
component at the subharmonic frequency from the TMM and MBs demonstrates the 
potential advantage of exploiting subharmonic respon e from MBs than fundamental 
or second harmonic components. However, in this study the numerator and 
denominator of the key parameters SFR in equation 6.2 are from the backscattered 
signal of MB suspension.  The backscattered signal from TMM is not used for 
normalisation because of the following three reasons. 1) The comparison can be 
conducted between measured SFR and the simulation results without modelling the 
backscattered signal from TMM. 2) Backscattered signal from MB suspension 
travels through the same medium, while TMM is generally measured in water and 
the different mediums introduce variation in attenuation of ultrasound. If measuring 
TMM in MB suspension or attenuation of ultrasound at long cycle signal, this would 
extend the time length of experiment and restrict the number of experiments using 
one vial of contrast agent. Applying UCAs from different vials raises extra 
uncertainties. 3) SFR defined in equation 6.3 is a concentration independent 
parameter which aims to certify which diameter of MB dominates the subharmonic 
































                           (a)                                                                   (b) 
Figure 6. 2: (a) The B-mode image of TMM at 25MHz, 100% power, 25-cycle using 
transducer 710B (b) The averaged spectrum of 300 backscattered samplings in 
response to the backscattered signal from the TMM in (a), red circle in (b) marks the 
position of the half the driving frequency. 
 
 






























                           (a)                                                                   (b) 
Figure 6. 3: (a) The backscattered signal from the suspension of MicroMarker MBs 
at 25MHz, 3% power, 25-cycle using transducer 710B. (b) The averaged spectrum of 
300 backscattered samplings in response to the signal from MicroMarker MBs in (a), 





6.4.2 The simulation of SFR as a function of frequency (25 - 55 MHz), 
pressure (0.05 – 0.95 MPa) and number of cycles (5/10/15/20/25) 
Figure 6.4 shows the variation of fundamental, subharmonic and SFR of (a) Definity, 
(b) SonoVue and (c) MicroMarker in a diameter range of 0.5-8 µm at four 
frequencies 25MHz, 30MHz, 40MHz and 55MHz. The variation in the position of 
the peak of the fundamental and subharmonic reflects MBs of changing diameters 
resonating at the driving frequencies and half of the driving frequency, respectively.  
The SFR shows 1) a trough in the curve because of the low subharmonic component 
from small MBs, 2) a peak at the same position as the peak of subharmonic occurs. 
The possible reason explaining the occurrence of the high SFR of Definity at MB 
sizes less than 1µm may be due to the fact that both fundamental and subharmonic 
components are very small and the logarithm of the quotient of which (two 
infinitesimals) produces an unstable solution (definition of SFR shown in Equation 
6.2). This value at small diameter would not interfere the experimental result as the 
transducer is not sufficiently sensitive to receiving the weak signal scattered from the 
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Figure 6. 4: The simulated response of the fundamental, subharmonic and SFR of (a) 
Definity, (b) SonoVue and (c) MicroMarker to insonati g frequencies at 25 MHz, 30 




Figure 6.5 shows the influence of pressure from 0.05 MPa to 0.95 MPa on the SFR 
of (a) Definity, (b) SonoVue and (c) MicroMarker ina diameter range 0.5-8 µm. 
Compared with SonoVue and MicroMarker, Definity presents the widest dynamic 
range of SFR with pressure variation.  
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Figure 6. 5: The simulated variation in the SFR of (a) Definity, (b) SonoVue and (c) 
MicroMarker with pressure from 0.05 MPa to 0.95 MPa, other insonating 




The simulation of the SFR of (a) Definity, (b) SonoVue and (c) MicroMarker varied 
with number of cycles is shown in Figure 6.6 in a MB diameter of 0.5-8 µm. The 
peak of the SFR is from the insonating signal of 5 cycles. A shorter number of cycles 
is found to produce a greater SFR than using long number of cycles. However, the 
SFR for the MB larger than 4 µm from 10-cycle signal is higher than the value from 
5-cycle signal.  



























































































































































Figure 6. 6: The simulated SFR of (a) Definity, (b) SonoVue and (c) MicroMarker 
varied with number of cycles from 5 to 25, other inso ating parameters fixed at 
560kPa and 25MHz 
6.4.3 The comparison of the measured data and the s imulation results 
Figure 6.7 - 6.9 show the simulation results of (a) energy density of RF data, 
fundamental and the subharmonic components and (b) the SFR as a function of 
bubble diameter for Definity, SonoVue and MicroMarker.  The transmitting signal 
uses the parameters from transducer 710B applied in the experiment: 25MHz, 25 
cycles and 0.67 MPa.  
 
From the simulation of Definity in Figure 6.7.a and MicroMarker in Figure 6.9.a, it 
can be seen that the fundamental energy density is the largest part of the response as 
it almost overlaps with RF signal. The bubble diameter yielding the peak of 
fundamental is shifted to a smaller diameter from the diameter where the peak of 
subharmonic appears. As expected, in Figure 6.7.b and 6.9.b the bubble generating 
the highest subharmonic response produces the peak of the SFR. The trough of the 
SFR is located at the resonant diameter (peak of the undamental component shown 
in Figure 6.7.a and 6.9.a). SonoVue in Figure 6.8 presents a different behaviour 
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compared with Definity and MicroMarker. Without a clear peak in the fundamental 
and subharmonic curves, both the energy density in Figure 6.8.a and SFR in Figure 
6.8.b display a lower amplitude of ‘oscillation’ with a larger increase that then 
doesn’t change with increasing diameter. 
 




































































 (a)                                                        (b) 
Figure 6. 7: The variation in (a) energy density of the simulated RF data, 
fundamental and subharmonic components as a function of bubble diameter (b) SFR 
of Definity MBs as a function of bubble diameter  
 





































































 (a)                                                        (b) 
Figure 6. 8: The variation in (a) energy density of the simulated RF data, 
fundamental and subharmonic components (b) SFR of SonoVue MBs as a function of 
bubble diameter  
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(a)                                                        (b) 
Figure 6. 9: The variation in (a) energy density of the simulated RF data, 
fundamental and subharmonic components (b) SFR of Micro arker MBs as a 
function of bubble diameter  
 
Using the above simulated fundamental and subharmonic components at each 
diameter and incorporating the measured size distribution in Equation 6.3, Figure 
6.10 shows the simulated SFR of Definity and SonoVue at three populations and 


































Figure 6. 10: The simulated SFR of groups of MBs of Definity, SonoVue and 
MicroMarker using volume based size distribution curve based on the experimental 




6.4.4 The experimental data of the SFR 
Figure 6.11 shows the measured SFR of SonoVue and Definity of three populations 
and the native MicroMarker using transducer 710B. The SFR of the decanted small 
MBs population is higher than their corresponding native and large MB population. 
In the comparison of the three native UCAs, MicroMarker shows a 3.2dB and 6.6dB 
higher SFR than SonoVue and Definity, respectively.   
 
Compared with the experimental data, the simulated values in Figure 6.10 of 
Definity are close to the measured data and small MB population produces higher 
SFR than the native and large MB populations. But SonoVue and MicroMarker 
display an approximate 5dB difference in the SFR. 
 






























Figure 6. 11: The SFR measured by transducer 710B at 25-cycle, 0.67 MPa-PNP, 25 
MHz-transmitting frequency, 12.5MHz-receiving frequncy, the error bars were 
calculated from the three independent measurements  
 
The measured SFR of SonoVue at three subpopulations in Table 6.4 shows good 
consistency at each dilution and supports hypothesis that SFR is independent with 




Table 6. 4: Measured SFR of SonoVue at three subpopulations and three dilution 
ratios using transducer 710B (25-cycle 0.67 MPa-PNP, 25 MHz-transmitting 
frequency) 
 
Dilution Small MB Native Large 
1:312.5 -23.59 ± 2.48 -27.22 ± 1.42 -26.45 ± 2.47 
1:625 -23.38 ± 2.45 -26.75 ± 1.38 -26.64 ± 2.43 
1:1250 -23.19 ± 2.50 -25.83 ± 1.37 -27.34 ± 2.37 
 
6.5 DISCUSSION 
6.5.1 The influence of pressure, frequency and numb er of cycles on 
subharmonic generation – simulation study   
The driving frequency determined the diameter of the MBs producing the highest 
subharmonics, i.e., MBs resonate at half of the driving frequency shown in Figure 
6.4. Additionally, subharmonic signals are known to be stimulated by narrow band 
signals (de Jong et al. 2009). The resonant MBs at the driving frequency reduce the 
SFR owing to its high fundamental component. Mono-disperse MBs resonating at 
half the driving frequency may optimize the subharmonic generation. To optimize 
the population for subharmonic generation the mono-disperse MBs resonating at half 
the driving frequency may be the ideal. This population is different from the MBs for 
the fundamental generation in Chapter 5, as both the resonant and large off-
resonance MBs can be the main contributors.  
 
The pressure shows its impact on the magnitude of the SFR of MBs in Figure 6.5. 
Only Definity displays a sensitive pressure dependence of SFR compared with 
SonoVue and MicroMarker. For SonoVue and MicroMarker their SFRs become 
approximate pressure independent. Possible reasons may be related to the current 
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published different shell parameters in Table 5.2. The shell stiffness of Definity and 
SonoVue are comparable but are only one tenth the magnitude of MicroMarker. The 
shell friction of MicroMarker and SonoVue are 10 and 20 times higher than Definity, 
respectively. The results of high shell stiffness and high friction impose strong 
resistance to the forced stress and may provide a transformation mechanism of the 
kinetic energy to heat dissipation. The nonlinear properties of Definity, such as the 
generation of subharmonics are more obvious due to its relative low shell stiffness 
and friction. The experimental subharmonic data of De inity from a previous study 
(Cheung et al. 2008) also showed this sensitive variation from rapid growth to steady 
state, then gradual reduction as a function of pressur  in the range 0.13-1.3 MPa. 
SonoVue showed a very low pressure threshold (<100kPa) for the emission of 
subharmonics at low frequencies (3.3MHz, 5MHz) (Biagi et al. 2007). At 25MHz 
MicroMarker showed a subharmonic threshold of 89kPa (subharmonic power is 3dB 
higher than noise floor) and smaller than 2µm were observed to disrupt at 1.2 MPa, 
but most MBs larger than 2.6 µm were not disrupted (Helfield et al. 2012). As 
reviewed in the introduction to this chapter there are generally two cases of 
subharmonic emission at low frequencies: 1. stable subharmonic emission when 
pressure above subharmonic threshold, 2. subharmoic emission related to 
destruction. Assuming the SonoVue and MicroMarker MBs emit stable 
subharmonics but are not destroyed at the simulated pr ssure, the magnitude of the 
subharmonics may increase proportionally to fundamental components with 
increasing pressure for SonoVue and MicroMarker. The resultant SFR becomes a 
stable constant without a high sensitivity to pressure.  
 
Shorter number of cycles produces a higher SFR of individual MBs in Figure 6.6. 
The experimental data of native Definity population also confirmed short 4-cycle 
signal generated high SFR which reduced in magnitude to a steady level of 13dB 
around 15 cycles (Cheung et al. 2008). The reason was attributed to narrower 
bandwidth at longer cycle increasing the fundamental and subharmonic 
logarithmically, which yielded decrease of the noise floor, the height of the side lobe 
and the adjacent fundamental signal. However, experimental results presented here 
give a limited experimental view at the subharmonic frequency using 25-cycle signal 
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in the frequency spectrum in Figure 6.12, while shorter number of cycles e.g., 4 or 10 
actually do not produce any discernable enhancement at the subharmonic frequency. 
But calculation of SFR by filtering the signal in the fundamental and subharmonic 
frequency leads to the same conclusion, i.e., transmitting signal of shorter cycles give 
higher SFR than long cycles. The spectrum using shorter cycle pulse is broader than 
long cycle pulse shown in Figure 2.17-2.18. In particularly around subharmonic 
frequency, the spectral energy of short cycle pulse di tributes in a wide range and no 
discernable peak does not mean none or low subharmonic energy. Thus, the 
bandwidth for filtering subharmonics from short cycle pulse requires to be carefully 
chosen. 
 

























































































             (a) cycle = 4                       (b) cycle = 10                       (c) cycle = 25 
Figure 6. 12: The measured SFR of MicroMarker insonating at 3% power and three 
cycle lengths (a) 4 cycles, (b) 10 cycles and (c) 25 cycles 
 
6.5.2 The discrepancy between the experimental data  and simulation 
results 
Figure 6.11 shows that small Definity and SonoVue MBs produces higher SFR than 
the native and large MBs population, which indicates that small MBs are 
predominantly responsible for subharmonic response at the tested 25 MHz 
frequency. Considering the resonant diameter of MBs and size distribution, in Figure 
6.7 Definity MBs of a diameter of 1.7 µm were found to resonate at 12.5 MHz (half 
of 25MHz). The volume percentage of this diameter is h gher in small MBs 
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population than the native and large MBs population shown in Figure 5.5.a, thus 
small MBs population produces the highest SFR.  
 
Among the three native UCA solutions, MicroMarker produced the highest SFR and 
the reason may be attributed to the diameter of its resonant MBs is the largest 
compared with Definity and SonoVue (resonant diameter a  12.5MHz:  1.7 µm for 
Definity and 3.1 µm for MicroMarker). Because the simulation results in Figure 5.1 
show that SonoVue does not, whereas Definity does resonate above 10MHz, 
theoretically Definity MBs emit a higher SFR than SonoVue (Figure 6.10). However, 
from experimental data SonoVue demonstrated a higher SFR than Definity in each 
pair group of small, native and large population (Figure 6.11). Additionally, 
SonoVue of 1 µm was found to resonate at 21MHz (Bouakaz and de Jong 2007). 
From this point of view, the shell properties of SonoVue acquired at low frequencies 
(Gorce et al. 2000) may not be suitable for the simulation at high frequencies. Thus 
the shell properties of the small SonoVue MBs in particularly at higher frequencies 
are worth further investigating to fully understand the nonlinearity of SonoVue at 
high frequencies.  
 
More than 5dB difference was found between the simulated and measured SFR of 
SonoVue and MicroMarker in Figure 6.10 and Figure 6.11.  The potential of 
numerical instability of the Keller – Miksis model is not the only possibility 
explaining this discrepancy. At the tested ultrasound parameters (25MHz, 0.67MPa, 
25-cycle signal), MBs may fragment or oscillate non-spherically which make the 
original simulated model lose stability and distrac feasibility. For instance, 
expansion-dominated behaviour of MicroMarker was found in the rupturing regime 
at high frequency (Helfield et al. 2012). This behaviour of one bubble is defined as 
its ratio of absolute expansion (Rmax-R0)/R0 to absolute compression (R0- min)/R0 is 
larger than 1, where R0, Rmax and Rmin are the equilibrium, maximum and minimum 
radii respectively. The shell properties may change during the oscillation as the shell 
of Definity was described as strain-softening materi l (Thomas et al. 2009). 
Additionally, non-spherical oscillation of MBs larger than 1.9 µm was investigated 
using a ultra-high-optical imaging and optical tweez rs to produce the subharmonic 
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response at 1.7MHz at acoustic pressures up to 200 kPa (Dollet et al. 2008). 
Although this study was conducted at low frequency, a similar phenomenon can be 
expected for the small MBs resonating at half the driving frequency to emit the 
subharmonic response.  As discussed above, the shell properties of SonoVue 
particularly may need further investigation because of the mismatch between the 
simulations and experimental results. In summary, the complexities of variation in 
MBs themselves during the oscillation and the limitation of the model cause the 
difference between the experimental data and simulation results. Thus the dynamic 
oscillation and shell properties of MBs may require further studies. 
6.5.3 The limitation of comparison of subharmonic t o fundamental ratio  
SFR is a relative parameter based on its definition in Equation 6.3, and as such is 
dependent upon the magnitude and characteristics of both the fundamental and sub-
harmonic components of the tested sample. Thus the ability to infer characteristics of 
the subharmonic from this parameter and to compare diff rent contrast agents and 
subpopulations using this parameter may be undermind. However, CTR of the three 
native UCAs at 25MHz are comparable shown in Figure 5.7. Due to normalizing to 
the same backscattered signal from TMM, CTR reflects the comparable 
backscattered signal of the three UCAs in the fundamental frequency range. Note 
that CTR is calculated in the 3dB bandwidth of the ransducer (transducers 710B, 
707 and 704 all covering 25MHz which is used in the subharmonic experiments), so 
it is not strictly equivalent to the averaged spectra within 2MHz-bandwidth applied 
in the SFR calculation. Nevertheless, the above analysis of MicroMarker producing 
higher subharmonic components than native Definity and SonoVue populations is 
very likely to be correct. Additionally, the above discussions suggest the small 
microbubble subpopulation dominates in subharmonic production compared with 
native and large subpopulations. Figure 5.7 shows that the small subpopulation of 
Definity and SonoVue produces more than 5dB decrease in CTR than their native 
and large subpopulations. Thus, it is unlikely that the absolute magnitude of the 
subharmonic component from small subpopulation is greater than native and large 
subpopulations despite the small subpopulation show the highest SFR. From the 
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practical subharmonic imaging point of view, SFR is a useful parameter as the core 
of imaging focuses on the difference between the signal and noise, i.e., a relatively 
high subharmonic value compared to its fundamental component would aid the 
subtraction of the subharmonics from the received signals. Further investigations are 




The simulation results suggest the role of the insonating parameters on the SFR. 
Briefly, MBs resonating at half of the driving frequency predominately drive the 
subharmonics, i.e., the frequency determines MB of the most effective diameter. The 
pressure and number of cycles influence the magnitude of the oscillation. Although 
discrepancy between the experimental data and simulation exist, the main reasons for 
this discrepancy may be the shell properties of MB especially the small MBs at high 
frequencies are not well established and the actual MB oscillation and the 
assumption of the model are mismatched.  
 
The experiments conducted in this chapter only show the global acoustic properties 
and provides insufficient evidence for the modelling results. However, from the 
experimental data three points can be concluded: 1. Native MicroMarker produced 
higher SFR at 25MHz compared with native Definity and SonoVue. 2. At low 
concentrations, SFR was a concentration independent parameter. 3. Changing size 
distribution altered the subharmonic response and at 25MHz the small population of 
Definity and SonoVue (diameter< 2µm) was found to be the most effective for the 
generation of subharmonic signals. From the designing and tailoring UCAs point of 
view, non-destructive SFR can be improved by selectiv ly increasing the number of 







Influence of temperature, needle gauge and injectio n rate on 
the size distribution and acoustic responses of ult rasound 





This chapter investigated the influence of needle gauge, injection rate and 
temperature on the size distribution, acoustic attenuation, contrast to tissue ratio 
(CTR) and subharmonic to fundamental ratio (SFR) of s lutions of Definity and 
SonoVue. The measurement of size distribution was performed by Ms Ioanna 
Panagakou as her Master Maxi-project (Centre for Cardiovascular Science, 
University of Edinburgh) under the supervision of the author of this thesis and the 
work of the acoustic measurement were completed by the author and Ms Ioanna 
Panagakou together.  
7.2 INTRODUCTION 
 
There is increasing application of UCAs in the preclini al field (Foster et al. 2011), 
and therefore in vitro studies using  UCAs at high frequencies are of importance 
(Goertz et al. 2005, Helfield et al. 2012).  However the difference between the 
administration of UCAs in an in vivo environment (small needle gauge and slow 
injection rate at body temperature) and the in vitro experiment (large needle gauge, 
fast injection rate and room temperature) need to be considered. Needle gauges 
selected for the in vivo small animals studies includes: 24G for rat tail ve n injection 
(Miller et al. 2007) , 27G for mice tail vein injection (Howard et al. 2006) and 30G 
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for pig cervical region of nerve (Heaton et al. 2005) and dog lymphatic system 
(Wisner et al. 2002). The injection rates are set at 0.5 mL/kg/min for rat tail injection 
(Miller et al. 2007) and 1.2-2.4 ml/ml for mice tail injection (Browning et al. 2011). 
Generally in vitro experiments of UCAs are performed at room temperature using the 
needle gauges 18G-20G at a relatively fast injection rate that simulates the process of 
bolus intravenous injection for human.   
7.2.1 The influence of temperature  
Both Definity and SonoVue are lipid coated UCAs. The fluid-gel phase transition 
temperature of the lipid in bilayer state vary from -1 °C and 75 °C (Pu et al. 2006) 
and -1 °C and 55 °C (Zook and Vreeland 2010) depending on the phospholipids acyl 
chain length. Lipid molecules are limited on the plane of the membrane in the two 
phases (fluid: liquid phase, gel: solid phase), but liq id phase allows a freer diffusion 
of molecules than in solid phase (Berg 1993). For this reason, the viscosity, 
membrane elasticity, free energy and diffusion coeffici nt of the shell can be 
changed below, at or above the transition temperature (Zook and Vreeland 2010). 
The lipid shell of Definity consists of three phospholipids (DPPA, DPPC and MPEG 
5000 DPPE) (Helfield et al. 2012). SonoVue possesses an amphiphilic phospholipid 
shell  (a hydrophilic surface outside and a hydrophobic surface inside) (Greis 2004) 
and involves two lipids (DSPC and DPPG) (Mulvana et l. 2011). The shells of both 
UCAs are mono-layered and are a combination of lipids, thus a specific phase 
transition temperature is unknown and its resultant influence needs to be 
investigated. 
 
Previously the thermal response of SonoVue was studied at 37-43 oC and its lipid 
transition temperature was measured to be 40oC, which was derived from an 
observation of maximal diameter and backscattering intensity (ultrasound frequency: 
2.5- 8MHz, low MI: 0.0081-0.113) at 40 oC and a rapid decrease afterwards (Guiot et 
al. 2006).  Individual Definity and SonoVue MBs were measured at 21 oC – room 
temperature and 37 oC –body temperature using a high speed optical camera under an 
insonation of 1.7 MHz, 10-80 kPa pulse (Vos et al. 2008). Compared with the 
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performance at room temperature, Definity and SonoVue showed an increase in 
radical excursion (which equals to ∆D/D0, where ∆D is the maximum peak-zero 
amplitude of the linear oscillation, D0 is the initial diameter of MBs) and a decrease 
in onset of acoustic oscillation at body temperature. Intensive temperature 
dependence studies of SonoVue were completed at 3.5 MHz-ultrasound (Mulvana et 
al. 2010, Mulvana et al. 2011). Due to the increasing temperature close to transition 
temperature, it was found that the resultant expanding MBs and rapid diffusion raised 
the mean diameter, attenuation, backscatter and nonlinear components. 
7.2.2 The effect of needle size and injection rate  
Talu (Talu et al. 2008) measured the variation in co centration and mean diameter of 
one in-house lipid-encapsulated UCA at 3 concentrations (1, 5, 10×108 MBs·ml-1) 
using 3 needle gauges (23G, 27G and 30G) at 5 injection rates (0.01, 0.03, 0.1, 0.3 
and 0.5 ml/sec). Due to the measured significantly declining concentration with 
increasing needle gauge (i.e., decreasing inner diameter), the main reason was 
inferred to be the destruction of MBs. The reduction in mean diameter was attributed 
to the decrease in the entire population due to diffusion by forced compression and 
possibly destruction of large MBs.  A similar study investigating the influence of 
administration variables (2 needle gauges: 18G and 25G; 2 syringes: 5ml and 10ml; 5 
discrete flow rates from 2 to 3.3 ml· in-1; 2 suspending fluid: distilled water and 
95% volume-glycerol) was performed using another in-house MB (Barrack and 
Stride 2009).  The results from this study showed that in addition to the hydrostatic 
pressure, shear stress due to the increasing pressure and velocity gradient played a 
key role in destroying MBs. However, one difference was that the growing volume 
flow rate reduced the destruction of MBs, which is not in agreement with the study 
of Talu (2007). The discrepancy was blamed on the diff rence of initial diameter, 
size distribution, concentration and composition of MBs.  An in vivo experiment 
improving the plasmid transfection and MBs-mediated gene transfection using 
SonoVue also supported the above findings by testing the effects of using 3 needle 




From the above reviewed studies, temperature, needle gauge and injection rate have 
effects on the structure, size distribution and acoustic properties of UCAs. However, 
many questions remain unsolved. Firstly, the previous studies are limited to the 
ultrasound frequencies relevant for clinical applications and little research has been 
performed at high frequency. Secondly, the impact of emperature, needle gauges 
and injection rate were discussed separately and neither interactions between them 
nor their importance were compared and ranked. Thirdly, some in-house MBs have 
been studied while commercial UCAs are the products that are most commonly used 
preclinically and their characterisation is not clear.   
 
In this chapter, the influence of needle gauges (19G, 27G and 30G), injection rate 
(0.85ml·min-1 and 3ml·min-1) and temperature (room temperature 20± oC and body 
temperature 37± 5oC) on the size distribution and acoustic properties of Definity and 
SonoVue have been measured in the frequency range of 17-31MHz. The 
experimental details are presented initially and selective results of measured 
parameters between i  vitro (19G, 3ml/min at RT) and in vivo (27G/30G, 0.85ml/min 
at BT) are shown. Then differences between the in vitro and in vivo are summarized 
after discussing the impact of each factor. 
 
7.3 METHOD AND MATERIALS 
 
This experiment employed one transducer 707B (nominal centre frequency=30MHz, 
3dB bandwidth=17-31MHz, 6dB bandwidth=13-35MHz at 3% transmitting power 
and the peak negative pressure (PNP) was measured to be -0.56 MPa). From the 
pressure experiments in Chapter 4, at this PNP MBs are not destroyed at room 
temperature. A full experimental procedure is described below after the description 
of the 3 needle gauges, 2 injection rates and temperatur  manipulation. 
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7.3.1 Needle gauge 
Three needle gauges including 19G, 27G and 30G (Becton, Dickinson and Company 
(BD), USA) were employed.  These needles are generally used in human intravenous 
injection but also in vitro experiments including the mice tail injection and mice 
heart injections. Table 7.1 listed the information f these needles including inner 
diameter and cross-sectional area. 
 
Table 7. 1: The inner diameter and cross-sectional area  
Needle Gauge Inner Diameter (mm) Area (mm2) 
19G 0.686 0.37 
27G 0.21 0.03 
30G 0.159 0.02 
 
7.3.2 Injection rate  
Two injection rates were applied 0.85 ml· in-1 and 3ml·min-1, where 0.85 ml·min-1 
was generally used for bolus injection in mice vein tail and 3 ml·min-1 simulates the 
injection rate applied in in vitro experiments. The steady and reproducible injection 
rate was controlled using a syringe pump (Aladdin, World precision instruments Inc., 
USA) by connecting a tested needle with 1ml-syringe (ID = 4.78 mm) to reach an 
injection rate of 0.85 ml·min-1 and 2ml-syringe (ID=8.66 mm) for 3ml· in-1 injection 
rate. 
7.3.3 Temperature control and the measurement of di ssolved oxygen 
level  
The experiments were undertaken in air saturated distilled water at both the room 
temperature (RT) 20± 2oC and body temperature (BT) 37± 5oC environment.  A 
dissolved oxygen probe (Vernier Software & Technology, OR, USA) monitored 
 
 170 
dissolved oxygen value in the water by assuming: 1. oxygen (O2) and nitrogen (N2) 
are the dominant gas in the water, 2. the dissolved O2 is proportional to the N2 at 
atmospheric pressure under Henry’s law (Mulvana et al. 2012).  Based on the 
theoretical 100% dissolved O2 capacity in the water at the temperature from 0
 oC to  
35 oC at 760 mm Hg pressure provided by the manufacturer, an exponent curve was 
fitted to extrapolate the dissolved O2 value up to 42
 oC. Figure 7.1 shows the 
dissolved O2 varying with temperature and its value is 6.49 mg·L
-1 at 37 oC. The air-
saturated water at RT was prepared by leaving the distilled water over 24 hours. The 
air-saturated water at BT was obtained by heating the water till 42 oC then degassing 
using a vacuum pump. The resultant air saturated water at BT was sealed in a bottle 
placed on a hotplate to maintain temperature of the wat r during the experiment. 
 


































Figure 7. 1: The 100% dissolved O2  capacity varies with temperature in water 
 
7.3.4 Experimental arrangement 
The method of UCAs reconstitution, sizing and measurement of attenuation (Chapter 
4), CTR and SFR (Chapter 5 and 6) at RT were described in the previous chapters. 
SFR was measured using a 25-cycle signal. For the process of withdrawing UCAs, a 
19G needle was inserted to a vial of activated Definity and a second 19G was 
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inserted for venting the gas. One of the 19G needles was connected to a syringe and 
the UCAs were withdrawn at a steady slow rate by hand. The activated SonoVue was 
withdrawn from the vial using the syringe incorporated in the SonoVue contrast 
reconstitution kit. The choice of connected syringe depends on the injection rate 
selected (1ml-syringe for 0.85 ml· in-1 and 2ml-syringe for 3ml·min-1).   The syringe 
was then placed horizontally on a syringe pump and connected with one of the 
needles under test. At an injection rate setting, UCAs were pushed out into an 
Eppendorf PCR tube and were ready for sizing and acoustic measurement. The only 
difference for the experiments undertaken from BT to RT was replacing the water 
(solvent) at RT to the prepared air-saturated water t BT. The MB suspension was 
placed in an open tank and stirred continuously during the measurement. The water 
tank was placed on a hotplate setting at 42 oC to maintain the temperature at BT 
during the acoustic measurements.  However, there was no temperature control for 
the MB sizing measurement using Mastersizer and the resultant variation in 
temperature during the experiment might potentially contribute to the uncertainties of 
the sizing results. 
 
In addition to the different size distributions and capabilities of light scatter, the 
initial maximum concentration of reconstituted Definity (1.2×1010 MBs·ml-1) and 
SonoVue (5×108 MBs·ml-1) varied in magnitude, thus different volumes of MBs 
(0.25 mL-Definity and 1.5 ml-SonoVue) were diluted in 240 ml-water for their 
individual MB sizing experiment to reach a obscuration above 5%, based on which 
Mastersizer generated a volume-based size distribution outcome. 
 
Taking the above three factors into consideration: A: Needle Gauge (A1＝19G，
A2=27G, A3=30G), B: injection rate (B1=3ml/min, B2=0.85ml/min) and C: 
Temperature (C1=RT, C2=BT), there are 12 combinatios shown in Table 7.2. In 
this study, the setting of 19G, 3ml/min at RT (A1B1C1) is defined as ‘in vitro’ 
representing a typical in vitro situation. Both 27G 0.85ml/min at BT (A2B2C2) and 
30G 0.85ml/min at BT(A3B2C2) are defined as ‘ in vivo’ representing values 
typically used in an in vivo study.   The size distribution, attenuation, CTR and 
SFRof the resultant 12 combinations were measured. Each experiment was repeated 
 
 172 
three times and the measurements were acquired in 0.5-3 minutes after introducing 
MBs into water. After acquisition, the data were thn downloaded to a local pc and 
analyzed using MATLAB. 
 
Table 7. 2: Experiment arrangement of the 12 combinations from 3 needle gauges, 2 
injection rates and 2 temperatures 
 
 A(Gauge) B(injection rate) C(Temperature)  
1 19G 3ml/min RT 19G_ RT3ml/min 
2 19G 3ml/min BT 19G_ BT3ml/min 
3 19G 0.85ml/min RT 19G_RT0.85 ml/min 
4 19G 0.85ml/min BT 19G_BT0.85 ml/min 
5 27G 3ml/min RT 27G_RT3ml/min 
6 27G 3ml/min BT 27G_BT3ml/min 
7 27G 0.85ml/min RT  27G_RT0.85 ml/min 
8 27G 0.85ml/min BT  27G_BT0.85 ml/min 
9 30G 3ml/min RT 30G_RT3ml/min 
10 30G 3ml/min BT 30G_BT3ml/min 
11 30G 0.85ml/min RT 30G_RT0.85 ml/min 
12 30G 0.85ml/min BT 30G_BT0.85 ml/min 
 
 
Pressure drop and shear stress in the syringes and nee les 
 
The shear stress τ in the syringes and needle can be calculated using Equation 7.1 
(Barrack and Stride 2009) 
                                                τ i =
8 µ ui
Di
                                                   (7.1) 
 
Where µi is viscosity of the suspending liquid (for water, µ water=0.001 Pa·s), ui is the 
velocity of the liquid, Di is the inner diameter, i indicates either syringe or needle. 
 
The pressure drop from the syringe to the needle is calculated using Equation 7.2 




                                                 ( )22
2
1
snns uuPP −=− ρ                                             (7.2) 
where Ps is the pressure near the piston in the syringe, Pn is the pressure at the outlet 
of the needle which equals atmospheric pressure, ρ is the density of the suspending 
liquid (for water, ρ water =1000 kg·m
-3), un and us are the velocity of liquid in the 
needle and syringe respectively and are calculated Equation 7.3 
 








=                                                      (7.3) 
where Q is the flow rate of the liquid. 
7.3.4 Statistics 
The impact of needle gauge (19G, 27G and 30G) was determined by the groups with 
significant differences calculated using a one-way ANOVA. The influence of 
injection rate and temperature was determined by groups with significant difference 
from T test.  T test was performed between the in vivo (27G/30G 0.85ml/min at BT) 
and in vitro (19G 3ml/min at RT) cases to understand the integra d effect of the 
needle gauges, injection rate and temperature on the size distribution and acoustic 
properties in the frequency range 17-31MHz.  
 
The rescale range analysis determines the importance of each of the factors 
(Ziayoddin et al. 2012) and specifically in this study it ranks the influence of needle 
gauge, injection rate and temperature on the measurd variables of mean diameter, 
attenuation, CTR and SFR. Compared to the general calculation based on an 
orthogonal array, the calculations in this study used an entire date set (complete 
combination of all possibilities) and the algorithm was listed in the Appendix 5 and 
6. The orthogonal array design is proposed by Genichi Taguchi and aids to improve the 
efficiency of manufacture by reducing the variability (Montgomery 2008). The 
calculated R value represented the difference between the maximal and minimal 
results in each group of results (mean diameter, attenuation, CTR or SFR) and the 
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experimental factor in response to the largest R value is the one that has the most 
influence on the results (Di et al. 2003, Li et al. 2001).  
7.4 RESULTS 
 
The results of in vitro (RT 3ml/min) and in vivo (BT 0.85ml/min) measured by three 
needle gauges are selectively presented in this section and the remainder of the data 
in the Appendix 7 and 8.  The results of T test were marked between i  vitro (19G 
3ml/min RT) and in vivo (27G/30G 0.85ml/min BT) on the Figure 7.3-7.6. 
7.4.1 The size distribution and mean diameter of De finity and SonoVue 
The volume based size distributions of Definity and SonoVue in the in vitro (19G 
3ml/min RT) and in vivo (27G/30G 0.85ml/min BT) are shown in Figure 7.2.  
Compared with the size distribution curve from the RT measurements in each figure, 
the trend is that the size distribution made at BT measurement reduces in mean 
diameter and total gas volume compared to RT measurments. 
 




















           




















                      (a) Definity                                                         (b) SonoVue 
Figure 7. 2: The size distribution of (a) Definity and (b) SonoVue in the in vitro case 
(19G RT 3ml/min) and in vivo case (27G/30G BT 0.85ml/min). The line at 1.5 µm in 
(a) corresponds to the Definity MBs resonate at 15MHz based on the simulation of 
resonant frequency in Chapter 5  
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Figure 7.3 shows the mean diameter of Definity and SonoVue. At RT, the mean 
diameter decreases with increasing needle gauge. There is no significant difference 
in mean diameter of Definity between in vitro and in vivo cases. For SonoVue, 
significant decrease of 0.7 µm in mean diameter is shown in Figure 7.3.b. For each 
pair (same needle gauge, different injection rates nd temperatures) of both UCAs, 
the mean diameter decreases from RT to BT and from fast to low injection rate using 
19G and 27G needle. However, the result using the smallest diameter needle (30G) 

















































                        (a) Definity                                                 (b) SonoVue 
Figure 7. 3: The mean diameter comparison of (a) Definity and (b) SonoVue in the 
in vitro case (RT 3ml/min) (white bar) and in vivo case (BT 0.85ml/min) (shaded 
bar), NS: no significant difference, * P<0.05 
7.4.2 The acoustic properties comparison of Definit y and SonoVue  
Attenuation  
 
The attenuation of Definity and SonoVue are presented in Figure 7.4. At RT, the 
attenuation decreases with increasing needle gauges. Th  attenuation of SonoVue in 
Figure 7.4.b shows extremely significant difference of 0.94dBcm-1 between the in 
vitro (RT) and in vivo (BT) cases. For each pair (same needle gauge, different 
injection rates and temperatures) of both UCAs, the att nuation of the two UCAs 
measured in the frequency range from 17-31 MHz decreases from RT to BT and 
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from high to low injection rate except the results of Definity measured at 27G needle. 
But the difference is not significant between the two settings (19G, 3ml/min, RT and 






















































                        (a) Definity                                                         (b) SonoVue 
 
Figure 7. 4: The attenuation comparison of (a) Definity and (b) SonoVue in the in 
vitro case (RT 3ml/min) and in vivo case (BT 0.85ml/min), NS: no significant 




Figure 7.5 shows little variation in CTR of Definity and SonoVue except for the 
result of SonoVue measured by 19G needle at BT overthe frequency range 17-31 
MHz. CTR of Definity increases significantly from 19G at RT to 27G at BT. CTR of 
SonoVue presents very significant difference of 1.70dB between in vitro and in vivo 
cases. In each pair group of the same needle gauge, the value of CTR decreases from 
RT to BT and from high to low injection rate measured at 19G and 27G and the 
contrary is true for the result of 30G needle. At RT, CTR decreases with increasing 











































                       (a) Definity                                           (b) SonoVue 
Figure 7. 5: The CTR comparison of (a) Definity and (b) SonoVue in the in vitro 
case (RT 3ml/min) and in vivo case (BT 0.85ml/min), NS: no significant difference, 
** P<0.01, ***P<0.001  
 
 
Subharmonic to fundamental ratio  
 
The SFR of Definity and SonoVue are shown in Figure 7.6. In Figure 7.6a, Definity 
demonstrates a significant difference of 0.96dB betwe n 19G and 27G in SFR, but 
there is little variation between the groups of 19G and 30G.  In Figure 7.6b, for 
SonoVue, there is a significant decrease in the SFRbetween the in vitro and in vivo 
setting. At RT for Definity and SonoVue, SFR increas s with increasing needle 












































































                       (a) Definity                                           (b) SonoVue 
Figure 7. 6: The subharmonic to fundamental ratio comparison of (a) Definity and 
(b) SonoVue in the in vitro case (RT 3ml/min) and in vivo case (BT 0.85ml/min), NS: 
no significant difference, * P<0.05 
 
7.4.3 Pressure drop and shear stress in the syringe s and needles 
Table 7.3 lists the calculated shear stress in the syringes and needles and the pressure 
drop from the piston in the syringe to the outlet of the needle at different tested 
combinations. At certain injection rates (0.85 ml/min using 1ml-syringe, 3ml/min 
using 2ml-syringe), the pressure drop and the shear stress in the needle increase with 
the increasing needle gauge (i.e., decreasing I.D.).  Applying the same needle, the 
fast injection rate (3ml/min) produces a higher pressure drop and shear stress in the 
needle than from the slow injection rate (0.85 ml/min), but the shear stress in the 










Table 7. 3: The velocity, shear stress in the tested syringe (1ml I.D.: 4.78mm, 2ml 
I.D.: 8.66) and needles (19G, 27G, 30G) and the pressure drop (Ps-Pn) from syringe 
to needle 
 
7.4.4 Rescale range analysis 
The impacts of needle gauge, injection rate and temperature rated from high to low 
on the mean diameter and acoustic properties of Definity and SonoVue are listed 
below: 
Definity 
Mean diameter: needle gauge > injection rate > temperature 
Attenuation: needle gauge > temperature> injection rate 
CTR: temperature > needle gauge > injection rate 
Subharmonic to fundamental ratio: needle gauge > injection rate> temperature 
 
SonoVue 
Mean diameter: injection rate > needle gauge> temperature 
Attenuation: temperature>needle gauge > injection rate 
CTR:  temperature > needle gauge >injection rate  




























0.85 4.78 0.79 0.686 38.35 0.73 1.32 0.45 
0.85 4.78 0.79 0.21 409.22 83.73 1.32 15.59 
0.85 4.78 0.79 0.159 713.84 254.79 1.32 35.92 
3 8.66 0.85 0.686 135.35 9.16 0.78 1.58 
3 8.66 0.85 0.21 1444.31 1043.02 0.78 55.02 




The discussion of individual factors is based on the entire dataset including data 
presented in Appendix 7 and 8.  Figures 7.2-7.6 only show the difference between 
selected typical in vitro and in vivo settings. 
7.5.1 The impact of needle on the MBs 
The results obtained from the study of needle gauges obtained at RT agree with the 
studies (Barrack and Stride 2009, Talu et al. 2008) that increasing needle gauges 
(i.e., narrower ID) reduces the mean MB diameter due to the aggravated diffusion of 
the MBs owing to an increase in the forced compression, hear stress (Table 7.3) and 
velocity gradient (Barrack and Stride 2009).  From Chapter 5 it has been shown that 
both the resonant MBs and large off-resonance MBs contribute to the fundamental 
acoustic properties, consequently the attenuation (Figure 7.4) and CTR (Figure 7.5) 
decrease with increasing needle gauges at RT as expect d. However, SFR (Figure 
7.6) was found to increase. As shown in Chapter 6 subharmonic response was found 
to rely on the MBs that resonate at half the driven fr quency.  The driving frequency 
in this study was 30MHz, the diameter of Definity MBs that resonate at 15MHz is 
1.5 µm shown in Figure 7.2a. The volume percentage of this diameter may increase 
at narrower needle size (size distribution curves not i cluded) and may account for 
the increase in its SFR.  
 
7.5.2 The impact of injection rate on the MBs 
The increase in injection rate from 0.85 ml/min to 3ml/min at RT is found to increase 
the mean diameter of MBs which is not in agreement with the results from (Barrack 
and Stride 2009, Talu et al. 2008). Both Defintiy and SonoVue are poly-disperse 
large MBs (4-5µm) of a concentration 1.2×1010 MBs/ml (Lantheus Medical Imaging 
2011) and 2-5×108 MBs/ml (Schneider 1999) respectively. The structure and the size 
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distribution of Definity and SonoVue are comparable to in-house MBs in Barrack’s 
study and different from the mono-disperse small MB in Talu’s experiment. 
However, the concentration of MBs is similar to Talu’s study but not with Barrack’s 
as the latter used a concentration around 107 MBs/ml.  At RT, the reason for the 
increase in mean diameter from low to high injection rate may be because higher 
injection rate at 3ml/min using a 2ml-syringe introduces lower shear stress in the 
syringe shown in Table 7.3 compared with the low injection rate at 0.85ml/min using 
1ml-syringe.  
 
Although the mean diameter increased from low to high injection rates at RT, for 
Definity and SonoVue in the frequency range of 17-3MHz the measured attenuation 
was not found to vary significantly.  However, a significant increase was found in 
CTR and a significant decrease in the SFR. Note that the only exception occurs in the 
result of SonoVue using 30G needle at RT, which show  a decrease in mean 
diameter and CTR and an increase in SFR. This trend may result from the interaction 
between the narrow needle gauge and high injection rate. In this setting, the shear 
stress is 126.76 Pa shown in Table 7.3 and the value is close to the threshold 150 Pa 
above which cell damage is predominately due to shear stress (Leverett et al. 1972).  
The shear resistance of the monolayer lipid MBs are not expected to be stronger than 
the bilayer, lipid and protein mixed membrane of the animal cells. Thus, this high 
shear stress by using 30G needle at high injection rate may cause destruction of most 
MBs and a decrease in the mean diameter of the entire MB population. 
7.5.3 The impact of temperature on MBs 
The mean diameter of Definity and SonoVue MBs increases from RT to BT based on 
the data of the same injection rate and needle gauge in Appendix 7 and 8, though in 
Figure 7.3 the measured diameter at BT is smaller than he diameter obtained at RT 
that may be influenced by the compression from increasing needle gauges and low 
injection rate. The process of MB dissolution was previously found to be in 3 phases: 
(1) an initially quick growth, (2) steady dissolution (Van Liew and Burkard 1995), 
(3) phase changes from low vapour pressure to vapour-to-liquid under Laplace 
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pressure (Kabalnov et al. 1998, Kwan and Borden 2010). In the first growth stage, 
the increasing temperature further enables MBs expansion by weakening the 
chemical bonds between lipid molecules and changing the shell elasticity and surface 
tension (Mulvana et al. 2011).  
 
The attenuation of Definity and SonoVue MBs reduces at BT compared with the 
values at RT in the frequency range 17-31MHz. However, the attenuation of 
SonoVue measured at 3.5 MHz 100kPa pressure was found to increase with 
temperature below 40oC (Mulvana et al. 2010).  This finding also contradicts the 
results from Chapter 5 that MBs of large mean diameters correspond to large 
backscatter cross section leading to a higher attenua ion and scattering energy. 
Taking into consideration the instability of MBs at BT, MBs may be disrupted under 
the insonating 0.56 MPa-PNP, despite this pressure proving to be non-destructive for 
MBs at RT shown in Chapter 4. 
 
The CTR of Definity was found to increase at BT, but for SonoVue CTR decreases 
at BT compared with RT. On one side, the increased CTR may be attributed to the 
measured increase in mean diameter. On the other sid , based on the assumption that 
MBs were destroyed in the analysis of attenuation, the diffused gas from MBs to the 
suspension becomes free MB then is dissolved gradually. The MBs with the gas of 
low Ostwald coefficient (Kabalnov et al. 1998) and low diffusivity and low solubility 
(Sarkar et al. 2009) will have a longer lifetime. In Table 7.4 it can be seen that C3F8 
released from Definity processes a longer dissolution me compared the SF6 gas 
from SonoVue.  Consequently in the CTR measurement, the backscattered signal 
from the free SF6 gas in the SonoVue suspension will have little effect on the 
acoustic measurements due to rapid dissolution. Thus t e destruction of MBs and the 
difficultly in detecting free SF6 gas contributes to the loss in CTR of SonoVue. 
 
The SFR of Definity and SonoVue decreases from RT to BT. This indicates potential 
MB destruction during the subharmonic measurement due to the applied 25-cycle 




Table 7. 4:  Parameters of gas of SonoVue and Definity (Sarkar et l. 2009) 
 





Permeability of gas 
through the encapsulation 
SonoVue SF6  1.2×10
-9 m2·s-1 5.4×10-3 8.7×10-6 m·s-1 
Definity C3F8  7.45×10
-10 m2·s-1 5.2×10-4 1.2×10-6 m ·s-1 
 
7.5.4 The interaction between the needle gauge and injection rate with 
temperature  
The influence of needle gauge and injection rate on the size distribution and acoustic 
characterisation of MBs at RT changes from the results acquired at BT. For instance, 
the mean diameter (Figure 7.3) and attenuation (Figure 7.4) of Definity and SonoVue 
were expected to reduce with increasing needle gauges but the contrary is true at the 
measurement of a 0.85ml/min-injection rate and BT. The interaction between the 
needle gauge, injection rate and temperature may occur. A narrower needle raises the 
shear stress to compress MBs and may force the MB to buckle (Barrack and Stride 
2009), at which stage the surface tension (σ) equals to zero (Marmottant et al. 2005) 
leading to elimination of Laplace pressure (P = 2σ/R, R is the radius of MBs) (Van 
Liew and Burkard 1995). This makes the expansion of the MB at high temperature 
much easier compared with the MBs limited by the Laplace pressure. The potential 
change in the shell structure at BT on the other side promotes this process.  Further 
investigations are required to validate these thougts based on the optical 
observations. 
 
From the rescale range analysis, the physical compression from the combination of 
needle gauge and injection rate predominately influe ces the mean diameter and SFR 
at 30MHz for both Definity and SonoVue. Temperature outperforms in the 
measurements of attenuation and CTR in the frequency range from 17-31MHz. 
SonoVue is sensitive to temperature while Definity is sensitive to needle gauge. 
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7.5.5 Consideration of the change in properties fro m in vitro to in vivo 
settings  
Based on the above discussions of the impact of individual parameters and the 
interactions of needle gauge, injection and temperature, the variation of size 
distribution and the acoustic properties from the in vitro (19G, 3ml/min at RT) to in 
vivo (27G/30G, 0.85ml/min at BT) settings include: size distribution curves shift to 
the small diameter (Figure 7.2), mean diameters reduc  accordingly (Figure 7.3), the 
attenuation (Figure 7.4) and CTR (Figure 7.5) decrease. The volume percentage of  
1.5 µm-diameter MB (in response to the resonant diameter of Definity MBs at 
15MHz) in Figure 7.2a increases at BT results in an increase in its SFR of Definity 
(Figure 7.6). However, the SFR of SonoVue decreases significantly at BT, which 
may be caused by instability and the destruction of MBs. 
7.6 CONCLUSION 
 
In this chapter, the influence between the in vitro (19G, 3ml/min at RT) and in vivo 
(27G/30G, 0.85ml/min at BT) experimental settings on the size distribution and 
acoustic properties of Definity and SonoVue in the frequency range of 17-31MHz 
was investigated. Specifically, for Definity from in vitro to in vivo setting, (1) there 
was no significant difference in mean diameter; (2) a significant decrease was found 
in attenuation and SFR; (3) an extremely significant increase occurs in CTR. For 
SonoVue, a significant decrease is observed in all the measured parameters including 
mean diameter, attenuation and CTR in the frequency range 17-31MHz and SFR at 
30MHz. The reasons are from the combined effects of needle gauge and injection 
rate due to the physical compression and temperatur d e to the alteration of shell 
structure.  From the rescale range analysis, SonoVue was found to be most sensitive 
to temperature while Definity was most sensitive to the needle gauges. 
Quantification of these parameters (needle gauge, inj ct on rate and temperature) 
helps to explain quantitative differences in acoustic performance between i  vitro 




Chapter 8  
Conclusions and future work 
 
8.1 CONCLUSIONS  
 
As outlined in Chapter 1, this thesis aimed to investigate the acoustic properties of 
ultrasound contrast agents (UCAs) at high ultrasound frequencies using a preclinical 
ultrasound scanner operating in RF mode. Briefly, Chapters 2 and 3 used an agar-
based tissue mimicking material (TMM) to establish a platform for studying the 
essential acoustic parameters and developing the MATLAB codes necessary for this 
analysis, Chapters 4 to 6 focused on the comparative acoustic characterisation of 
three commercial lipid encapsulated UCAs using high frequency ultrasound. Before 
translation of the in vitro conclusions into explaining the future in vivo studies, an 
additional in vitro experiment using the practical in vivo administration process 
(thinner needle and slower injection rate at body temperature) was discussed in 
Chapter 7. Specific conclusions of each chapter are described below.  
 
In Chapter 2 five high frequency transducers were characterised using a membrane 
hydrophone with an active element of 0.2 mm in diameter.  Transmitting frequencies, 
pressures and spatial beam profiles were measured and provided quantitative 
information to support the studies of the following chapters.  
 
Using these transducers and development of appropriate software, high frequency 
acoustical characterisation of TMM was performed in Chapter 3 using a broadband 
substitution technique.  The speed of sound and attenuation were also acquired by a 
scanning acoustic macroscope (SAM) based in Dublin Institute of Technology. The 
results from the two independent systems were found to be comparable and showed 
that 1) the acoustical attenuation of TMM varied nonlinearly with frequency in a 
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format of 0.40 f + 0.0076 f 2 and 2) the speeds of sound in TMM measured by the 
Vevo 770 scanner and SAM system were found to be 1547.4 ± 1.4 m·s-1 and  
1548.0 ± 6.1 m·s-1 in the frequency range 12-47MHz, respectively.   
 
Chapter 4 described the extension of the experimental se -up and methods developed 
in chapter 3 to quantify the attenuation and normalized backscatter power (NBs) for 
UCAs. Through the concentration dependent experiments, a concentration of 0.8×106 
mbs/ml was determined to be used in the following chapters. It was shown that for 
the three contrast agents that his value lay in the range in which the attenuation 
varied linearly with concentration and NBs varied linearly with the concentration. 
Additionally, for the non-destructive study of high frequency acoustic properties of 
Definity, SonoVue and MicroMarker in Chapters 5-7, the influence of the insonation 
pressure and time on the attenuation and NBs of microbubbles (MBs) was 
investigated.  A power output of 3% on the Visualsonics scanner, corresponding to a 
PNP less than 0.56MPa was found not to destroy the MBs. 
 
Based on the developed experimental methods and the det rmined ultrasound 
parameters (concentration and pressure), Chapter 5 and 6 focused on the comparison 
of acoustical properties of three lipid-encapsulated UCAs Definity, SonoVue and 
MicroMarker (untargeted) as a function of their frequ ncy and size population. At 
the same number concentration below 30MHz, the acoustic characterisation of the 
three native UCAs are comparable, though their sized stributions and encapsulated 
gases and shells are significantly different. Native MicroMarker produces higher 
values of attenuation and CTR compared with native Definity and SonoVue at 
frequencies above 30MHz and higher subharmonic to fundamental ratio at 25MHz. 
Altering the size distribution and concentration of Definity and SonoVue through 
decantation enables further enhancement for specific applications and may take full 
advantage of the imaging capabilities of the scanner. I  Chapter 6, at 25MHz small 
Definity and SonoVue MBs (< 2µm in diameter) were predominantly responsible for 
the subharmonic response. Additionally, simulations were made using BUBBLESIM 
toolbox and showed that 1) MBs resonating at half of the driving frequency may 
predominately drive the subharmonics, 2) the pressur  and number of cycle influence 
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the magnitude of the oscillation. It was suggested that the main reasons causing the 
discrepancy between the experimental data and simulation may be the complicated 
variation in MBs during the oscillation and the limitations of the model.  
 
In Chapter 7, the influence between in vitro (19G needle, 3ml/min at RT) and in vivo 
(27G/30G needle, 0.85ml/min at BT) experimental settings on the size distribution 
and acoustic properties of Definity and SonoVue wasinvestigated in the frequency 
range from 17 to 31MHz. Because of the physical compression and variation in the 
shell structure, all the measured parameters (mean di meter, attenuation, CTR, 
subharmonic to fundamental ratio) were found to be significantly altered except for 
the mean diameter of Definity. SonoVue is found to be most sensitive to temperature 
while Definity is most sensitive to the needle gauges. 
8.2 FUTURE WORK  
 
The high frequency ultrasound transducers have been characterised at room 
temperature in Chapter 2. Similar quantifications may be also required at body 
temperature for the following reasons. 1) The practic l in vivo applications of UCAs 
are at body temperature and the results from Chapter 7 indicate a significant 
difference in the UCAs response between room temperature and body temperature. 
2) The speed of sound in the water varies with temperature leading to the variation in 
the spatial distribution of beam profile and change of the focal position. 3) Nonlinear 
effects of ultrasound increase with temperature (Van Dongen and Verweij 2008).  
 
In Chapter 3, the speed of sound and attenuation of ultrasound through TMM has 
been measured, further investigation of its backscatter properties and its frequency 
dependence remains to be studied. Note that the transmitting power applied in the 
study is at 10% for the tested transducers (transducer 710B: 1.06MPa, 707B: 
1.05MPa, 704: 0.52MPa and 711: 0.23MPa), the occurrence of nonlinearity of 
ultrasound through TMM at these PNP is likely to be low. However, the nonlinear 
effects within TMM become more significant with increasing transmitting power at 
higher frequencies. Dong (Dong et al. 1999) measured th  nonlinearity parameter 
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B/A of TMM (non-fat materials range from 5.6 to 6.6, fat materials are 9.8 and 11.1) 
at 2.25 MHz. Willams (Williams et al. 2006) found the B/A of a gelatine based 
TMM to be 7.4 ± 0.6. Thus it is of interest to study the relationship between the 
nonlinearity of TMM and transmitting power. Additionally, the previously published 
acoustic properties of biological tissue at high frequency are limited. Using the 
preclinical scanner it would be useful to acquire th  speed of sound, acoustic 
attenuation and backscatter of biological tissue. The protocol of manufacturing TMM 
can be adjusted to match the measured acoustic parameters of the tissue at high 
frequencies. This developed TMM can be used as a specific phantom for assessing 
and evaluating the high frequency preclinical ultrasound devices. 
 
A range of concentration within which a linear response of the attenuation and 
backscatter was confirmed in Chapter 4. The determination of this linear range of 
concentration can diminish the consideration of the multi-scattering between the 
MBs. But multi-scattering effects are likely to occur in vivo and introduce 
complicated interactions between the MBs thus further investigations at high 
frequencies under multi-scattering are necessary.  
 
In the concentration dependent experiment, an interes ing phenomenon of expansions 
and contractions of ‘MB’ were observed at low concentration in response to high 
insonation power shown in Figure 8.1. Theoretically, even at the applied ultrasound 
(12 – 47 MHz), spatial resolution is insufficient to observe the expansion and 
contraction of individual MB as well as the temporal resolution. But the oscillating 
particles look like the MBs. In Figure 8.1, the white line on the top of each 
oscillating particle may be the scatter from each MB under the sweeping of the single 
element transducer. The changing arc beneath the white line (the section in the 
highlighted yellow circle) may be attributed to the cavitation of the MB. Detailed 





Figure 8. 1: B-mode image of MicroMarker MBs suspension at 0.2×106 mbs/ml 
concentration under 100% transmitting power, the section in the highlighted yellow 
circles are the contracting and expanding arcs during the MB oscillation 
 
The contrast to tissue ratio was measured in Chapter 5 as a signature of the 
fundamental response of the MBs suspension. Due to the limited acoustical data from 
soft tissue published at high frequency, choosing a independent quantity like 
backscatter coefficient may provide a more independent measure of different 
experimental modalities.   
 
In Chapter 6, the subharmonic to fundamental ratio of SonoVue was found to be 
higher than Definity at 25MHz in each group of native, small and large population. 
However, the simulation results suggested that Definity MBs of a certain diameter 
resonated at 12.5 MHz but no SonoVue MBs resonated bove 10MHz. One of the 
explanations is the shell properties of SonoVue acquired at the low frequency range 
might not accurately reflect its properties at high frequencies, despite the measured 
attenuation was found to be constant with the published data at lower frequency 
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range. For this reason, the shell properties in particular of SonoVue require further 
investigation.  From the simulations in Chapter 6, discrepancies exist between 
simulation and experimental data that may be due to the mismatch between the 
experimental data and the model. The shell parameters are used in the model to 
simulate the oscillation of individual MB but they are acquired from a certain 
population of MB suspension. As known the shell properties vary with the diameter 
of the MBs. Thus, measuring the shell properties of a narrow range of bubble 
diameters (mono-disperse) would reduce the discrepancy between the simulation and 
experiment. This narrow range in diameter would be the most suitable to contribute 
to a targeted applications for specific frequency used for subhamonic study. From the 
simulation point of view, other models considering the diffusion in the insonating 
cycles and the variation in shell during the oscillation may be employed to study the 
subharmonic of MBs and further experimental data can be acquired to validate the 
efficacy of these models.  
 
The influence of needle gauges, injection rate and temperature on the two clinical 
UCAs Definity and SonoVue was studied in Chapter 7. The preclinical UCAs 
MicroMarker study was not completed. From the discus ion of the results at body 
temperature, the transmitting signal of long number of cycles and non-destructive 
pressure at room temperature may disrupt the MBs at body temperature, so future 
experiments using a lower pressure are necessary. Despite the published papers using 
high speed cameras showing a lower onset threshold of oscillation, larger radial 
oscillation and reduced stability of MBs at body temperature, explanations for this 
have centred almost solely around the proximity of body temperature to the transition 
phase temperature of lipids. How this process evolves and detailed explanations can 
be found through further research using a florescence microscope to capture the 
variation in the chemistry structure of lipid shell during the oscillation at body 
temperature. The experiments in this thesis are in vitro studies. The environment 
changes in this chapter already reveal the large distance from in vitro to in vivo. The 
complexities in the biological tissue are expected to introduce more uncertainties. 
The final goal is to successfully transfer the physics knowledge and understandings 




The applications of MBs destruction plays an important role in perfusion, gene and 
drug delivery (Stride and Saffari 2003). Three main mechanisms of UCAs 
destruction have been identified to be fragmentation, acoustically driven diffusion, 
and static diffusion depending on the insonation pressure from high to low level 
(Chomas et al. 2001). The destruction of Definity was measured at 20 MHz and 
25MHz using a flow phantom and the results indicated the destruction increased with 
the increasing pressure, number of cycles and frame rate (Cherin et al. 2005). The 
destruction of SonoVue was studied at 10MHz using a du l-high frequency 
ultrasound excitation (Chih-Kuang et al. 2009). Compared with single frequency-
excitation signal, this method significantly reduced the pressure threshold for 
destroying the MBs by employing a transmitting signal consisting of two-frequency 
sinusoids and the difference between the two frequencies equalled the resonance 
frequency of tested MBs. Due to the limited publications in studying the destruction 
of UCAs at high frequency and these two papers reviewed only used the lipid 
encapsulated UCAs at a frequency lower than 30MHz, the corresponding research of 
hard shell (polymer or albumin) MBs remains to be explored.  
 
The studies are based on a commercial ultrasound scanner allowing reproducible 
measurements but on other side use of this scanner limited the flexibilities of 
transmitting and receiving settings, in particular in RF data acquisition mode. Future 
work may include developing modules to connect with the scanners to facilitate 
functions for further research.    
 
In summary, acoustic characterisations of both TMM and UCAs in this thesis extend 
our understanding from low frequency to high frequency ultrasound and will enable 
the further development of ultrasound imaging techniques and UCAs design 













Appendix 1 The sensitivity of the membrane hydropho ne 
(certificate of calibration issued by National Phys ical 
Laboratory). 
 




























Appendix 2 The 3dB beamwidth (mm) of the transducer s in 
M-mode (Table a - e) / PW-Doppler mode (Table f - j ) 
 















Peak positive 0.15 0.16 0.15 0.15 0.14 0.15 
Peak negative 0.19 0.16 0.17 0.15 0.16 0.14 
 















Peak positive 0.15 0.13 0.12 0.12 0.12 0.12 
Peak negative 0.18 0.14 0.13 0.13 0.12 0.12 
 
    (c) 704 M mode 












Peak positive 0.14 0.14 0.14 0.14 0.16 0.13 
Peak negative 0.15 0.15 0.15 0.13 0.14 0.13 
 
   (d) 711 M mode 












Peak positive 0.15 0.43 0.17 0.21 0.17 0.33 




(e) 708 M mode, the bolded 3dB beamwidths are in particular broad because the 
















Peak positive 0.21 0.83 0.23 0.84 0.20 0.66 
Peak negative 0.18 0.17 0.19 0.18 0.20 0.20 
   (f) 710B PW-Doppler mode at 100% power 
Transducer 710 f=20MHz, SV=1 f=20MHz, SV=20 f=25MHz, SV=1 f=25MHz, SV=20 
Peak positive 0.15 0.15 0.15 0.25 
Peak negative 0.18 0.21 0.17 0.27 
(g) 707B PW-Doppler mode at 100% power 
Transducer 707 f=23MHz, SV=1 f=23MHz, SV=20 f=30MHz, SV=1 f=30MHz, SV=20 
Peak positive 0.14 0.16 0.15 0.13 
Peak negative 0.16 0.18 0.14 0.14 
   (h)704 PW-Doppler mode at 100% power 
Transducer  704 f=30MHz, SV=1 f=30MHz, SV=20 f=40MHz, SV=1 f=40MHz, SV=20 
Peak positive 0.17 0.16 0.15 0.14 
Peak negative 0.17 0.16 0.16 0.16 
  (i) 711 PW-Doppler mode at 100% power 
Transducer  711 f=40MHz, SV=1 f=40MHz, SV=20 f=55MHz, SV=1 f=55MHz, SV=20 
Peak positive 0.14 0.13 0.15 0.30 
Peak negative 0.14 0.15 0.15 0.24 
 (j) 708 PW-Doppler mode at 100% power 
Transducer  708 f=40MHz, SV=1 f=40MHz, SV=20 f=55MHz, SV=1 f=55MHz, SV=20 
Peak positive 0.15 0.15 0.15 0.25 
Peak negative 0.18 0.18 0.18 0.30 
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Appendix 3 The amplitude of signal measured by memb rane 
hydrophone for four transducers (a) 710B, (b)707B, (c) 704 

























100% 104.0 100.0 20 36.1 2.77 0.62 
79% 94.0 94.0 22 38.9 2.42 0.52 
63% 86.0 88.0 22 38.9 2.26 0.48 
50% 78.0 84.0 22 38.9 2.16 0.46 
40% 72.0 78.0 22 38.9 2.01 0.43 
32% 64.8 68.0 22 38.9 1.75 0.37 
25% 58.4 64.8 24 42.2 1.54 0.31 
20% 53.6 59.2 24 42.2 1.40 0.29 
16% 48.8 54.4 24 42.2 1.29 0.26 
13% 44.0 48.8 24 42.2 1.16 0.24 
10% 40.8 44.8 24 42.2 1.06 0.22 
8% 34.4 38.4 24 42.2 0.91 0.19 
6% 29.2 32.8 24 42.2 0.78 0.16 
5% 27.6 32.0 24 42.2 0.76 0.15 
4% 24.4 27.6 24 42.2 0.65 0.13 































100% 90 120 24 42.2 2.84 0.58 
79% 86 110 24 42.2 2.61 0.53 
63% 76 102 24 42.2 2.41 0.49 
50% 68 94 24 42.2 2.23 0.45 
40% 64 88 24 42.2 2.09 0.43 
32% 58 82 24 42.2 1.94 0.40 
25% 53.6 73.6 24 42.2 1.74 0.36 
20% 47.2 64 24 42.2 1.52 0.31 
16% 42.4 57.6 24 42.2 1.36 0.28 
13% 38.4 51.2 24 42.2 1.21 0.25 
10% 34.4 46.4 26 44 1.05 0.21 
8% 30.4 41.6 26 44 0.95 0.19 
6% 27.6 37.2 26 44 0.85 0.17 
5% 24.4 32.8 26 44 0.75 0.15 
4% 22.0 29.6 26 44 0.67 0.13 





























100% 55.2 77.6 26 44 1.76 0.35 
79% 46.6 64.8 26 44 1.47 0.29 
63% 40.8 57.6 26 44 1.31 0.26 
50% 38.4 52.0 28 45.5 1.141 0.22 
40% 32.8 44.8 28 45.5 0.98 0.19 




25% 26.4 34.8 28 45.5 0.76 0.14 
20% 23.2 30.8 28 45.5 0.68 0.13 
16% 20.4 27.2 28 45.5 0.60 0.11 
13% 19.6 25.6 26 44 0.58 0.11 
10% 17.6 22.8 26 44 0.52 0.10 
8% 15.8 19.4 28 45.5 0.43 0.08 




5% 12.4 14.8 28 45.5 0.33 0.06 
4% 11.0 12.6 30 46.6 0.27 0.05 


































100% 25.2 41.2 28 45.5 0.91 0.17 
79% 21.6 33.2 32 45.2 0.73 0.13 
63% 18.8 29.6 32 45.2 0.65 0.12 
50% 16.8 26 32 45.2 0.58 0.10 
40% 14.8 22.8 32 45.2 0.50 0.09 
32% 14.0 20.8 32 45.2 0.461 0.08 
25% 12.4 17.6 32 45.2 0.39 0.07 
20% 11.0 15.4 32 45.2 0.34 0.06 
16% 10.6 14.2 32 45.2 0.31 0.06 
13% 9.2 12.6 32 45.2 0.28 0.05 
10% 8.4 10.6 32 45.2 0.23 0.04 
8% 7.6 9.6 32 45.2 0.21 0.04 
6% 6.8 8.4 32 45.2 0.19 0.03 
5% 6.6 6.8 32 45.2 0.15 0.03 
4% 6.2 6.2 32 45.2 0.14 0.02 




Appendix 4 Performance verification certificate of Mastersize 





Appendix 5 The algorithms of the rescale range anal ysis  









 ∑Ai ∑Bi ∑Ci 
1 1 1 1 19G_ RT3ml 
K1 
i = 1:4 i=1,2,5,6,9,10 i=2n-1 (n=1-6) 
2 1 1 2 19G_ BT3ml 
K2 
i = 5:8 i=3,4,7,8,11,12 i=2n (n=1-6) 
3 1 2 1 19G_RT0.85 
K3 
i=  9:12   
4 1 2 2 19G_BT0.85 
k1 
K1A/4 K1B/6 K1C/6 
5 2 1 1 27G_RT3ml 
k2 
K2A/4 K2B/6 K2C/6 
6 2 1 2 27G_BT3ml 
k3 
K3A/4   
7 2 2 1  27G_RT0.85 R max(ki)- min(ki), (i =1,2,3) 
8 2 2 2 
 27G_BT0.85 
R’ R×0.52× 4   R×0.71× 6  
9 3 1 1 30G_RT3ml rank    
10 3 1 2 30G_BT3ml     
11 3 2 1 30G_RT0.85     









of Levels m 2 3 4 5 6 7 8 9 10 
Correction 















Appendix 7 The mean diameter, attenuation, CTR and 






(dB·cm-1) CTR (dB) 
Subharmonic to 
fundamental ratio (dB) 
19G_ RT3ml 4.94 ± 0.90 1.16 ± 0.06 -12.34 ± 0.31 -36.36 ± 0.45 
19G_ BT3ml 3.41 ± 0.04 1.15 ± 0.13 -11.26 ± 0.49 -35.94 ± 0.65 
19G_RT0.85 3.59 ± 0.03 1.22 ± 0.12 -12.96 ± 0.41 -35.46 ± 0.38 
19G_BT0.85 3.55 ± 0.03 0.93 ± 0.22 -12.12 ± 0.76 -36.59 ± 2.20 
27G_RT3ml 3.97 ± 0.06 1.10 ± 0.16 -12.33 ± 0.21 -35.36 ± 0.41 
27G_BT3ml 3.89 ± 0.03 1.13 ± 0.29 -11.28 ± 0.57 -35.30 ± 2.21 
27G_RT0.85 3.51 ± 0.02 1.20 ± 0.07 -12.96 ± 0.30 -35.23 ± 0.40 
27G_BT0.85 3.84 ± 0.03 1.23 ± 0.22 -10.85 ± 0.20 - 35.56 ± 0.97 
30G_RT3ml 3.57 ± 0.02 1.04 ± 0.15 -13.00 ± 0.35 -35.95 ± 0.54 
30G_BT3ml 3.25 ± 0.51 0.87 ± 0.45 -12.80 ± 0.37 -35.43 ± 1.65 
30G_RT0.85 3.17 ± 0.01 1.06 ± 0.31 -13.39 ± 0.50 -35.47 ± 0.57 




















Appendix 8 The mean diameter, attenuation, CTR and 







(dB·cm-1) CTR (dB) 
Subharmonic to 
fundamental ratio (dB) 
19G_ RT3ml 4.97 ± 0.06 1.45 ± 0.17 -11.86 ± 0.45 - 32.41 ± 0.69 
19G_ BT3ml 5.87 ± 0.31 0.83 ± 0.17 -10.44 ± 0.98 -35.47 ± 1.64 
19G_RT0.85 3.82 ± 0.26 1.28 ± 0.05 -12.74 ± 0.23 -32.36 ± 0.55 
19G_BT0.85 4.12 ± 0.24 0.13 ± 0.35 -23.18 ± 4.03 -26.94  ± 8.46 
27G_RT3ml 4.94 ± 0.07 1.31 ± 0.08 -12.49 ± 0.30 -31.34 ± 0.40 
27G_BT3ml 3.93 ± 0.23 0.37 ± 0.16 -15.24 ± 2.29 -32.97 ± 2.26 
27G_RT0.85 3.80 ± 0.05 1.27 ± 0.03 -13.00 ± 0.32 -32.37 ± 0.62 
27G_BT0.85 4.27 ± 0.25 0.51 ± 0.28 -13.26 ± 1.15 -33.92 ± 2.40 
30G_RT3ml 3.88 ± 0.02 0.76 ± 0.14 -15.35 ± 0.65 -30.96 ± 1.12 
30G_BT3ml 4.53 ± 0.28 0.00 ± 0.13 -27.30 ± 2.48 -20.78 ± 2.25 
30G_RT0.85 4.40 ± 0.11 0.91 ± 0.20 -14.32 ± 0.94 -32.62 ± 1.02 



















List of publications 
 
Journal Publications 
 C. Sun, S. Pye, J. Browne, A. Janeczko, B. Ellis, M. Butler, V. Sboros, A. 
Thomson, M. Brewin, C. Earnshaw, C.M. Moran. The Speed of Sound and 
Attenuation of an IEC Agar-Based Tissue-Mimicking Material for High 
Frequency Ultrasound Applications. Ultrasound in Medicine & Biology 
2012;38:1262-70. 
 X.Yang, C. Sun, T. Anderson, C. M. Moran, P.W. Hadoke, G.A. Gray, P.R. 
Hoskins. Assessment of spectral Doppler in preclinical ultrasound using a small-




 C. Sun, V. Sboros, M. Butler, C.M. Moran. The acoustic properties comparison 
of lipid microbubbles at high ultrasound frequencies, In Proceedings of IEEE 
International Ultrasonics Symposium, poster presentation by Dr. V. Sboros, 
Dresden, October, 2012. 
 C. Sun, S. Pye, A. Janeczko, B. Ellis, M. Brewin, M. Butler, V. Sboros, A. 
Thomson, J. Browne, C.M. Moran. The acoustic attenuation of an IEC agar-
based tissue-mimicking material measured at 12 - 47MHz, In Proceedings of 
IEEE International Ultrasonics Symposium, poster presentation, Orlando, 






 C. Sun, V. Sboros, M. Butler, C.M. Moran. The acoustic properties of different 
size-populations of microbubbles from 12 - 43 MHz, 2013 Rotterdam contrast 
symposium, poster presentation by Dr. C.M. Moran, Rotterdam, January, 2013.  
 C. Sun, I. Panagakou and C.M. Moran. Influence of temperature, needle gauge 
and injection rate on the size distribution and acoustic properties of UCAs at high 
frequency, 2012 British Medical Ultrasound Society (BMUS) annual meeting, 
poster presentation by Ms. I. Panagakou, Telfold, December, 2012.  
 C. Sun, V. Sboros, M. Butler, C.M. Moran. The acoustic properties of 
microbubbles and their concentration dependence at 12 - 45 MHz, 2012 the first 
meeting of Scottish Ultrasound, poster presentation, Glasgow, February, 2012.  
 C. Sun, V. Sboros, M. Butler, C.M. Moran. The acoustic properties of 
microbubbles and their concentration dependence at 12 - 45 MHz, 2012 
Rotterdam contrast symposium, poster presentation, Rotterdam, January, 2012.  
 C. Sun, S. Pye, J. Browne, A. Janeczko, B. Ellis, M.B. Butler, V. Sboros, C.M. 
Moran. Measurement of the acoustic attenuation of IEC agar-based tissue-
mimicking material from 10 - 33 MHz, 2011 British Medical Ultrasound Society 
(BMUS) annual meeting, poster presentation, Brighton, October, 2011.  
 C. Sun, S. Pye, A. Janeczko, B. Ellis, M. Brewin, M. Butler, V. Sboros, C. 
Earnshaw, A. Thomson, J. Browne, C.M. Moran. The acoustic speed and 
attenuation in an IEC agar-based tissue-mimicking material measured at 14 - 46 
MHz, 2011 Institute of Physics and Engineering in Medicine (IPEM) Physics & 





 Fourth preclinical ultrasound imaging day, November, 2012, Edinburgh 
 Leeds Microbubble Symposium, July, 2011, Leeds 
 BMUS preclinical ultrasound study day, October, 2010, London 










AIUM. Methods for specifying acoustic properties of tissue mimicking phantoms 
and objects, Stage I. American Institute of Ultrasound in Medicine Technical 
Standards Committee Laurel, Maryland, 1995. 
Ali M, Magee D, Dasgupta U, Signal Processing Overview of Ultrasound Systems 
for Medical Imaging. Texas Instruments White Paper 2008:1–26. 
Andersen KS, Jensen JA, Ambient pressure sensitivity of microbubbles investigated 
through a parameter study. The Journal of the Acoustical Society of America 
2009;126:3350. 
Apfel RE, Holland CK, Gauging the likelihood of cavitation from short-pulse, low-
duty cycle diagnostic ultrasound. Ultrasound Med. Biol. 1991;17:179-85. 
Badea R, Seicean A, Diaconu B, Stan-Iuga R, Sparchez Z, Tantau M, Socaciu M, 
Contrast-enhanced ultrasound of the pancreas--a method beyond its potential or 
a new diagnostic standard. J Gastrointestin Liver Dis 2009;18:237-42. 
Barnett S, Nonthermal issues: Cavitation--Its nature, detection and measurement. 
Ultrasound Med. Biol. 1998;24:S11-S21. 
Barrack T, Stride E, Microbubble Destruction During I travenous Administration: A 
Preliminary Study. Ultrasound Med. Biol. 2009;35:515-22. 
Berg HC. Random walks in biology: Princeton Univ Pr, 1993. 
Bertolotto M, Martegani A, Aiani L, Zappetti R, Cernic S, Cova M, Value of 
contrast-enhanced ultrasonography for detecting renal i farcts proven by 
contrast enhanced CT. A feasibility study. European Radiology 2008;18:376-
83. 
Biagi E, Breschi L, Vannacci E, Masotti L, Stable and transient subharmonic 
emissions from isolated contrast agent microbubbles. Ultrasonics, 
Ferroelectrics and Frequency Control, IEEE Transactions on 2007;54:480-97. 
Bideau-Mehu A, Abjean R, Guern Y, Refractive index of octofluoropropane (C3F8) 
in the 300-150 nm wavelength range. Nuclear Instruments and Methods in 
 
 207 
Physics Research Section A: Accelerators, Spectromeers, Detectors and 
Associated Equipment 1996;381:576-77. 
Bilaniuk N, Wong GSK, Speed of sound in pure water s a function of temperature. 
The Journal of the Acoustical Society of America 1993; 3:2306. 
BMUS, Guidelines for the safe use of diagnostic ultrasound equipment. The British 
Medical Ultrasound Society 2009. 
Boliren CF, Huffman DR, Absorption and scattering of light by small particles. J 
Wiley & Sons, New York 1983. 
Bouakaz A, de Jong N, WFUMB safety symposium on echo-contrast agents: Nature 
and types of ultrasound contrast agents. Ultrasound Med. Biol. 2007;33:187-
96. 
Bouakaz A, Versluis M, de Jong N, High-speed optical observations of contrast 
agent destruction. Ultrasound Med. Biol. 2005;31:391-99. 
Bracco, SonoVue package leaflet: information for the user 2011. 
Brewin MP, Pike LC, Rowland DE, Birch MJ, The Acoustic Properties, Centered on 
20 MHz, of an IEC Agar-Based Tissue-Mimicking Material and its 
Temperature, Frequency and Age Dependence. Ultrasound Med. Biol. 
2008;34:1292-306. 
Bridal SL, Roberjot V, Laugier P, Berger G. Attenuation and backscatter coefficient 
measurements from 2 to 60 MHz using backscattered RF signals from a tissue-
mimicking phantom. Ultrasonics Symposium, 1996. Proceedings., 1996 IEEE, 
1996. pp. 1151-54 vol.2. 
Bristol-MyersSquibb. Luminity Summary of the European Public Assessment Report 
(EPAR) 2006. 
Browne JE, Ramnarine KV, Watson AJ, Hoskins PR, Asses ment of the acoustic 
properties of common tissue-mimicking test phantoms. Ultrasound Med. Biol. 
2003;29:1053-60. 
Browne JE, Watson AJ, Gibson NM, Dudley NJ, Elliott AT, Objective 
measurements of image quality. Ultrasound Med. Biol. 2004;30:229. 
Browning RJ, Mulvana H, Tang M, Hajnal JV, Wells DJ, Eckersley RJ, Influence of 
Needle Gauge On In Vivo Ultrasound and Microbubble-M diated Gene 
Transfection. Ultrasound Med. Biol. 2011;37:1531-37. 
 
 208 
Bruce M, Averkiou M, Tiemann K, Lohmaier S, Powers J, Beach K, Vascular flow 
and perfusion imaging with ultrasound contrast agents. Ultrasound Med. Biol. 
2004;30:735-43. 
Burns PN, Becher H. Handbook of contrast echocardiog aphy: Frankfurt: Springer 
Verlag, 2000. 
Burns PN, Wilson SR, Simpson DH, Pulse inversion imaging of liver blood flow: 
improved method for characterizing focal masses with microbubble contrast. 
Investigative radiology 2000;35:58. 
Butler M, B. , Thomas D, H. , Pye S, D. , Moran C, M. , McDicken WN, Sboros V, 
The acoustic response from individual attached and u attached rigid shelled 
microbubbles. Applied Physics Letters 2008;93:223906. 
Cannon LM, Fagan AJ, Browne JE, Novel Tissue Mimicking Materials for High 
Frequency Breast Ultrasound Phantoms. Ultrasound Med. Biol. 2011;37:122-
35. 
Catalano O, Aiani L, Barozzi L, Bokor D, De Marchi A, Faletti C, Maggioni F, 
Montanari N, Orlandi P, Siani A, Sidhu P, Thompson P, Valentino M, Ziosi A, 
Martegani A, CEUS in abdominal trauma: multi-center study. Abdom. Imaging 
2009;34:225-34. 
Chen X, Wang J, Villanueva FS. Ultra fast brightfield and fluorescence imaging. 
17th EUROPEAN SYMPOSIUM ON ULTRASOUND CONTRAST 
IMAGING. Rotterdam,Netherland, 2012. 
Cherin E, Needles A, Stapleton S, Williams R, Foster FS, Tavakkoli J, Mehi J. 
Microbubble contrast agent destruction using 20-25 MHz ultrasound. 
Ultrasonics Symposium, 2005 IEEE, 2005. pp. 751-54. 
Chetty K, Stride E, Sennoga CA, Hajnal JV, Eckersley RJ, High-speed optical 
observations and simulation results of SonoVue microbubbles at low-pressure 
insonation. Ultrasonics, Ferroelectrics and Frequency Control, IEEE 
Transactions on 2008;55:1333-42. 
Cheung K, Couture O, Bevan PD, Cherin E, Williams R, Burns PN, Foster FS, In 
vitro characterization of the subharmonic ultrasound signal from Definity 




Chih-Kuang Y, Shin-yuan S, Che-chou S, Microbubble destruction by dual-high-
frequency ultrasound excitation. Ultrasonics, Ferroelectrics and Frequency 
Control, IEEE Transactions on 2009;56:1113-18. 
Chin CT, Lancee C, Borsboom J, Mastik F, Frijlink ME, de Jong N, Versluis M, 
Lohse D, Brandaris 128: A digital 25 million frames per second camera with 
128 highly sensitive frames. Rev. Sci. Instrum. 2003;74:5026-34. 
Chomas J, Dayton P, May D, Ferrara K, Nondestructive subharmonic imaging. 
Ultrasonics, Ferroelectrics and Frequency Control, IEEE Transactions on 
2002;49:883-92. 
Chomas JE, Dayton P, Allen J, Morgan K, Ferrara KW, Mechanisms of contrast 
agent destruction. Ultrasonics, Ferroelectrics and Frequency Control, IEEE 
Transactions on 2001;48:232-48. 
Claudon M, Cosgrove D, Albrecht T, Bolondi L, Bosio M, Calliada F, Correas JM, 
Darge K, Dietrich C, D'Onofrio M, Evans DH, Filice C, Greiner L, Jager K, 
Jong Nd, Leen E, Lencioni R, Lindsell D, Martegani A, Meairs S, Nolsoe C, 
Piscaglia F, Ricci P, Seidel G, Skjoldbye B, Solbiati L, Thorelius L, Tranquart 
F, Weskott HP, Whittingham T, Guidelines and Good Clinical Practice 
Recommendations for Contrast Enhanced Ultrasound (CEUS) - Update 2008. 
Ultraschall in Med 2008;29:28-44. 
Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsoe CP, Piscaglia F, 
Wilson SR, Barr RG, Chammas MC, Chaubal NG, Chen M-H, Clevert DA, 
Correas JM, Ding H, Forsberg F, Fowlkes JB, Gibson RN, Goldberg BB, 
Lassau N, Leen ELS, Mattrey RF, Moriyasu F, Solbiati L, Weskott H-P, Xu H-
X, Guidelines and Good Clinical Practice Recommendations for Contrast 
Enhanced Ultrasound (CEUS) in the Liver-Update 2012: A WFUMB-
EFSUMB Initiative in Cooperation With Representatives of AFSUMB, AIUM, 
ASUM, FLAUS and ICUS. Ultrasound Med. Biol. 2012. 
Correas J-M, Bridal L, Lesavre A, Méjean A, Claudon M, Hélénon O, Ultrasound 
contrast agents: properties, principles of action, tolerance, and artifacts. 
European Radiology 2001;11:1316-28. 




Culjat MO, Goldenberg D, Tewari P, Singh RS, A Review of Tissue Substitutes for 
Ultrasound Imaging. Ultrasound Med. Biol. 2010;36:861-73. 
De Jong N, Acoustic properties of ultrasound contrast gents. Ph.D thesis. 
Rotterdam: Erasmus University 1993. 
de Jong N, Emmer M, van Wamel A, Versluis M, Ultrasonic characterization of 
ultrasound contrast agents. Medical and Biological Engineering and Computing 
2009;47:861-73. 
de Jong N, Frinking PJA, Bouakaz A, Ten Cate FJ, Detection procedures of 
ultrasound contrast agents. Ultrasonics 2000;38:87-92. 
de Jong N, Hoff L, Skotland T, Bom N, Absorption and scatter of encapsulated gas 
filled microspheres: Theoretical considerations and some measurements. 
Ultrasonics 1992;30:95-103. 
Del Grosso VA, Mader CW, Speed of sound in pure water. The Journal of the 
Acoustical Society of America 1972;52:1442. 
Di X, Chan KKC, Leung HW, Huie CW, Fingerprint profiling of acid hydrolyzates 
of polysaccharides extracted from the fruiting bodies and spores of Lingzhi by 
high-performance thin-layer chromatography. J. Chromatogr. A 2003;1018:85-
95. 
Dobrucki LW, Sinusas AJ. Cardiovascular molecular imaging. Semin. Nucl. Med., 
2005. p. 73. 
Doinikov AA, Bouakaz A, Review of shell models for contrast agent microbubbles. 
Ultrasonics, Ferroelectrics and Frequency Control, IEEE Transactions on 
2011;58:981-93. 
Dollet B, van der Meer SM, Garbin V, de Jong N, Lohse D, Versluis M, 
Nonspherical Oscillations of Ultrasound Contrast Agent Microbubbles. 
Ultrasound Med. Biol. 2008;34:1465-73. 
Dong F, Madsen EL, MacDonald MC, Zagzebski JA, Nonlinearity parameter for 
tissue-mimicking materials. Ultrasound Med. Biol. 1999;25:831-38. 
Duck FA. Physical properties of tissue: a comprehensive reference book. London: 
Academic Press, 1990. 




Duck FA, Baker AC, Starritt HC. Ultrasound in medicine: Taylor & Francis, 1998. 
Duineveld PC, Bouncing and Coalescence of Bubble Pairs Rising at High Reynolds 
Number in Pure Water or Aqueous Surfactant Solutions. Applied Scientific 
Research 1997;58:409-39. 
Edler I, Lindström K, The history of echocardiography. Ultrasound Med. Biol. 
2004;30:1565-644. 
Eller A, Flynn HG, Generation of Subharmonics of Order One-Half by Bubbles in a 
Sound Field. The Journal of the Acoustical Society of America 1969;46:722. 
Faez T, Goertz D, De Jong N, Characterization of Definity(TM) Ultrasound Contrast 
Agent at Frequency Range of 5-15 MHz. Ultrasound Med. Biol. 2011;37:338-
42. 
Feshitan JA, Chen CC, Kwan JJ, Borden MA, Microbubble size isolation by 
differential centrifugation. Journal of Colloid and Interface Science 
2009;329:316-24. 
Fish P. Physics and instrumentation of diagnostic medical ultrasound: John Wiley & 
Sons Inc, 1990. 
Forsberg F, Liu JB, Burns PN, Merton DA, Goldberg BB, Artifacts in ultrasonic 
contrast agent studies. Journal of ultrasound in medicine 1994;13:357-65. 
Forsberg F, Shi WT, Goldberg BB, Subharmonic imaging of contrast agents. 
Ultrasonics 2000;38:93-98. 
Foster FS, Hossack J, Adamson SL, Micro-ultrasound for preclinical imaging. 
Interface Focus 2011;1:576-601. 
Foster FS, Pavlin CJ, Harasiewicz KA, Christopher DA, Turnbull DH, Advances in 
ultrasound biomicroscopy. Ultrasound Med. Biol. 2000;26:1-27. 
Frenkel V, Ultrasound mediated delivery of drugs and genes to solid tumors. 
Advanced Drug Delivery Reviews 2008;60:1193-208. 
Fry WJ, Dunn F, Ultrasonic intensity gain by composite transducers. The Journal of 
the Acoustical Society of America 1962;34:188-92. 
Goertz DE. High frequency flow imaging of the microirculation. Toronto: 
University of Toronto, 2002. 
Goertz DE, Cherin E, Needles A, Karshafian R, Brown AS, Burns PN, Foster FS, 
High frequency nonlinear B-scan imaging of microbuble contrast agents. 
 
 212 
Ultrasonics, Ferroelectrics and Frequency Control, IEEE Transactions on 
2005;52:65-79. 
Goertz DE, de Jong N, van der Steen AFW, Attenuation and Size Distribution 
Measurements of Definity(TM) and Manipulated Definity(TM) Populations. 
Ultrasound Med. Biol. 2007;33:1376-88. 
Goertz DE, Frijlink M, Bouakaz A, Chin CT, de Jong N, van der Steen AWF. The 
effects of bubble size on nonlinear scattering from microbubbles. Ultrasonics, 
2003 IEEE Symposium on, 2003. pp. 1503-06 Vol.2. 
Goertz DE, Frijlink ME, de Jong N, van der Steen AFW, Nonlinear intravascular 
ultrasound contrast imaging. Ultrasound Med. Biol. 2006;32:491-502. 
Goertz DE, Frijlink ME, Tempel D, Bhagwandas V, Gisolf A, Krams R, de Jong N, 
van der Steen AFW, Subharmonic Contrast Intravasculr U trasound for Vasa 
Vasorum Imaging. Ultrasound Med. Biol. 2007;33:1859-72. 
Goertz DE, Needles A, Burns PN, Foster FS, High-frequency, nonlinear flow 
imaging of microbubble contrast agents. Ultrasonics, Ferroelectrics and 
Frequency Control, IEEE Transactions on 2005;52:495-502. 
González RC, Woods RE. Digital Image Processing: Prentice Hall, 2001. 
Gorce J, Arditi M, Schneider M, Influence of Bubble Size Distribution on the 
Echogenicity of Ultrasound Contrast Agents: A Study of SonoVue (TM). 
Investigative radiology 2000;35:661. 
Gramiak R, Shah PM, Echocardiography of the Aortic Root. Investigative Radiology 
1968;3:356-66. 
Greis C, Technology overview: SonoVue (Bracco, Milan). European Radiology 
Supplements 2004;14:P11-P15. 
Guan J, Matula TJ, Using light scattering to measure the response of individual 
ultrasound contrast microbubbles subjected to pulsed ultrasound in vitro. The 
Journal of the Acoustical Society of America 2004;116:2832. 
Guiot C, Pastore G, Napoleone M, Gabriele P, Trotta M, Cavalli R, Thermal 
response of contrast agent microbubbles: Preliminary results from physico-




Hall TJ, Bilgen M, Insana MF, Krouskop TA, Phantom materials for elastography. 
Ultrasonics, Ferroelectrics and Frequency Control, IEEE Transactions on 
1997;44:1355-65. 
Harvey CJ, Blomley MJK, Eckersley RJ, Cosgrove DO, evelopments in ultrasound 
contrast media. European Radiology 2001;11:675-89. 
Harvey CJ, Blomley MKJ, Eckersley RJ, Cosgrove DO, evelopments in ultrasound 
contrast media. European Journal of Radiology 2000;11:675-89. 
Heaton DA, Golding S, Bradley CP, Dawson TA, Cai S, Channon KM, Paterson DJ, 
Targeted nNOS gene transfer into the cardiac vagus rapidly increases 
parasympathetic function in the pig. J. Mol. Cell. Cardiol. 2005;39:159-64. 
Helfield BL, Cherin E, Foster FS, Goertz DE, Investiga ing the Subharmonic 
Response of Individual Phospholipid Encapsulated Microbubbles at High 
Frequencies: A Comparative Study of Five Agents. Ultrasound Med. Biol. 
2012;38:846-63. 
Helfield BL, Huo X, Williams R, Goertz DE, The Effect of Preactivation Vial 
Temperature on the Acoustic Properties of DefinityTM. Ultrasound Med. Biol. 
2012. 
Hill CR. Physical Principles of Medical Ultrasonics. 1st edn: Ellis Horwood, 1986. 
Hoff L. Acoustic characterization of contrast agents for medical ultrasound imaging: 
Kluwer Academic Publishers, 2001. 
Hoskins P. Diagnostic ultrasound: physics and equipment: Cambridge Univ Pr, 2002. 
Hoskins PR, Martin K, Thrush A. Diagnostic ultrasound: physics and equipment: 
Cambridge University Press, 2010. 
Howard CM, Forsberg F, Minimo C, Liu JB, Merton DA, Claudio PP, Ultrasound 
guided site specific gene delivery system using adenoviral vectors and 
commercial ultrasound contrast agents. J. Cell. Physiol. 2006;209:413-21. 
Huang YP, Zheng YP, Leung SF, Choi APC, High Frequency Ultrasound 
Assessment of Skin Fibrosis: Clinical Results. Ultrasound Med. Biol. 
2007;33:1191-98. 
Humphrey VF, Nonlinear propagation in ultrasonic fields: measurements, modelling 
and harmonic imaging. Ultrasonics 2000;38:267-72. 
 
 214 
Huo E, Helfield B, Goertz D, Scaling of viscoelastic shell properties of lipid 
encapsulated microbubbles with frequency. The Journal of the Acoustical 
Society of America 2010;128:2280. 
IEC. Ultrasonics – Flow measurement systems – Flow test object. Standard 61685. 
London: International Electrotechnical Commission 2001. 
Inglis S, Ramnarine KV, Plevris JN, McDicken WN, An a thropomorphic tissue-
mimicking phantom of the oesophagus for endoscopic ultrasound. Ultrasound 
Med. Biol. 2006;32:249-59. 
Insana M, Wagner RF, Brown DG, Hall TJ, Describing small-scale structure in 
random media using pulse-echo ultrasound. Journal of the Acoustical Society 
of America 1990;87. 
Janssen BJA, Smits JFM, Autonomic control of blood pressure in mice: basic 
physiology and effects of genetic modification. American Journal of 
Physiology - Regulatory, Integrative and Comparative Physiology 
2002;282:R1545-R64. 
Kabalnov A, Klein D, Pelura T, Schutt E, Weers J, Dissolution of multicomponent 
microbubbles in the bloodstream: 1. theory. Ultrasound Med. Biol. 
1998;24:739-49. 
Kagadis GC, Loudos G, Katsanos K, Langer SG, Nikiforidis GC, In vivo small 
animal imaging: current status and future prospects. Med. Phys. 2010;37:6421. 
Kaufmann BA, Wei K, Lindner JR, Contrast Echocardiography. Curr. Probl. Cardiol. 
2007;32:51-96. 
Kaye GWC, Laby TH. Tables of Physical and Chemical Constants 16th edition. 
Essex, England: Longman, 1995. 
Keller JB, Miksis M, Bubble oscillations of large amplitude. The Journal of the 
Acoustical Society of America 1980;68:628. 
Kennedy JE, High-intensity focused ultrasound in the reatment of solid tumours. 
Nature Reviews Cancer 2005;5:321-27. 
Kennedy JE, Ter Haar GR, Cranston D, High intensity focused ultrasound: surgery 
of the future? Br. J. Radiol. 2003;76:590-99. 
Khismatullin DB, Resonance frequency of microbubbles: Effect of viscosity. Journal 
of the Acoustical Society of America 2004;116:1463-73. 
 
 215 
King RL, Herman BA, Maruvada S, Wear KA, Harris GR. Development of a HIFU 
phantom, 2007. pp. 351-56. 
Kips JG, Segers P, Van Bortel LM, Identifying the vulnerable plaque: A review of 
invasive and non-invasive imaging modalities. Artery Research 2008;2:21-34. 
Kofler JM, Madsen EL, Improved method for determining resolution zones in 
ultrasound phantoms with spherical simulated lesions. Ultrasound Med. Biol. 
2001;27:1667-76. 
Kwan JJ, Borden MA, Microbubble Dissolution in a Multigas Environment. 
Langmuir 2010;26:6542-48. 
Lantheus Medical Imaging. Prescribing Information of Definity vial for (perflutren 
lipid microsphere) injectable suspension, In: Inc LMI, ed: Lantheus Medical 
Imaging Inc, 2011. 
Leen E. Ultrasound contrast harmonic imaging of abdominal organs. Seminars in 
Ultrasound, CT, and MRI: Elsevier, 2001. pp. 11-24. 
Leen E, Ceccotti P, Kalogeropoulou C, Angerson WJ, Moug SJ, Horgan PG, 
Prospective multicenter trial evaluating a novel method of characterizing focal 
liver lesions using contrast-enhanced sonography. Am. J. Roentgenol. 
2006;186:1551-59. 
Leighton TG. The acoustic bubble: Academic Press, 1997. 
Leighton TG, Dumbrell HA, New approaches to contrast agent modelling. Journal of 
Physics: Conference Series 2004;1:91. 
Leverett LB, Hellums JD, Alfrey CP, Lynch EC, Red blood cell damage by shear 
stress. Biophys. J. 1972;12:257-73. 
Li Y, Chen J, Lun SY, Rui XS, Efficient pyruvate production by a multi-vitamin 
auxotroph of Torulopsis glabrata: key role and optimization of vitamin levels. 
Appl. Microbiol. Biotechnol. 2001;55:680-85. 
Lindner JR, Evolving applications for contrast ultrasound. The American Journal of 
Cardiology 2002;90:72-80. 
Liu Y, Miyoshi H, Nakamura M, Encapsulated ultrasound microbubbles: 




Lizzi FL, Greenebaum M, Feleppa EJ, Elbaum M, Coleman DJ, Theoretical 
framework for spectrum analysis in ultrasonic tissue characterization. The 
Journal of the Acoustical Society of America 1983;73:1366. 
Lockwood GR, Ryan LK, Hunt JW, Foster FS, Measurement of the ultrasonic 
properties of vascular tissues and blood from 35-65 MHz. Ultrasound Med. 
Biol. 1991;17:653. 
Looney P. Theoretical modelling of ultrasound contrast agents. Edinburgh: The 
University of Edinburgh, 2011. 
Lotsberg O, Hovem JM, Aksum B, Experimental observation of subharmonic 
oscillations in Infoson bubbles. The Journal of the Acoustical Society of 
America 1996;99:1366. 
Lubbers J, Graaff R, A simple and accurate formula for the sound velocity in water. 
Ultrasound Med. Biol. 1998;24:1065-68. 
MacGillivray TJ, Ellis W, Pye SD, The resolution integral: visual and computational 
approaches to characterizing ultrasound images. Physics in Medicine and 
Biology 2010;55:5067. 
Madsen EL, Deaner ME, Mehi J, Properties of Phantom Tissuelike 
Polymethylpentene in the Frequency Range 20-70 MHz. Ultrasound Med. Biol. 
2011;37:1327-39. 
Malvern Instruments Ltd., Operators Guide. 1999. 
Marmottant P, Van Der Meer S, Emmer M, Versluis M, De Jong N, Hilgenfeldt S, 
Lohse D, A model for large amplitude oscillations of coated bubbles 
accounting for buckling and rupture. The Journal of the Acoustical Society of 
America 2005;118:3499. 
Marsh J, N. , Hughes M, S. , Hall C, S. , Lewis S, H. Trousil R, L., Brandenburger 
G, H. , Levene H, Miller J, G. , Frequency and concentration dependence of the 
backscatter coefficient of the ultrasound contrast agent Albunex. The Journal of 
the Acoustical Society of America 1998;104:1654-66. 
Martinoli C, Pretolesi F, Crespi G, Bianchi S, Gandolfo N, Valle M, Derchi LE, 




Maruvada S, Shung KK, Wang S-H, High-frequency backscatter and attenuation 
measurements of selected bovine tissues between 10 a d 30 MHz. Ultrasound 
Med. Biol. 2000;26:1043-49. 
McDicken WN. Diagnostic ultrasonics: principles and use of instruments: WB 
Saunders Company, 1991. 
Miller DL, Dou C, Wiggins RC, Wharram BL, Goyal M, Williams AR, An in vivo 
rat model simulating imaging of human kidney by diagnostic ultrasound with 
gas-body contrast agent. Ultrasound Med. Biol. 2007;33:129-35. 
Montgomery DC. Design and analysis of experiments: Wiley, 2008. 
Moran CM, Bush NL, Bamber JC, Ultrasonic propagation properties of excised 
human skin. Ultrasound Med. Biol. 1995;21:1177-90. 
Moran CM, Butler MB, Sboros V, Anderson T, Anderson D, McDicken WN. High 
frequency characterisation of commercial contrast agents. Ultrasonics 
Symposium, 2005 IEEE, 2005. pp. 1996-98. 
Moran CM, Pye SD, Ellis W, Janeczko A, Morris KD, McNeilly AS, Fraser HM, A 
Comparison of the Imaging Performance of High Resolution Ultrasound 
Scanners for Preclinical Imaging. Ultrasound Med. Biol. 2011;37:493-501. 
Moran CM, Thomson AJW, Rog-Zielinska E, Gray GA, High resolution 
echocardiography in the assessment of cardiac physiology and disease in 
preclinical models. Exp. Physiol. 2012. 
Moran CM, Watson RJ, Fox KAA, McDicken WN, In vitro acoustic characterisation 
of four intravenous ultrasonic contrast agents at 30 MHz. Ultrasound Med. 
Biol. 2002;28:785-91. 
Morse PMC, Ingard KU. Theoretical acoustics: Princeton Univ Pr, 1986. 
Mulvana H, Stride E, Hajnal JV, Eckersley RJ, Temperature Dependent Behavior of 
Ultrasound Contrast Agents. Ultrasound Med. Biol. 2010;36:925-34. 
Mulvana H, Stride E, Tang M-X, Hajnal JV, Eckersley RJ, The Influence of Gas 
Saturation on Microbubble Stability. Ultrasound Med. Biol. 2012;38:1097-100. 
Mulvana H, Stride E, Tang M, Hajnal JV, Eckersley R, Temperature-Dependent 
Differences in the Nonlinear Acoustic Behavior of Ultrasound Contrast Agents 




Narayana PA, Ophir J, The measurement of attenuation in nonlinearly attenuating 
media by the zero crossing method. Ultrasound Med. Biol. 1984;10:715-18. 
Needles A, Arditi M, Rognin NG, Mehi J, Coulthard T, Bilan-Tracey C, Gaud E, 
Frinking P, Hirson D, Foster FS, Nonlinear Contrast Imaging with an Array-
Based Micro-Ultrasound System. Ultrasound Med. Biol. 2011;36:2097-106. 
O'Neil HT, Theory of focusing radiators. The Journal of the Acoustical Society of 
America 1949;21:516. 
Obriot J, Ge J, Bose TK, St-Arnaud JM, Determination f the density from 
simultaneous measurements of the refractive index and the dielectric constant 
of gaseous CH4, SF6, and CO2. Fluid Phase Equilibria 1993;86:314-50. 
Ophir J, Alam SK, Garra BS, Kallel F, Konofagou EE, Krousko T, Merritt CRB, 
Righett R, Souchon R, Srinivasan S, Elastography: imag ng the elastic 
properties of soft tissues with ultrasound. Journal of Medical Ultrasonics 
2002;29:156. 
Ophir J, Parker KJ, Contrast agents in diagnostic ul rasound. Ultrasound Med. Biol. 
1989;15:319-33. 
Patton CA, Harris GR, Phillips RA, Output levels and bioeffects indices from 
diagnostic ultrasound exposure data reported to the FDA. IEEE Transactions 
on Ultrasonics Ferroelectrics and Frequency Control 1994;41:353-59. 
Pinkerton JMM, The absorption of ultrasonic waves in liquids and its relation to 
molecular constitution. Proceedings of the Physical Society. Section B 
1949;62:129. 
Piscaglia F, Nolsoe C, Dietrich CF, Cosgrove DO, Gilja OH, Bachmann Nielsen M, 
Albrecht T, Barozzi L, Bertolotto M, Catalano O, The EFSUMB Guidelines 
and Recommendations on the Clinical Practice of Contrast Enhanced 
Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med. 
2011;33:33. 
Porter TM, Smith DAB, Holland CK, Acoustic techniques for assessing the Optison 
destruction threshold. Journal of ultrasound in medicine 2006;25:1519-29. 
Postema M. Medical Bubbles Veenendaal, Nertherland, 2004. 
 
 219 
Postema M, Marmottant P, Lancee CT, Hilgenfeldt S, Jong Nd, Ultrasound-induced 
microbubble coalescence. Ultrasound in Medicine & Biology 2004;30:1337-
44. 
Postema M, Van Wamel A, Lancee CT, De Jong N, Ultrasound-induced 
encapsulated microbubble phenomena. Ultrasound Med. Biol. 2004;30:827-40. 
Preston RC. Output Measurements for Medical Ultrasound. Teddington, UK: 
Springer-Verlag, 1991. 
Pu G, Borden MA, Longo ML, Collapse and Shedding Transitions in Binary Lipid 
Monolayers Coating Microbubbles. Langmuir 2006;22:2993-99. 
Qin S, Caskey C, F. , Ferrara K, W. , Ultrasound contrast microbubbles in imaging 
and therapy: physical principles and engineering. Physics in Medicine and 
Biology 2009:R27. 
Quaia E, Microbubble ultrasound contrast agents: an update. European Radiology 
2007;17:1995-2008. 
Quaia E, Whittingham T. Contrast-Specific Imaging Techniques: Technical 
Perspective. Contrast Media in Ultrasonography: Springe  Berlin Heidelberg, 
2005. pp. 43-70. 
Ramnarine KV, Anderson T, Hoskins PR, Construction and geometric stability of 
physiological flow rate wall-less stenosis phantoms. Ultrasound Med. Biol. 
2001;27:245-50. 
Rhee S. High frequency (IVUS) ultrasound transducer technology - applications and 
challenges. Applications of Ferroelectrics, 2007 ISAF 2007 Sixteenth IEEE 
International Symposium, 2007. pp. 856-57. 
Rijsterborgh H, Mastik F, Lancee CT, Verdouw P, Roelandt J, Bom N, Ultrasound 
myocardial integrated backscatter signal processing: Frequency domain versus 
time domain. Ultrasound Med. Biol. 1993;19:211-19. 
Saijo Y, Sasaki H, Okawai H, Nitta S-i, Tanaka M, Acoustic properties of 
atherosclerosis of human aorta obtained with high-frequency ultrasound. 
Ultrasound Med. Biol. 1998;24:1061-64. 
Sarkar K, Katiyar A, Jain P, Growth and Dissolution f an Encapsulated Contrast 




Sboros V, Response of contrast agents to ultrasound. Advanced Drug Delivery 
Reviews 2008;60:1117-36. 
Schneider M, SonoVue, a new ultrasound contrast agent. European Radiology 
1999;9:S347-S48. 
Sennoga CA, Yeh JSM, Alter J, Stride E, Nihoyannopoulos P, Seddon JM, Haskard 
DO, Hajnal JV, Tang M-X, Eckersley RJ, Evaluation of Methods for Sizing 
and Counting of Ultrasound Contrast Agents. Ultrasound Med. Biol. 2012. 
Shankar PM, Krishna PD, Newhouse VL, Advantages of Subharmonic Over Second 
Harmonic Backscatter for Contrast-To-Tissue Echo Enhancement. Ultrasound 
Med. Biol. 1998;24:395-99. 
Shaw A, Hekkenberg R. Standards to support performance evaluation for diagnostic 
ultrasound imaging equipment. NPL Report AC 2. Teddington, Middlesex, 
UK: National Physical Laboratory, 2007. 
Shi W, Forsberg F, Raichlen J, Needleman L, Goldberg B, Pressure dependence of 
subharmonic signals from contrast microbubbles. Ultrasound Med. Biol. 
1999;25:275-83. 
Sidhu PS, Allan PL, Cattin F, Cosgrove DO, Davies AH, Do DD, Karakagil S, 
Langholz J, Legemate DA, Martegani A, Diagnostic efficacy of SonoVue, a 
second generation contrast agent, in the assessment of x racranial carotid or 
peripheral arteries using colour and spectral Doppler u trasound: a multicentre 
study. Br. J. Radiol. 2006;79:44-51. 
Silverman RH, High-resolution ultrasound imaging of the eye – a review. Clinical & 
Experimental Ophthalmology 2009;37:54-67. 
Silverman RH, Ketterling JA, Mamou J, Coleman DJ, Improved high-resolution 
ultrasonic imaging of the eye. Archives of ophthalmology 2008;126:94. 
Sirsi S, Feshitan J, Kwan J, Homma S, Borden M, Effect of Microbubble Size on 
Fundamental Mode High Frequency Ultrasound Imaging in Mice. Ultrasound 
Med. Biol. 2010;36:935-48. 
Smith DAB, Porter TM, Martinez J, Huang S, MacDonald RC, McPherson DD, 
Holland CK, Destruction Thresholds of Echogenic Liposomes with Clinical 
Diagnostic Ultrasound. Ultrasound Med. Biol. 2007;33:797-809. 
 
 221 
Sprague MR, Cherin E, Foster FS, A new transducer receive transfer function 
calibration method: application to microbubble backscattering cross-section 
measurements at high frequency. Ultrasonics, Ferroelectrics and Frequency 
Control, IEEE Transactions on 2011;58:1159-68. 
Sprague MR, Chérin E, Goertz DE, Foster FS, Nonlinear Emission from Individual 
Bound Microbubbles at High Frequencies. Ultrasound Med. Biol. 2010;36:313-
24. 
Stapleton S, Goodman H, Zhou Y-Q, Cherin E, Henkelman RM, Burns PN, Foster 
FS, Acoustic and Kinetic Behaviour of Definity in Mice Exposed to High 
Frequency Ultrasound. Ultrasound Med. Biol. 2009;35:296-307. 
Stapleton SA, Needles A, Henderson E, Foster FS. Concentration Requirements for 
Subharmonic Quantitative Contrast Enhanced High Frequency Ultrasound 
Flow Studies. Ultrasonics Symposium, 2007. IEEE, 2007. pp. 1061-64. 
Stride E, Saffari N, On the destruction of microbuble ultrasound contrast agents. 
Ultrasound Med. Biol. 2003;29:563-73. 
Stride E, Saffari N, Investigating the significance of multiple scattering in ultrasound 
contrast agent particle populations. IEEE Transactions on Ultrasonics 
Ferroelectrics and Frequency Control 2005;52:2332-45. 
Sun C, Pye SD, Browne JE, Janeczko A, Ellis B, Butler MB, Sboros V, Thomson 
AJW, Brewin MP, Earnshaw CH, Moran CM, The Speed of S und and 
Attenuation of an IEC Agar-Based Tissue-Mimicking Material for High 
Frequency Ultrasound Applications. Ultrasound Med. Biol. 2012;38:1262-70. 
Takeuchi M, Ogunyankin K, Pandian NG, McCreery TP, Sweitzer RH, Caldwell VE, 
Unger EC, Avelar E, Sheahan M, Connolly R, Enhanced visualization of 
intravascular and left atrial appendage thrombus with the use of a thrombus-
targeting ultrasonographic contrast agent (MRX-408A1): In vivo experimental 
echocardiographic studies. J. Am. Soc. Echocardiogr. 1999;12:1015-21. 
Talu E, Powell RL, Longo ML, Dayton PA, Needle Size and Injection Rate Impact 
Microbubble Contrast Agent Population. Ultrasound Med. Biol. 2008;34:1182-
85. 
Tang M-X, Eckersley RJ, Noble JA, Pressure-dependent attenuation with 
microbubbles at low mechanical index. Ultrasound Med. Biol. 2005;31:377-84. 
 
 222 
Teirlinck CJPM, Bezemer RA, Kollmann C, Lubbers J, Hoskins PR, Fish P, 
Fredfeldt K-E, Schaarschmidt UG, Development of an example flow test object 
and comparison of five of these test objects, constructed in various laboratories. 
Ultrasonics 1998;36:653-60. 
Teirlinck ICJPM, Validation of a flow Doppler test object for diagnostic ultrasound 
scanners. 1997. 
ter Haar G, Therapeutic applications of ultrasound. Progress in Biophysics and 
Molecular Biology 2007;93:111-29. 
ter Haar G, Harnessing the interaction of ultrasound with tissue for therapeutic 
benefit: high-intensity focused ultrasound. Ultrasound Obstet. Gynecol. 
2008;32:601-04. 
Thomas DH. Acoustic investigation of microbubble response to medical imaging 
ultrasound pulses. The University of Edinburgh: The University of Edinburgh, 
2009. 
Thomas DH, Looney P, Steel R, Pelekasis N, McDicken WN, Anderson T, Sboros 
V, Acoustic detection of microbubble resonance. Applied Physics Letters 
2009;94:243902. 
Treeby BE, Zhang EZ, Thomas AS, Cox BT, Measurement of he Ultrasound 
Attenuation and Dispersion in Whole Human Blood andits Components From 
0-70 MHz. Ultrasound Med. Biol. 2011;37:289-300. 
Uhlendorf V, Hoffmann C. Nonlinear acoustical response of coated microbubbles in 
diagnostic ultrasound. Ultrasonics Symposium, 1994. Proceedings., 1994 
IEEE: IEEE, 1994. pp. 1559-62. 
Unger EC, Hersh E, Vannan M, Matsunaga TO, McCreery T, Local drug and gene 
delivery through microbubbles. Progress in Cardiovascular Diseases 
2001;44:45-54. 
Unger EC, Matsunaga TO, McCreery T, Schumann P, Sweitzer R, Quigley R, 
Therapeutic applications of microbubbles. European Journal of Radiology 
2002;42:160-68. 
Van Dongen KW, Verweij MD, Sensitivity study of the acoustic nonlinearity 
parameter for measuring temperatures during High Intensity Focused 
 
 223 
Ultrasound treatment. Journal of the Acoustical Society of America 
2008;123:3225. 
Van Liew HD, Burkard ME, Behavior of bubbles of slow y permeating gas used for 
ultrasonic imaging contrast. Investigative radiology 1995;30:315. 
Van Trees HL. Optimum array processing: Wiley NY, 200 . 
VisualSonics, VisualSonics® Vevo 770® Digital RF Option Operator Manual. 2006. 
VisualSonics, VisualSonics® Vevo 770® High-Resolution Imaging System Operator 
Manual. 2006. 
Visualsonics, Vevo MicroMarker™ Non-Targeted Contras  Agent Kit: Instructions 
and Protocols Rev1.4. 2012. 
Vogt M, Scharenberg R, Moussa G, Sand M, Hoffmann K, Altmeyer P, Ermert H, A 
New High Frequency Ultrasound Skin Imaging System: I aging Properties 
and Clinical in Vivo Results. Acoustical Imaging 2007:137-44. 
Vokurka K, On Rayleigh's model of a freely oscillatng bubble. I. Basic relations. 
Czechoslovak Journal of Physics 1985;35:28-40. 
Vos HJ, Emmer M, de Jong N. Oscillation of single microbubbles at room versus 
body temperature. Ultrasonics Symposium, 2008. IUS 2008. IEEE, 2008. pp. 
982-84. 
Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S, Quantification of 
Myocardial Blood Flow With Ultrasound-Induced Destruction of Microbubbles 
Administered as a Constant Venous Infusion. Circulation 1998;97:473-83. 
Wells PNT. Biomedical ultrasonics: Academic Press New York, 1977. 
Whittingham TA, WFUMB safety symposium on echo-contras  agents: Exposure 
from diagnostic ultrasound equipment relating to cavitation risk. Ultrasound 
Med. Biol. 2007;33:214-23. 
Williams R, Cherin.Emmanuel, Lam.Toby YJ, Tavakkoli  J, Zemp  RJ, Stuart FF, 
Nonlinear ultrasound propagation through layered liquid and tissue-equivalent 
media: computational and experimental results at high frequency. Physics in 
Medicine and Biology 2006;51:5809. 
Wisner ER, Ferrara K, Gabe JD, Patel D, Nyland TG, Short RE, Ottoboni TB, 
Contrast enhanced intermittent power Doppler ultrasound with sub-micron 
bubbles for sentinel node detection. Acad. Radiol. 2002;9:S389-S91. 
 
 224 
Zagzebski JA. Essentials of ultrasound physics: Mosby, 1996. 
Zeqiri B, Hodnett M, Measurements, phantoms, and standardization. Proceedings of 
the Institution of Mechanical Engineers, Part H: Journal of Engineering in 
Medicine 2010;224:375-91. 
Ziayoddin M, Shinde M, Lalitha J, Orthogonal Array Approach for Optimization of 
Carrageenase Production by Solid State Fermentation of Pseudomonas 
aeruginosa ZSL-2. J Microb Biochem Technol 2012;4:096-95. 
Zook JM, Vreeland WN, Effects of temperature, acyl hain length, and flow-rate 
ratio on liposome formation and size in a microfluidic hydrodynamic focusing 
device. Soft Matter 2010;6:1352-60. 
 
 
